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SUMMARY
Section 1.
The effects on pulmonary prostaglandin (PG) synthesis of pulmonary
hypertension and oedema has been studied in an isolated, perfused
lung preparation and in the intact animal.
In order to detect prostaglandin-like substances (PGLS), 10 ml/min
of the venous effluent from the lungs (or carotid arterial blood
in intact animals) superfused a series of smooth muscle tissues
sensitive to prostaglandins and thromboxane A0 : rat stomach strip
(RSS), rat colon (RC), chick rectum (CR) and rabbit aorta (RbA).
Tissues were pretreated with antagonists of catecholamines,
histamine, serotonin and acetylcholine, and were calibrated with
standard doses of PGE„ and PGF„
d dCX*
Nineteen pairs of isolated lungs of rabbit, cat and guinea-pig
were perfused with plasma, whole blood, Krebs Ringer solution (KR)
or 2.7% dextran T70 in KR (KRD) in a recirculating system.
Left atrial pressure (was increased by between 10 and 30 mraHg
for periods of 3-59 min. Gross alveolar oedema developed in all cases.
Only in the (3 ) lungs perfused with KRD was there any release of
PGLS. Neither pulmonary hypertension nor subsequent oedema caused
release of PGs into the venous effluent in plasma, whole blood or
KR perfused lungs.
The lack of PG synthesis in oedema in isolated lungs was confirmed
using radioimmunoassay of PGP in perfusate, tracheal foam and
c oc»
rapidly-frozen lung tissue.
The effect of dextran T70 (KRD) on pulmonary synthesis of PGs was
also studied.
Twelve pairs of isolated rabbit lungs were perfused with KR, KRD
or horse plasma in a recirculating system. The lungs were
ventilated with 5% CO^ in air.
In 6 lungs perfused with KRD, PG-like substances corresponding
to 0.5-1 ng/ml of PGE^ appeared in the venous effluent after
60-150 min of perfusion. Lungs perfused with KR or horse plasma
did not release PGs during perfusion for up to 4 hours.
When dextran-perfused lungs had increased their basal output
of PG, stimuli which normally do not release PGs caused an
additional, transient, release of PGs.
Indomethacin added to the perfusate inhibited the observed cont¬
ractions of the assay tissues, confirming that they were caused
by synthesis of PGs.
Mepyramine maleate, a blocker of histamine ()-receptors, but not
metiamide, an H^-receptor blocker, inhibited the PG-release
during dextran perfusion. This indicates that PG-release is
secondary to liberation of histamine and H^-receptor activation.
In 9 intact anaesthetized cats increased pulmonary hydrostatic
pressure (and occasionally oedema) was induced by inflating a
balloon catheter sewn into the left atrium.
P^ was elevated (18 times) to 21-49 mmHg for between 2 and 26 min.
In each animal release of PGLS was detected.
In a further 3 experiments the pulmonary degrading capacity for
exogenously-infused PG was shown to be unaltered during and after
periods of elevated PT..JjA
The possible relevance of these findings in pulmonary hypertension
is discussed, with special reference to the effects of PGs on
the systemic circulation.
Section 2.
Using the bioassay method, experiments were performed to see if
release from lungs of PGLS caused the pulmonary vaso- and broncho-
V.
constriction which occurs after experimentally-induced pulmonary
microembolism.
Repeated episodes of platelet aggregation were made by i.v. inf¬
usions of collagen in anaesthetized cats ventilated at constant
tidal volume.
Collagen infusions caused lung responses, as judged from the rise
in peak tracheal pressure, and in most cases a transient systemic
hypotension also. PGLS were detected simultaneously — but only
for as long as lung responses could be elicited.
The role of PG3 as mediators of pulmonary smooth muscle constriction
after microembolism is discussed.
Section 3.
Pulmonary oedema was quantified and the sequence of oedema formation
in isolated rabbit lungs ventilated at constant tidal volume was
studied. The relationship between oedema formation and the changes
in dynamic lung compliance (C ) when hydrostatic pulmonary oedema
Li
was induced by raising P was investigated.
l_ir\
Nineteen lungs were fixed by perfusion with a solution of
glutaraldehyde, post-fixed with osmium tetroxide and embedded in
epon. They were examined by light microscopy (LM), and alveolar
oedema was quantified.
In 22 lungs fixed by rapid freezing, i.e. by immersion in liquid
dichlorodifluoro methane (DDM), dried and embedded in paraffin,
both interstitial and alveolar oedema were quantified from sections
seen in LM by a point-counting method.
A correlation was seen between the amount of alveolar oedema and
the fall in observed during perfusion at raised P^ and the
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The lungs are the only organ in the "body through which the
total cardiac output must be pumped, as they lie in series between
the right and left ventricles of the heart. This, and their
particular anatomy of extensive branching of the vascular tree and
their huge capillary bed, accounts for their suitability as the
organ of gas exchange, and also for their more recently discovered
important metabolic function (Bakhle & Vane, 1974).
The lung as an organ of gas exchange
A brief outline of the structure and function of the lungs will
be given here. Lung anatomy has been extensively studied (von Eayek,
I960; Parker, Korsfield & Cumming, 1971; Staub & Storey, 1962) for
example by scanning electron microscopy (Nowell & Tyler, 1971) by
serial sectioning for light and electron microscopy (V/eibel, 1963)
and by three dimensional reconstruction (Ogawa, 1920; Miller, 1937;
Angus & Thurlbeck, 1972).
The tissue framework of the lungs is well organized for the
uptake of oxygen into and the removal of CO^ from the blood. In the
mature lung airways and blood vessels have a characteristic positional
relationship to each other: from the hilum to the septa (periphery)
\
the pulmonary arteries and the airways lie in close proximity while
the pulmonary veins lie between two airway trees. For convenience,
the lungs can be pictured as three functional zones (b'eibel & Gomez,
1962a):
l) The conductive zone consists of bronchi, bronchioles,
2
pulmonary arteries and veins, where airways and blood vessels have
well-developed walls containing smooth muscle, which may play a
regulatory role.
2) The transitory zone, where respiratory bronchioles, alveolar
ducts and sacs lie in close proximity with the pre- and postcapillaries
and where a little gas exchange can take place and
3) The respiratory zone, which contains the alveoli and the
alveolar capillaries in such close contact that gas exchange between
air and blood takes place.
1. The conductive zone. Air enters the trachea at high velocity
but this decreases due to branching of the bronchial tree which
increases total cross sectional area. In the terminal lung units
fresh inspired gas mixes with gas present in the units only by the
kinetic energy of the molecules, and blood gas exchange takes place
by diffusion.
2. The transitory zone. Airways (and pulmonary arteries) branch at
an acute angle (von Hayek, 1953). The branching structure of the
bronchial tree is best described using an order numbering system as
used for river branching. In this context, a branch is an airway
having a single axial direction. Since it is very asymmetrical, the
smallest structures having no alveoli (terminal bronchioles) have
order number 1. Where structures of like number join, the
"confluence" takes the next higher number and where structures of
unlike number join the "confluence" takes the higher of the two
numbers and does not increase ("Strahler system").
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The order number is directly related to the log of the number
of branches. That is, the number of structures increases
exponentially with decreasing order number. The same relationship
exists between the diameter of branches and order number, and between
length and order number.
3• The respiratory zone i.e. the terminal ventilatory unit
Definitions and terminology. A terminal ventilatory unit is
defined as that structure supplied by a single terminal bronchiole.
Beginning proximally the terminal bronchiolar unit consists of a
respiratory bronchiole, alveolar duct and alveolar sac. The terminal
bronchiole is that branch in the airways immediately preceeding a
branch which contains an alveolus in its wall. Walls of the terminal
bronchiole are covered with bronchial epithelium. The first branch
containing an alveolus is a respiratory bronchiole(RB), an airway with
RB or ducts as major outlets. Its walls have a significant ( > 5°/°)
amount of bronchial epithelium and a few alveoli and/or sacs. This
is the first gas exchanging structure.
Branching distal to the terminal bronchiole is probably
dichotamous: each branch gives rise to two daughter branches.
Successive orders of respiratory bronchiole often have increasing
numbers of alveoli. An alveolar duct is an air space with several
outlets: one or more sacs or ducts and one or more alveoli with
limited (< 3r>) patches of bronchial epithelium. The alvoli are
grouped round a central duct in a helical fashion and there may be
several orders of alveolar ducts. An alveolar sac is an airspace
with only alveoli as outlets and an alveolus is a terminal airspace
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without outlets other than pores of Kohn.
There is an arithmetric progression in the number of structures
from the terminal bronchiole to the alveolar sac.
The acinus includes the terminal bronchiole and all other
branches of airways (respiratory bronchioles) and air spaces (alveolar
ducts, alveolar sacs, and alveoli) distal to the terminal bronchiole.
It is defined as that portion oflung parenchyma connected to the
first order respiratory bronchiole (Gamsu, Thurlbeck, Macklem &
Fraser, 197l) and is the site of gas exchange (Miller, 1937; von
Hayek, i960).
Morphometry of the alveolus
The alveoli exist in a honeycombe-like structure, the walls of
which contain the capillary network that is shared between neighbouring
alveoli. Alveoli are suspended by connective tissue fibres (Miller,
1937; Haugaard, 1968) that extend between two anchor points: a
peripheral (septal) fibre system connected to tie pleura and an axial
fibre sleeve, in the "wall" of the alveolar duct, continuous with the
fibrous wall of the conducting airways. The size of the alveoli is
quite homogeneous (Storey & Staub, 1962; Staub, 1963; Klingele &
Staub, 1970) although there is a vertical gradient of alveolar size
in lungs (Section 3). The shape depends on the degree of inflation.
Alveolar size is about 25Cyu in human adults, and the lung contains
approximately 3x10 alveoli (Veibel & Gomez, 1962a & b; Veibel,
1963).
The capillary network forms a continuum throughout large parts
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of the lung, extending across several acini and being supplied and
drained at short intervals by pre- and post- capillaries (Weibel,
1963).
The structure of the interalveolar septum, which is the air-
tissue barrier, has been elucidated by electron microscopy and is
composed of three layers: ' a capillary endothelium, an alveolar
epithelium and a very narrow interstitial space (Bensch, 1967; Weibel,
1969; Bartlett & Remmers, 1971).
Capillary endothelium is a single cell layer sheet of squamous
cells as in muscle capillaries, with a thin layer of cytoplasm round
the nucleus. The cytoplasm contains few organelles but many small
pinocytotic vesicles for macromolecular transport (Bensch, Dominguez
& Liebow,1967; Bruns & Palade, 1968; Palade & Bruns, 1968;
Schneeberger & Karnovsky, 1968) and may be extremely thin (20 nra) in
parts (Weibel, 1972). These cells are metabolically active (see
page 7 ) •
Interstltium:
Nearly half the contact surface between capillary endothelium
and alveolar epithelium is fused basement membranes of the two cell
layers. In parts where basement membranes are separated the space
contains collagen elastic fibres (Ross & Benditts1965; Low, 197l)
and fibroblasts may also be present.
It is possible that mast cells, which are known to exist in the
lungs (Riley, 1961; Hill, 1965) lie in the pulmonary interstitium
(Conradi, Burri, Kapanci, Robinson & Weibel, 1971; Said,et al.,1968).
Leucocytes are only present in pathological conditions. The inter¬
stitium of the interalveolar septum is thus very thin and forms a
connective fibrous network from the alveolar duct wall to the walls
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of small vessels and bronchioles (Weibel, 1967). Sobin, Fung,
Tremer & Rosenquist (1972) have postulated a sheet flow model for
fluid movement in pulmonary interstitium and have suggested that
collagen fibres may lie at right angles to the alveolar septum to
form a post supporting,and accounting for the compliance of the
capillary sheet. However, there is no evidence for this in alveolar
walls.
The interstitium provides the pathway for fluid drainage from
alveolar capillaries to the lymphatics (Fishman & Hecht, 1969) which
lie in the connective tissue surrounding small vessels and bronchioles
(Staub, 1967; Staub, Nagano & Pearce, 1967; Lauweryns, 1970).
The alveolar epithelium
The alveolar epithelium is made up of three cell types:
1) Type I cells are squamous epithelial cells and provide the
lining of the alveolar surface.
2) Type III cells, called alveolar brush cells because of their
brush border of microvilli, are not very common. They are cuboidal
and do not contain osmophilic granules. A function as a receptor
site has been postulated (Keyrick & Reid, 1968).
3) Type II epithelial cells contain osmophilic granules. The
alveolar surface of the cell has abundant microvilli and the cell
contains many organelles, such as mitochondria, endoplasmic reticulum,
ribosomes, and Golgi apparatus. It probably secretes the substances
which form the extracellular lining of the alveoli, a thin surface
film of mucopolysaccharide and surfactant, a surface-tension reducing
monomolecular film of phospholipid (Gil & t.'eibel, 1969-70). It is
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an important lung metabolic cell, as evidenced by its high content
of oxidative enzymes (Tyler & Pearse, 1965).
The lung as a metabolic orp;an
2
The pulmonary capillary bed has a huge surface area (50 m in
adult human) and normally contains 75-100 ml blood, which has the
effect of spreading the blood such that red corpuscles pass through
slowly in single file. Thus blood is in very close contact with the
metabolically-active endothelial cells. Recently attention has been
focused on the role of the lung as a metabolic organ (Said, 1968;
1973; Bakhle & Vane, 1974; Junod, 1974; Fishman & Pietra, 1974a
1974 b )* The importance of the effects of circulating
vasoactive substances must be noted in the context of the lung itself,
as well as their effects in the systemic circulation. For example,
oxygen tension in arterial blood may be altered by substances which
affect the tone of the pulmonary arterioles.
The metabolic function of the lungs consists of three main areas;
inactivation, potentiation and secretion.
(i) Inactivation, binding and depredation
Histamine does not appear to be removed from the pulmonary
circulation of isolated dog lungs (Eiseman, Bryant & Waltuch^l964)•
However, preparations of chopped lungs of guinea-pig and rat are
capable of metabolizing histamine (Bennet, 1965). Thus it is
important to use perfused lungs to determine the fate of circulating
vasoactive substances (Vane, 1969). Johnson (1970) has shown
3
in vivo that injected H histamine rapidly disappears from plasma
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due to uptake and metabolism and accumulates in various tissues in
the body: kidney, liver, ileum, skin and, to a lesser extent, lung,
where uptake was into non-raast cell pools. Johnson also showed
that tissue uptake and/or inactivation of histamine decreases during
anaphylaxis.
5-hydroxytryptamine (!?HT) is removed from the pulmonary
circulation (Gaddum, 1953) and its metabolite, 5-hydroxy indole acetic
acid (5-HIAA) appears in the effluent. This has been shown to occur
in many species: rat, cat, dog, rabbit and man (Alabaster & Bakhle,
1970; Gaddum, Hebb, Silver & Swan, 1953; Thomas & Vane, 1967; Gillis
& Iwasawa, 1972 and Gillis, Green, Cronau & Hammond, 1972). It is .
taken up by the lung (Alabaster & Bakhle, 1970) by a 'carrier mediated
transport system into endothelial cells of large vessels and
capillaries (Strum & Junod, 1972) and oxidised by monoamine oxidase
(MAO).
Noradrenaline (NA) is also removed from the blood by a carrier
mediated process and metabolised by MAO and COKT. 96fo of infused
NA (150yug to 1 mg) was degraded by the isolated dog lung (Siseman,
Bryant & Waltuch (1964), while blood alone degraded 51/^. Uptake is
probably extraneuronal (i.e., uptake 2 (junod, 1974)). However,
adrenaline passes through the pulmonary circulation without change.
The nucleotides ATP and AMP are dephosphorylated during passage
through the lungs, probably by enzymes in caveolae of the endothelial
cells of the lumen (Smith & Ryan, 1970; Ryan & Smith, 197l).
(ii) Potentiation
During passage through the lungs the relatively inactive peptide
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angiotensin I (Ang l) is converted to angiotensin II (Ang II) (2% &
Vane, 1967, 1968; Fanburg & Glazier, 1973; Ryan, Stewart, Leary &
Ledingham, 1970) which is a potent systemic vaso-constrictor. The
enzyme complex, angiotensin converting enzyme (ACE), or Kinase II,
has been located (Smith & Ryan, 1972; Ryan, Smith & Itfeimeyer, 1972;
Caldwell, Seegal, Hsu, Das & Soffer, 1976) in caveolae, on the surface
of the endothelial cells, which open directly into the lumen.
Conversion of Ang I has been reported not to occur in other
vascular beds (Ng & Vane, 1968). However, caveoli probably exist
on all endothelial surfaces but conversion might occur more rapidly in
the lungs due to the slower linear velocity of blood in the lungs
allowing longer blood-endothelial cell contact. Angiotensin II is
not retained or inactivated in the pulmonary circulation but is
eliminated by the systemic circulation (Eg & Vane, 1968).
(iii) Secretion
Lungs are rich in histamine, which is present in mast cells,
mainly around small blood vessels and in alveolar walls (Said et al.,
1968) and in non-mast cell tissue pools (Johnson, 1970). Histamine
is discharged frora mast cells of human and rat lung by an IgE-
dependent mechanism (Paterson, Leid, Said, Vasserman & Austen, 1976)
or from bronchial lumen of human, monkey and dog (Paterson, Ts'ao &
Suszko, 1976), and is one of the mediators of the cardiovascular and
respiratory responses to antigen - antibody reactions (Bartosch,
Feldberg & Nagel, 1932; Dragstedt & Gebauer-Fuelnegg, 1932), to
microembolism (Nadel, Colebatch & Olsen, 1964) and probably to hypoxia
(llauge, 1968).
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Lungs are also capable of releasing prostaglandins (p. 18)
which they synthesize from essential fatty acids (Anggard &
Samuelsson, 1965; Bergstrom, Carlson & Weeks, 1968). Prostaglandins
and their metabolites are released during anaphylaxis (Piper & Vane/
1969; Mathe & Levine, 1973; Liebig, Bernauer & Peskar, 1974). Also
released during anaphylaxis are 5HT (Rowley & Benditt, 1956; Paratt &
West, 1957), adrenaline (Piper, Collier & Vane, 1967), kinins
(Brocklehurst & Lahiri, 1962, 1963), slow reacting substance of
anaphylaxis (SPS-A; Brocklehurst, I960) and eosinophil chemotaxic
factor of anaphylaxis (ECF-A; Kay, Stechschulte & Austen, 1971).
11
Section 1. The release of prostaglandins from lungs during
increased hydrostatic pressure and oedema
Introduction
Prostaglandin synthesis
Prostaglandins are 20 carbon fatty acids which contain a cyclopentane
ring, and are grouped according to their various substituents at Cn,y
C.n and C1[r into PGs of the E, F, D, G and H series. PGA, B and C11 ly
are formed by dehydration of PGE. Each series is further divided
into up to 3 groups denoted by the subscripts 1, 2 or 3 according to
their degree of saturation of the side chains, i.e. the members of
a series with subscript 1 have a double bond at the position
( Z\ ) while subscript 2 means an unsaturated bond at C^_ and ;
and subscript 3 also at C-^7* (Oesterling, 1974).
Prostaglandins are physiologically active compounds which are
present in many animal tissues. Their structures are known and they
are formed by enzymatic convertion of the essential fatty acids in
many tissues (Xngg§rd & Samuelsson, 1965; Bergstrom, Danielsson &
Samuelsson, 1964; Dorp, Beerthuis, Nugteren & Vonkeman, 1964).
The pathway for PG synthesis is catalyzed by the enzyme complex,
prostaglandin synthetase, associated with the microsomal fraction in
almost all mammalian cell types so far tested. The convertion
pathways from the essential fatty acid, arachidonic acid are shown in
fig.l while the precursor for the less saturated prostaglandins of
subscript 1 is dihomo - ^ -linolenic acid. The pathway to PGI^






















Endogenous AA is derived froia phospholipid "by the activity of
the enzyme phospholipase A. Arachidonic acid is then converted by
the enzyme cyclo-oxygenase to the endoperoxides PGG^ and via
peroxidase to PGH^ (Hamberg & Samuelsson 1973; Eamberg, Svensson &
Samuelsson 1974; Nugteren & Hazelhof, 1973). These cyclic
endoperoxides are very unstable, with a half life of about 4 minutes.
The endoperoxides are then converted to PGE^, PGF^^. an<l PGNg
by isomerase and peroxidase reactions of the microsomal enzyme system.
The type of prostaglandin that predominates in the synthesis depends
on the tissue involved. It is interesting to note that the
proportion of, for example, PGE to PGF synthesized may be chemically
altered (Lands, Lee & Smith, 1971; Nugteren, Beerthuis & van Dorp,
1967 ).
PGD^, previously thought to be inactive, is formed during
platelet aggregation (Oelz, Oelz, Knapp, Sweetman & Oates, 1977).
It is an extremely potent inhibitor of platelet aggregation (Smith,
Silver, Ingerman & Kocsis, 1974). PGD^ and PGD^ possess opposing
actions on vascular permeability in the rat skin (Flower & Kingston,
1975) and PGD^ has pulmonary and cardiovascular effects (VJasserman,
du Charme, Griffin, De Graaf and Robinson, 1977).
The conversion of arachidonic acid may follow another pathway
from the endoperoxides, namely conversion by the microsomal enzyme,
thromboxane synthetase, to thromboxanes (Hamberg, Svensson & Samuelsson,
1975; Needleman, Moncada, Bunting, Vane, Hamberg & Samuelsson, 1976)
(see fig.l). Thromboxane A„ is highly unstable with a half life of
approximately 30 sec. in aqueous medium at 37°C (Samuelsson 1976),
14
although longer (about 3 min) in plasma (Granstrom, Kindahl &
Samuelsson, 1976).
Thromboxane is so called because it is a very potent platelet
aggregating agent (llamberg, Svensson & Samuelsson, 1975 ), and is
now considered (Samuelsson, 1976) to be the main constituent of the
rabbit aorta contracting substance (RCS) released from anaphylactic
guinea-pig lungs (Piper & Vane, 1969).
Recently an enzyme was found which transforms the endoperoxides
to a new prostaglandin substance, PGI. (Moncada, Gryglewski,
Bunting & Vane, 1976). This compound is formed in certain cell
layers of the arterial wall, notably in highest concentrations in
the vascular endothelium, (Herman, Moncada & Vane, 1977), where it
has been postulated to play a role as an endogenous inhibitor of
platelet aggregation and preventer of thrombus formation (Moncada,
et al., 1976; Moncada, Herman, Higgs & Vane, 1977).
Two other products, HETE and HHT(see fig.l), which appear to
possess no biological activity, are formed during the metabolism of
arachidonic acid in human platelets (Hamberg, Svensson & Samuelsson,
1974).
Prostaglandins are present in most tissues in small amounts
(Karim, Hillier & Devlin, 1968; Karim, Sandler & Williams 1967).
When PGs are released the quantities are usually higher and synthesis
must be stimulated.
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Inhibition of prostaglandin synthetase
Non-steroid anti-inflammatory drugs (NSAID) inhibit the PG
synthetase activity of many tissues (Vane 1971; Flower, 1974;
Ferreira & Vane.1974). Indomethacin inhibits the activity of the
oxygenase component but not the isomerase component of the
prostaglandin synthetase system (Miyamoto, Yamamoto & Hayashi, 1974).
Flower & Vane (1972) report that indomethacin in a variety of tissues
inhibits synthetase activity to a different extent and this is
confirmed by Flower, Cheung & Cushman (1973). Pong & Levine (1976)
have shown that the dependent factor is the concentration of the
substrate arachidonic acid. The mechanism of action of these drugs
has not been completely elucidated, although inhibition must take
place at an early stage in synthesis since the production of
endoperoxides is .inhibited (Kamberg, Svensson, Wakabayashi & Samuelsson,
1974; Hamberg, Svensson & Samuelsson, 1974). Lands, le Tellier,
Rome & Vanderhoek (1973) have suggested'a mechanism by which the
inhibitor could bind to a site on the synthetase complex near to the
active site and thus cause inhibition of synthesis.
Metabolism of prostaglandins
Removal from the circulation. In a single passage through the lungs
of cat, dog and rabbit about 9Ofyo of>PGE^ and PGE^ is removed from the
blood (Ferreira & Vane, 1967a). Also prostaglandin E , E_ and F01 c. tL c\*
are almost completely inactivated during passage through the pulmonary
circulation of cat, dog, rat, guinea-pig and man (Biron, 1968a,
McGiff, Terragno, Strand, Lee, Ng & Lonigro, 1969; Horton & Jones,
1969; Piper & Vane, 1969 and Biron 1968b). Prostaglandins of the A^
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series have also recently been shown to be metabolized to a certain
extent (Gross & Gillis, 1976), and PGA^ is 23-75/^ removed (Piper, Vane
& Wyllie, 1970) , although neither PGA^ nor PGA^ is inactivated in
dog lung (KcGiff et al, 1969) when estimated by superfusion.
\
Breakdown
Although prostaglandins are stable in blood (Perreira & Vane,
1967a) their half life in the circulation is short. They are inactivated
by an enzyme complex present intracelluiarly in the particle-free
fraction of cells (Anggard & Samuelsson, 1965), and converted to
compounds which are usually less biologically active than the parent
ones. They showed that homogenates of guinea-pig lung tissue converted
PGE1 to 15- keto, 13,14- dihydro PGEj^ and 13,14- dihydro PGE . PGE2
and PGS^ are similarly transformed by oxidation of the secondary
alcohol group at and/or by reduction of the i/\ - trans double
bond (Anggard, Green & Samuelsson 1965, Anggard & Samuelsson 1965.)
In vivo metabolism has been studied in several species. In
man, four enzymic processes act to metabolize PGE2< Initially there
is oxidation of the hydroxy group at C^ by 15-hydroxyprostaglandin
dehydrogenase (15-OH PGDH), then reduction of the trans double bond
by prostaglandin ^ reductase. This reaction is assisted by the
electron withdrawal effect of the keto group previously formed at C1ir.
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It is followed by two steps of p> - oxidation of the carboxyl side
chain and an 00 - oxidation reaction. Two additional metabolites
have been found during breakdown of PGF^^ PGS^ and are
converted to the same main metabolites as outlined for PGE- and PGF„
2 <;«<>
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(Samuelsson, Granstrom, Green & Hamberg, 197l).
The enzyme capacity of the 2 lungs is considerable: it i3 only
exceeded at an infusion rate of ICyug/min of PGE^ (Piper, Vane&Wyllie,
1970). Since they are so rapidly metabolized in lungs, prostaglandins
are likely to act either intracellularly, or close to their site of
synthesis, i.e. as local, not circulating, hormones (Vane, 1969;
Silver & Smith, 1975). However modification of the action of the
metabolizing enzymes may occur either chemically or as a function of
different physiological and pathological conditions. For instance,
prostaglandin dehydrogenase activity has been shown to vary with age
in rat lung (Pace-Asciak & Miller, 1973); rabbit lung (Sun & Armour,
1974) rat kidney (Pace-Asciak, 1975) and sheep brain, lung and kidney
(Pace-Asciak, 1976). PGDH activity increased to peak at 19 days
after birth, then decreased to adult levels in rat kidney and rat
lung (Pace-Asciak, 1975; Pace-Asciak & Miller, 1973); while in the
maternal rabbit lung enzyme activity near term was approximately 20
times that of the foetus, newborn or adult animal (Sun & Armour, 1974).
While confirming this observation, Bedwani & Marley (1974, 1975) have
also shown a corresponding increase of the pulmonary inactivation of
exogenous PGE^ in the rabbit during pregnancy.
Decreased PGE metabolism has been found in homogenates of rat
lung and kidney during endotoxin shock (liakano & Prankan, 1973) and
v
in guinea-pig lung homogenates after exposure of the animals to pure
oxygen for several hours (Parkes & Eling, 1975).
Cellular uptake of PG is necessary for subsequent metabolism
(Ryan, Niemeyer & Ryan, 1975) and this process may be inhibited, for
example by the use of chemicals, or drugs, such as diphloretin and
18
polyphloretin phosphate. (Eling, Hawkins & Anderson, 1977; Crutchley
& Piper, 1974, 1975a). Other authors have postulated that PGs may
be metabolized in the caveolar sites of the endothelium of the vascular
lumen (Jose, Niederhauser, Piper, Robinson & Smith, 1976), but an
intracellular site would appear to be favoured by the majority of
investigators. The requirement of a carrier mediated mechanism for
transport of PGs across the normally impermeable cell membrane has
also been postulated (Bito, 1972).
Prostaglandin synthesis and release due to -physiological, -pathological
or chemical stimuli
As outlined by Ramwell & Shaw (1970) and Piper & Vane (1971)
virtually all tissues are able to release prostaglandins as a result
of various physiological, mechanical and pathological stimuli.
Lungs are also capable of releasing other vasoactive substances
(see p. 9 ) whose release can be affected by prostaglandins and vice
versa. For example PGE^ potentiates the effect of histamine in
perfused rabbit kidney and guinea-pig lung (Srcan & Turker, 1975); it
also causes release of histamine from skin (Sondergaard & Greaves,
1971). Low doses-of PGE^ have been shown to enhance the release
of histamine while depleting cyclic AMP (Tauber, Kaliner, Stechschulte &
Austen, 1973) and high doses of PGE^ inhibit release (Tauber et al.,
. >.
1973; Kaliner & Austen, 1974). Inhibition of prostaglandin synthetase
also inhibits the release of histamine by antigen from rat peritoneal
mast cells (Thomas & Whittle, 1976).
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Release cf prostaglandins from sympathetic nerve stimulation
There is a large body of evidence in favour of the hypothesis
that prostaglandins could play a role in the regulation of noradrenaline
release to nerve stimulation in many organs, including the spleen
(Davies, Horton & Withrington, 1968; Hedqvist, 1970a), heart
(Wennmalm, 1976) and pancreas (Hamamdzic & Malik, 1977). The
mechanism involved is most likely reduction of transmitter release
(Hedqvist 1970b) but a post synaptic action may sometimes be involved
(Clegg, 1966). Prostaglandins of the E series are the major type
released by nerve stimulation (Hedqvist, 1970b) and they decrease
the responses produced by nerve stimulation. However, PGs of the F
series facilitate transmission and enhance the effects of noradrenaline
(Kadowits, George, Joiner & Hyman, 1973) in lungs.
Recently Kathe, Tong, Tisher & Yen (1977) have reported release
of prostaglandin E from lungs due to sympathetic nerve stimulation.
•
Release of prostaglandins during platelet aggregation
PGE0 and PGF are released in vitro during aggregation in
• c C.
platelet-rich plasma (Smith & Willis, 1970; Smith, Ingerman, Kocsis
and Silver, 1973). In Section 2 (p.28 ) this release is discussed
more fully.
x
Release from lungs of -prostaglandins due to chemical stimuli
Alabaster & Bakhle (1976) have shown release of prostaglandins
from isolated perfused rat, guinea-pig and dog lung after infusion
of tryptamine, 5-HT, acetyl choline (ACh) and histamine. Release due
to 5-HT and tryptamine was antagonized by methisergide, while that due
to histamine was blocked by mepyramine, an H^ receptor blocker.
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Release was accompanied by a rise in perfusion pressure which may
have been the stimulus for PG release (p. 21 ). Bradykinin,
arachidonic acid and dihomo - - linolenic acid also stimulate PG
synthesis and release (Palmer, Piper & Vane, 1973). Mathe, Strandberg
& Yen (1977), have reported prostaglandin and PG metabolites are
released by slow reacting substance in guinea-pig and human lung
tissue. Noradrenaline infusion has been reported to release
prostaglandins from the vasculature of isolated perfused rabbit ear
(Gryglewski & Korbut 1975), but it inhibits anaphylaxis-induced
prostaglandin release from guinea-pig lung (Kathe & Levine, 1973).
Release of prostaglandins due to -physiological or pathological stimuli
Various physiological and pathological stimuli release PGs,
possibly through their common action of cellular distortion (Piper &
Vane, 1971). Massage of isolated perfused lungs releases prostaglandins
into the perfusate (Piper & Vane, 197l). Tissue distension for
example of the rat stomach (Bennet, Friedman & Vane 1967) dog bladder
(Gilmore 1968) and human (Horton, Jones, Thompson & Poyser, 197l) or
guinea-pig uterus (Poyser, Horton, Thompson & Los, 197l), causes
release of prostaglandins . Also Karim (1968) reported release of
PG into blood during labour.
The mechanical stretching of lung tissue during hyperventilation
releases prostaglandins from guinea-pig lung (Berry, Edmonds &
Vyllie, 197l) or from dog lungs (Said, Kitamura & Vreim, 1972). Also
chopped lung tissue can be stimulated to release PGs (Palmer, Piper &
Vane 1973; Piper & Walker 1973). Release of prostaglandins from
lungs has also been reported after embolism by infusion of particles
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(Palmer , Piper & Vane 1967; Lindsey & Wyllie, 1970) or by infusion
of air (Piper & Vane, 1971)• Particle infusion into dog spleen
(Gilmore, Vane & Wyllie, 1969) also releases PGs and Piper & Vane
(l97l) have suggested that the mechanism by which release occurs may
be distortion of cells during expansion of the extravascular space,
when fluid filtration is induced.
Pulmonary oMema in the early stages involves considerable
distension of the extravascular (interstitial) space of the lung by
protein and water before fluid overflows into the alveoli (see
Section 3)♦ Said & Yoshida (1974) and Chijimatsu, Hara & Said (1976)
have reported that prostaglandins, most probably of the F type, are
released in considerable amounts (up to 20ng/ml PG ) into the
venous effluent and tracheal fluid of isolated lungs during oedema.
Oedema was induced either by prolongation of perfusion or by elevation
of outflow pressure, and this would seem to suggest that both stretching
of blood vessels during raised outflow pressure and distension of the
extravascular space may release PGs.
Release of PGs E and F from splenic capsular strips has been
shown to occur after incubation with Ang II (Diekmarm, Jobke, Peskar &
Herttingj1977). Since release also occurs after contractions produced
by NA or methoxamine (Jobke, Peskar & Hertting, 1976), it is possible
that release is due to mechanical stimulation during contraction.
>
However, there may be a modulator role for PGs in the systemic
vasoconstriction due to Ang II, since indomethacin potentiates the
Ang II - induced contractions (Diekmamet al, 1977) and the vasocon¬
strictor actions of Ang II in man (h'egus, Tannen & Dunn, 1976). Also
in rabbit AA has been shown to increase and indomethacin to decrease
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plasma renin activity (Larsson,Weber and AnggSrd, 1974).
However, not all stimuli which cause mechanical distension lead
to release of PGs. ATP causes a decrease in perfusion pressure
(Minkes, Douglas & Needleman, 1973), as does the vasodilator bradykinin
(Messina, Weiner & Kaley, 1976).
The prostaglandin— and histamine- releasing actions of dextran
Dextran is known to release histamine from mast cells in rats (Beraldo,
Dias da Silva and Lemos Pernandes, 1962; Baxter, 1972) and probably
5-HT and other vasoactive agents (Rowley & Benditt, 1956; Baxter,
Beaven & Horakova, 1974-). Dextran can also release histamine from
rabbit blood (Raining, 1956). In man concentrations of 1.3 to 5.0
ng/ml of histamine have been reported as a regular occurrence after
dextran infusion ( Lorenz, Doenicke, Messmer, Reimann, Thermann,
Lahn, Berr, Schmal, Dormann, Regenfuss and Hamelmann, 1976),
probably unrelated to hypersensitivity.
Hyman, Mathe, Spannhake & Kadowitz (1976), whilst studying the
icL
effects of infused arachonic acid on dog lungs, noted that prostaglandinA
synthesis from AA was greatly enhanced in dextran —fcompared with
blood-perfused lungs, as evidenced by a tripling of the pulmonary
vascular effects of arachidonic acid. Thus dextran increases PG
synthetase activity, and this is confirmed in intact dog lung lobes
by Hyman, Bennett, Joiner, Chapnick, Mathe' & Kadowitz (1976).
Dextran-induced anaphylactioid reactions have also been reported
in man (Data & Nies, 1974; Maddi, Vyso & Zinner, 1969; Ring & Messmer,
1977) and in this situation vasoactive substances other than histamine
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have been postulated to contribute to the clinical symptoms (Lorenz
et al., 1976).
Experimental aims
One aim of the experiments was to develop the superfusion
technique of (Vane, 1964, 1969) for detection and estimation of PG
like material and other active substances such as angiotensin II and
kinins (see p. 47 ). A technique vas also developed for the extraction
of prostaglandin P200 ^roin rapidly frozen tissue, from blood or from
tracheal fluid, the concentration of which was then estimated by
radioimmunoassay (see Section I, part 2, p. 25 )•
The experiments described in this section were carried out in
order to determine whether the stimuli of raised vascular hydrostatic
pressure and pulmonary oedema formation, sufficient to cause severe
mechanical disturbance in lungs of intact animals and in isolated lungs
could cause release of PGs into the blood, perfusate or the tracheal
fluid. Possible species differences were also evaluated since many
species have been used when investigating stimuli for PG synthesis.
Also studied was the ability of several perfusates to release
PGLS from isolated, perfused lungs. In view of the large variety of
stimuli reported to induce PG synthesis and because of the different
experimental methods involved it is important to clarify if a
perfusate in itself can stimulate PG synthesis.
In intact animals pulmonary vascular pressures were elevated by
inflating a balloon in the left atrium of the heart. This manoeuvre
Is accompanied by systemic hypotension (llauge, Boand Aarseth, 1977) and
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therefore probably by release of angiotension II. Since Angiotensin
II has been reported to release PGs (p. 21 ) the effect of an increased
blood concentration of angiotensin II on the arterial level of PGs
was also studied.
PGs were detected in arterial blood of intact cats by means of
continuous bioassay (Vane, 1964) of a fraction of the cardiac output.
Preliminary experiments indicated release of PG-like substances (PGLS)
in this preparation during pulmonary hypertension and congestion. In
order to ascertain the origin of the active substances detected,
bioassay was also performed on perfusate from isolated lung preparations.
The lower limit of concentration of PG detectable by bioassay is
approximately 1 ng/ml of PGE^ and PGP^^ • Since the lungs actively
degrade PGLS, outflow concentrations may be very low despite substantial
release of PGs (Mathe*& Levine, 1973), and a more sensitive assay
for prostaglandin was performed. Serial radioimmunoassay of PGP
c w
was made on samples of perfusate and tracheal fluid from several
isolated perfused lungs (section 1, part 2, p. 25 )• In one pair of
lungs a pulmonary metabolite of PGP^^ , 15-keto, 13-14 dihydro
prostaglandin F„ . was also estimated.2 K>
If pulmonary hypertension and/or oedema stimulate PG-synthesis
in lung tissue this may have important physiological and pathophysio¬
logical consequences on lung functiori (Kadowitz, Joiner & Hyman, 1975).
When released into the bloodstream PGs may also affect the systemic
circulation (Malik and McGiff, 1976).
Reports of this work have been published (Scott, Vaage and Wiberg, 197
1979 ; Scott, Vaage & Wiberg, in prep; Wiberg, Vaage & Scott in prep .
Y/iberg, Scott & Vaage, 1976, in press, in press; Vaage, Scott &
V/iberg, 1977,1978; Vaage, Wiberg & Scott, in press}.
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Section 1 - part 2.
Radioimmunoassay estimation of PGF„ in perfusate, lung tissue and
2.eC
tracheal foam from isolated lungs during pulmonary oedema
Introduction
The extent to which an unlabled compound competes >7ith its
radioactive equivalent for a limited number of receptor sites on a
macromolecule is the basis for the radioimmunoassay (RIA) technique
of Berson & Yalow (i960)* RIA is a simple, specific and sensitive
method used to study the biosynthesis and metabolism of prostaglandins.
When the receptor molecule and labled PG are available, the assay is
relatively simple to perform. In principle, mixtures containing
labled PG, receptor molecule and the sample of PG to be quantified are
incubated. Free labled PG Is separated from receptor bound labled PG
and the extent of binding can be determined.
Antibodies are proteins (found in the globulin fractions of
blood) that are produced by vertebrates in response to the presence
of an antigen, i.e. a substance that is recognised as foreign by the
host. Antibodies very selectively bind the antigen that stimulates
their production and this is the basis for the radioimmunoassay.
Kacromolecules (proteins, polysaccharides etc.) elicit this
immune response when injected, although low molecular vreight compounds
(haptens) such as PGs must be bound co-valently to an antigenic
macromolecule (e.g. protein).
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The first successful production of antibodies to certain
prostaglandins was reported by Levine & Van Vunakis (1970). During
the last few years the radioimmunological detection of prostaglandins
at the pico gram level has been made possible by the development of
antiprostaglandin sera with sufficient binding affinities.
Radioimmunassay has advantages over other methods of measuring
prostaglandins. Superfusion bioassay, although a good measure of
total biological activity where PG synthesis is stimulated, is neither
specific nor sensitive enough to enable identification of a particular
compound, nor to quantify it below the nanogram level. Chromatographic
methods (including thin layer and gas-liquid chromatography) are
widely used. Gas-liquid chromatography, and mass spectrometry
combined are sensitive to the picomole level (Green, 1973)» but samples
must be extracted to prevent interference with the assays.
RIA is equally, if not more sensitive than these methods and the
antigen-antibody specificity may, in some cases, allow direct analysis
without previous separation from other compounds.
Increased hydrostatic pressure and pulmonary oedema in intact
anaesthetized cats causes release of small amounts of PG-like
substances, probably from lungs (results:section 1, p.73 ). However,
release of PGLS is not detectable from isolated perfused lungs when
measured by bioassay of the perfusate', and a more sensitive method
for detection of PGs was required, since they may act as local
hormones (Silver & Smith, 1975), being released into the circulation
only, in very low concentrations. Besides lungs have a high
degrading capacity for PGs (Perreira & Vane 1967a) which may further
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decrease the amount of PGs released, with a proportional increase in
metabolites in the outflow.
Bioassay tissues register short changes in PG concentration in
the superfusate; smaller, more gradual, long-lasting release, as
might occur in oedema formation, may go undetected as a change in
tissue baseline. Pulmonary oedema, with fluid filtration into the
interstitium may cause release of PGs into the interstitial fluid,
perhaps remote from the site of PG degredation in endothelial cells.
Alternatively it may stimulate increased tissue content of PGs.
Thus the concentration of PG in tracheal fluid (a measure of
interstitial PG content) and in lung tissue and plasma before and
after induced oedema was determined. Lungs were perfused with plasma
as described until a period of stable weight was obtained, when left
atrial pressure (P ) was raised by clamping the outflow tubing.LA
For details of the perfusion method see p. 40 •
A report of this work has been published by 7/iberg, Vaage,
Scott, Teig & Gautvik, 1976.
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Section 2» Release of POLS during intravascular platelet aggregation
in intact cats
Introduction
Pulmonary microembolism with platelet aggregates ia probably a
causal factor in the development of acute respiratory insufficiency
after various types of shock and trauma (Blaisdell, 1974, Wardle, 1974),
Berman, 1975), and experimentally induced platelet aggregation has
been shown to cause severe pulmonary insufficiency (Vaage, 1976).
There is also evidence that platelet aggregation and the subsequent
release of bioactive substances cause the acute pulmonary and
cardiovascular effects seen after various types of lung embolization
(Thomas, Tanabe , Khan & Stein, 1965; Bf4, Hognestad and Vaage, 1974).
When intravascular platelet aggregation is induced experimentally
platelet aggregates are trapped in the pulmonary microcirculation and
cause smooth muscle constriction in lung vessels and airways (Radegran,
1971; Bp and Eognestad, 1972; Vaage, Band Hognestad, 1974; Vaage
and Hauge, 1977). The cause of these lung reactions is not fully
understood. However, there is considerable indirect evidence that
the release of bioactive substances from platelets is important:
inhibitors of the platelet release reaction also inhibit the lung
effects of platelet aggregation caused by i.v. infusions of thrombin,
protamine (Radegran, 1971) and ADP (Kobayashi and Didisheim, 1973).
Besides, it has been shown that after several i.v. infusions of ADP
the lung effects of ADP-induced platelet aggregation eventually
vanish, but are restored on infusion of a more powerful inducer of
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the platelet release reaction, such as collagen (Vaage, and
Hognestad 1974).
However when the platelet release reaction was monitored by
measuring the appearance in blood of one of the substances released,
platelet factor 4 (PF-4) there was no correlation between the lung
responses and the release of PF-4 after several consecutive episodes
of collagen-induced intravascular platelet aggregation (Vaage and
Gjesdal, 1976). These authors showed that the plasma level of PF-4
increased only after the initial collagen infusion, although lung
responses were repeatedly elicited. This could mean that pulmonary
smooth muscle constriction is not dependent on platelet release, or
rather, that the release of smooth muscle contracting substances from
platelets does not parallel the release of PF-4.
It was therefore of interest to monitor other substances released
from platelets during in vivo aggregation. PGs are of special
interest in this context since PG-synthesis in platelets plays a key
role in the release of storage organelles (Willis, Vane, Kuhn, Scott
& Petrin , 1974). Besides, both "native" PGs (Kadowitz, Joiner
and Hyman 1975) and intermediates in PG-synthesis (Palmer, Piper
and Vane^l973> Hamberg, pjedqvist, Strandberg, Svensson & Samuelsson,
1975) are potent constrictors of pulmonary vascular and bronchial
smooth muscle (see p. 167). Prostaglandins are also released when
lung reactions occur during platelet agregation both in isolated,
perfused lungs (Vaage and Piper?1975) and in intact animals (Radegran,
Olsson, Aline & Granstrom, 1977).
The purpose of the present experiments was to study the relation-
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ship between smooth muscle constriction in the lungs and the
release of PGLS during collagen-induced platelet aggregation in
cats.
This work has previously been reported by Vaage, Scott &
Wiberg, 1976 and Vaage, V/iberg & Scott, 1978.
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3 : Hydrostatic Pressure Oedema and changes in C^.
Introduction
General Introduction;
Vischer, Haddy and Stephens (1956) have uei'ined pulmonary
oedema as the pathological state in which the extravascular
water content in the lung is abnormal. This is essentially the
same definition as that of Laennec in 1819, who wrote that
pulmonary oedema is " an infiltration of serum into the pulmonary
tissue, carried to a degree such that it significantly diminishes
its permeability to air."
Although this is a correct clinical definition, it overemph¬
asizes the final event of alveolar flooding, when gas exchange
is impaired ( Williams, 1953; Porster, 1957; Said, Longacher,
Davis, Banerjee, Davis and Wooddell, 1964 ). Little or no
consideration is given to the earlier events in oedema formation:
accumulation of interstitial oedema without significant impairment
of gas exchange.
Mechanics of pulmonary oedema: the fluid transport equation
In all organs there is a net flow of fluid and protein from
the vascular bed through the interstitium to the lymphatics and
thence back to the the vascular system. The general'equation
applicable under steady state conditions is the Starling equation
(Starling, 1396 ):
Qf = Kf (Pmv-Ppmv) - of (Ilmv -Ilpmv)
Qf is the net transvascular fluid flow; Kf is the fluid conductance
(filtration coefficient); Pmv and Ppmv are the'hydrostatic pressures
(P) in the microvascular lumen (mv) and in the perimicrovascular
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interstitial tissue(pmv); cr is the reflection coefficient (i.e. the
effectiveness of the membrane in preventing the flow of solute
compared to the flow of water); Ilmv and Ilpmv are the osmotic
pressures (II) contributed by the solutes in the microvascular
lumen (nTv) and the perimicrovascular interstitial space (pmv).
In pulmonary oedema the large plasma proteins are the only-
substances that do not equilibrate across the microvascular
membranes.( Visscher, Haddy and Stephens, 1956).
Alteration of one or more of these factors can upset the
balance of liquid and solute exchange and lead to oedema formation.
Thus according to the Starling hypothesis for bulk capillary
water transport, there are several factors that could lead to
pulmonary oedema: elevated capillary hydrostatic pressure, incr¬
eased capillary permeability to plasma proteins, increased
capillary surface area, decreased plasma colloid osmotic pressure,
increased alveolar surface tension and decreased lymphatic drainage
(Greene, 1965). Since one or more of these factors may change,
and since they interact in a complex manner they will not be
considered in detail here except in relation to the present
experiments. The left atrial pressure is the main intravascular
force promoting fluid and solute exit from the capillaries, and
colloid osmotic pressure is the main inward force.
Extravascular forces:
Net fluid transport is affected by the pericapillary pressures
of the pulmonary interstitium. This has been estimated by Meyer,
Meyer and Guyton (1968) as ranging from -7 to-16 mmHg in the
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normal lung. However,the role of the extravascular forces (Ppmv
and Ilpmv) in the progres 'on of pulmonary oedema has long been
disputed (Guyton and Lindsey,1959; Guyton 1965; Levine, Mellins,
Senior and Pishman, 1967 ; Meyer ct al 1968; Wiederhielm, 1968).
This is probably because they are very difficult or impossible
to measure in some situations, or overridden by other factors.
The roie of the interstitial protein osmotic pressure has been
researched by Staub's group ( Staub, 1970; Staub, 1971 ).
In summary, they have shown that every increment
in microvascular hydrostatic pressure is half offset by an increase
in the protein osmotic pressure difference. Thus, changes in ilpmv
and increases in lymph flow are major factors in keeping the
lung "dry".
Membrane parameters;
when membrane permeability changes (i.e. Kf and <y are altered)
fluid filtration increases without necessarily changing hydro¬
static pressure. Clinically this is characterised as non-cardio-
genie pulmonary oeuema (Robin, Carey, Grevnik, Glauser and Gaudio,
1971). Experimentally, alloxan can induce this (-aviudo, 1953;
Hultgren and Flamm, 1969). There is no increase in pulmonary
12
blood volume as measured by the content of P' -marked erythrocytes
(Aviado,1953;. Microscopic studies show that alloxan destroys
pulmonary capillary cells and the underlying baseme.it membrane,
resulting in severe injury to the capillaries. Increased lung
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weight and extravascular water are readily demonstrated on post¬
mortem examination, but impaired perfusion makes it difficult to
document by the indicator dilution technique.
EDTA, a chelator of calcium and magnesium ions, induces perm¬
eability oedema in the isolated, perfused rabbit lung (Hicolaysen
1971b). However, no abnormalities in the ultrastructure of the
microvascular membrane were observed (Hovig, Kicolaysen and
Nicolaysen, 1971). Some electron microscopy studies have shown a
complete breakdown of membrane structure in permeability oedema
(Schulz, 1959; Cottrell, Levine, Senior, Weiber, Spiro & Pishman,
1967). That is, the endothelium no longer acts as a selective
barrier to protein permeability, and fulminant oedema develops
(Robin et al, 1971).
One characteristic of increased permeability oedema is that
the protein flow (lymph flow times concentration of lymph protein)
is always increased (Brigham, Woolverton and Staub, 1973).
Intravascular forces;
Elevated intravascular hydrostatic pressure (Pmv) is the cause
of probably the commonest clinically observed form of pulmonary
oedema, congestive heart failure. It is due to an abnormality in
heart function, especially left ventricular failure or mitral stenosis.
Hon-cardiogenic causes include pulmonary venous-occlusive disease,
\
pulmonary venous fibrosis or stenosis or overinfusion of physiol¬
ogical solutions (Robin, Cross and Zelis, 1973).
Although the initiating stimulus for lung water accumulation
varies, the clinical manifestations are the same for all kinds
of lung oedema : diffuse X-ray picture and progressive impairment of
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gas exchange and mechanics. In addition, the sequence of fluid
accumulation is essentially the same. This has been shown by
Staub, Nagano and Pearce (1967). Microscopic examination of
rapidly-frozen lungs showed that the earliest accumulation of
■fluid is in the interstitial connective tissue compartment
around larger blood vessels and airways. Alveolar walls then
became thickened and finally,when the interstitial compartment
was filled, alveolar flooding took place. In addition, they
showed that alveolar filling occured independently and rapidly
in individual alveoli, without the occurence of air trapping,
when they reached a critical configuration at which the existing
transpulmonary pressure could not maintain alveolar stability.
Fluid accumulates initially in the interstitial space and not
in the alveoli, probably because the capillaries are more perm¬
eable than the alveolar epithelium to water (V/angensteen, V/ittmers
and Johnson, 1969). Schneeberger-Keeley and Karnovsky (196»),
using electron microscope techniques, have clearly shown that
capillary endothelial cell junctions are looser than those of
alveolar epithelium. Thus macromolecules (eg plasma proteins
and haemoglobin) can cross endothelium at lower driving pressures
than are required for epithelium (Pietra, Szidon , Leventhal & Fishman,
196y). However, the presence of protein in oedema fluid shows
that a large change in permeability must have occurred. Hovig
et al.(197l) did not show any alveolar disruption in high pressure
oedema, although probably intracellular junctions must have
opened.
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Hydrostatic oedema and changes in lung compliance
As early as 1887, von Basch produced acute pulmonary vascular
engorgement in living dogs and observed changes in the mecharlics
of the lungs. In open-chested preparations, ventilation was
produced by means of a pump with constant pressure amplitude.
With congestion the tidal volume decreased and end expiratory
lung volume increased simultaneously. The reduction in tidal
volume was regarded as increased lung stiffness, i.e. reduced
specific compliance^ and the increased end expiratory volume
( functional residual capacity, PRC ) as evidence of
vascular engorgement.
Other animal studies confirmed von Basch's work. Drinker,
Peabody and Blumgart (1922) showed that occlusion of cat
pulmonary veins was associated with a reduction in pulmonary
ventilation, and that these changes were immediately reversed
when vasoconstriction was removed. Mack, Grossman and Katz
(1947) found decreases in lung distensibility following acute
vascular engorgement in excised dog lungs and in lungs of intact
dogs. Also Heyer, Holman and Shires (1948) found marked reduction
in lung distensibility following rapid Infusion of saline solution.
The lungs of these animals were found post mortem to be haemorrhagic
and heavy, and it is not possiDie to dissociate The possible
contribution of alveolar oedema from their results.
Borst, Berglund, Whittenberger. Mead, McGregor and Collier
(,1957) have separately examined in vivo the mechanical effects
of changes in pulmonary blood flow and pulmonary arterial pressure
from those of left atrial pressure elevations. Large variations
3 7
in pulmonary blood flow did not influence the mechanical behaviour
of the lungs. However, elevation of left atrial pressure caused
a reduction in dynamic lung compliance (Ch) of about 20-30>S,
JJ
roughly proportional to the magnitude of P^fi elevation.
returned to control level within 10 sec of lowering P from 50
to 6 cmH^O. This would argue against increased filtration causing
the fall in C as this would have to be extremely rapid, and1J
could rather be due to distension of veins or capillaries. These
authors found reductions in CT of smaller magnitude than thoseJj
reported by Bondurant, Hickam and Isley (1957) after acute central
congestion in normal human subjects, due to inflation of an
anti-gravity suit or to submersion in water. They showed more
than a 50$S reduction in CT at PT . not greater than 45 cmH_0.J-j JJA CL
This may represent a true difference between dog and human lungs,
or may be due to.differences in techniques of measurement.
The changes in CT observed in the experiments of Borst e-t alll v
(1957) are small compared to those seen in patients with chronic
congestive heart failure or pulmonary hypertension. Possibly
changes in lung mechanics in such patients are largely caused
by factors otner than the pulmonary congestion per se, such as
chronic changes in the vessel walls and parenchyma or increased
heart size.
Experimental work in many species supports the concept that
oedema formation in the lung begins in the interstitial peri¬
vascular tissue while the escape of fluid into the alveoli takes
place at a later stage ( see general introduction to this section).
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However, what is not clear is whether the fall in complianc
which these workers measured was due to distension of the
intravascular compartment of the lungs as they have shown or,
as some other authors claim,to pulmonary interstitial oedema
( Gump, Zikria and Mashima, 1972; Sladen, Laver and Pontoppidan
1968; Rief, McCurdy, Coalson and Greenfield, 1972)«
Gump, Zikria and Mashima (1972) confirm the observations
of the sequence of fluid accumulation in the lungs. However,
they conclude that CT and, to a lesser extent, pulmonaryJj
shunt flow are sensitive indicators of interstitial oedema.
They ensured that alveolar oedema had not occurred ( by X-rays
and histological examination ) when they created interstitial
oedema by steam inhalation in intact dogs. In addition, Sladen
Laver and Pontoppidan (1968) found a 30% fall in lung
compliance when extravascular lung water increased in respir¬
atory failure. They suggested using the measurement of
compliance as a means of detecting oedema in its early
(interstitial) stage. Also, in experimental studies in
perfused dog lungs, Rief et al.(1972) correlate their observed
decrease in C with interstitial oedema since it was not
-Ll
reversible on releasing the venous constriction. Electron
micrographs showed that very little alveolar oedema had
occurred, but that interstitial oedema was clearly visible
in the perivascular space.
On the other hand, Hauge, Bo and Waaler (1975) have
concluded that C falls in association with changes in pulm-
Ju
onary blood volume. They clearly showed that a sharp fall
in dynamic CT ( about 20% ) took place when pulmonary bloodll
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volume (PBV) increased in hydrostatic oedema in isolated
rabbit lungs. Also, returning PT . to control levels restoredIxA.
CT in several seconds, even when extravascular fluid volumeIf
had almost tripled (Bo, Hauge, Nicolaysen and Waaler, 1973). Hauge,
Bo & Waaler (1975) have also shown that, after the initial
reduction due to increased P_., CT then remained constant,liA li
though reduced, during the period of raised PT. until aJbA
second, more gradual fall occurred. The question then arose
as to whether the period of stable, reduced could be
equated with interstitial oedema formation and whether this
secondary fall, which was irreversible on returning P^ to
control (own experimental observations) coincided with the
start of alveolar flooding in this preparation.
The purpose of this study was to perform a detailed
histological examination to see the sequence of fluid accum¬
ulation, and to investigate a possible correlation between
the onset of alveolar oedema and the secondary fall in CT.il
This project (unpublished) was done in collaboration with Drs.
Nicolaysen and Hauge.
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Rahbits weighing 2.5-4.0 kg were used. Fifteen rabbits were
prenedicated with lOmg diazepam (Valium) intraperitoneally. All
rabbits were anaesthetized with 30-40 ng/kg sodium pentobarbitone
dD(Nembutal 'diluted 1:3 with isotonic saline) into the v. auricularis
caudalis. Cats weighing 2,0-2.5 kg and guinea-pigs (320—800g) were
'R~-
anaesthetized with 30-40 rag/kg Nembutalwintraperitoneally.
Intact Cats
Cats weighing 3.3-4.4 kg were used for the experimental procedure.
Cats weighing 1.8-2.3 kg were used as blood donors. All cats were
anaesthetized with 30-40 ng/kg Nembutal in. Blood donors were
heparinized with 500 lU/kg heparin and exsanguinated by cardiac
puncture. One thousand IU heparin powder was added per 100 ml of
this blood.
The Isolated Lung Preparation
This lung preparation is according to the method of Hauge, Lunde
and Waaler (1966). Animals were tracheotoiaized and ventilated at
constant volume with positive pressure at approximately 7 cm HpO peak
inspiratory pressure (Pup) and 1-2 cm KgO end expiratory pressure
(P£S). Lignocaine (lCj) was injected (3 ml total dose) subcutaneously
at intervals along the sternum and the thorax was opened widely by a
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midline incision and the pleura rare dissected open. The pleural
structures above the diaohragn end the phrenic nerves were cut. The
oesoph-agus was ligated with two threads and cleaned as far as possible
of pleural structure before being cut close to the diaphragm between
the two threads. Two threads were placed around the inferior vena
cava but not tied.
The pericardium was removed to expose the heart. The thymus was
dissected free, ligated close to the trachea and removed. Tissue
over the trachea was dissected until the trachea was exposed as far as
possible and the oesophagus was clamped at the level of the tracheal
cannula and drawn carefully out. Thread was placed around the aorta
and the pulmonary artery close to the heart.
Heparin (10 ng in 1 ml of saline solution to rabbits and cats;
1.5 ng to guinea-pigs) was injected directly into the right ventricle.
The inferior but not the superior vena cava was tied end ventilation
was stopped. The preparation (trachea, lungs and heart) was removed,
being careful not to touch or in any way to damage the lungs, by lift¬
ing the tracheal cannula and dissecting carefully close to the dorsal
surface of the thoracic cage and cutting the descending aorta.
The preparation was then suspended by a clamp on the apex of the
heart ventricles and a plastic cannula (stainless steel cannula for
guinea-pigs) was placed in the pulmonary artery (PA) by insertion
through the wall of the right ventricle. The cannula was tied with
V
the ligature which had been placed round the PA, at the same time
ligating the aorta, and secured by a thread tied round the ventricles
of the heart. The cannula was primed with saline. A wide necked
curved glass (or stainless steel) outflow cannula was placed in the
left atrium, by means of an incision in the wall and securely tied.
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The cannula also curved outwards at the rim which enabled it to be
drawn out as far as possible to minimise resistance. The width of
the cannula also minimised resistance to flow. The preparation was
suspended freely in a closed, heated Perspex chamber from the thread
tied round the heart and connected to a force transducer (Sanborn
FTA 100-1) (Ricolaysen, 1971a; also see fig. 2).
Perfusion
Lung perfusion was always begun a maximum of 10-15 nin after the
animals' circulation was stopped. Perfusion was begun with Krebs
Ringer solution and the first 50-100 ml used to wash out residual
blood from the preparation was discarded. The change from Krebs
Ringer to the required perfusate was performed within 1-2 nin of the
start of perfusion.
The lungs were perfused by a variable speed peristaltic
pump in a recirculating system with constant volume inflow of
between 100 to 300 ml/min for cat or rabbit lungs and 20-25 ml/min
for guinea-pig lungs. Pump rate was set to give a perfusion pressure
in the pulmonary artery (PpA) °f between 10 and 15 mm Hg. Ppg was
measured from a sidearm of the inflow cannula which was positioned at
the level of the hilum, and recorded on a Hewlett-Packard recorder
(p.188).
Perfusate temperature was thermostatically controlled at 37°C in
\
water jackets round the venous reservoir, the Perspex chamber enclos¬
ing the lungs and the inflow tubing to the lungs. Left atrial
pressure was kept constant during control perfusion at 1 mm Hg. The
total volume of the perfusion system was about 5CO-350 ml unless
otherwise stated.
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Fig. 2. Diagram of the isolated lung perfusion apparatus.
Ventilated lungs were perfused in a recirculating system.
Perfusion pressure was measured in the pulmonary artery
(Pp^). A fraction (lOml/min) of the outflow from the
pulmonary veins (pulm vein) was pumped over the assay tissues;
rat stomach strip (RSS), rat colon (RC) and chick rectum (CR)
and returned to the venous reservoir (Reservoir). Lungs were
suspended from a weight transducer and enclosed in a plastic
box surrounded by a water jacket, thermostatically-controlled
at 37°C. Perfusate was also heated to 57°C in the venous
reservoir and before superfusing the assay tissues. Left
atrial pressure could be raised by clamping successive





























Pig. 2 shows a diagram of the perfusion system.
Ventilation
Isolated rahhit and cat lungs were inflated after the start of
I
perfusion to about 20cm H2O for about 3-5 sec. They were ventilated
at positive pressure using a Starling "Ideal" pump (Palmer Ltd,
London) at a frequency of 20 strokes per min, and a ventilation volume
of about 40-50 ml.
Ventilation was begun at constant pressure: peak; inspiratory
pressure was set at 7-lOcm HpO by means of a water seal overflow
system which could be adjusted. Pump volume was set such that P^p
was between 5 and 9cm KpO and ventilation at constant volume commenced.
Pv:?. was maintained at l-2cm H^O throughout all experiments by means of
a water seal. Ventilation gas was %\ CO2 an air and perfusate pH was
7.4-7.5 throughout each experiment.
P.pp was measured with a differential transducer and monitored on
a Hewlett-Packard 2-channel recorder (7402A). In experiments where
bioassay of prostaglandins in perfusate from isolated lungs was per¬
formed, P<j>p was measured with a Grass pressure transducer and monitored
on an 8-channel Grass polygraph, model "JB.
Guinea-pig lungs were not ventilated because of high airway
resistance. However, the perfusate was gassed with % CO2 an air»
measurement of '.'/eight Changes
Lungs were freely suspended from the ligature tied around the
ventricles of the heart and changes in preparation weight were recorded.
Prom the start of perfusion, the weight . changes followed a pattern of 1) a
period of gradually decreasing weight, which may last up to 30 min
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"but mas normally shorter.
This is followed by 2) a period of stable weight and 3) a period
of increasing weight which accelerated until eventually oedema
occurred. The length of these periods varies according to the type
of perfusate used (Nicolaysen, 1971a). I/hen KR was used as perfusate,
the period of decreasing and stable weight was short (approx. 15 min)
and lungs quickly became oedematous thereafter.
In experiments where left atrial pressure (PTA) was raised the
lungs were perfused at Pjj^=1 until the period of stable weight was
obtained. P^ was raised by clamping steps of a ladder of tubes on
the venous side of the lungs which diverted the outflow perfusate up¬
wards before it returned to-the venous reservoir (see fig. 2).
Pressure could thus be raised in increments of 5 mmHg. '.Then Pj^is
raised there is an initial steep increase in preparation weigdrb
followed by a more gradual, steady vrei^it gain (fig. 9). The first
pha,se is due to increased pulmonary blood volume due to vasodilatation
and opening of more capillaries (Lunde and Waaler, 196$). The second
phase is due to accumulation of fluid in the extravascular space
(Kicolaysen, Aarseth and Waaler, 1976). Weight increases were
measured 30 sec after Pj^ was raised, thus reducing the contribution
to the weight increase of raised pulmonary blood volume .
The change in weight after 30 sec was measured in order to be able to
estimate the extent to which extravascular fluid had increased in the
v
preparation, distending the interstitium and causing alveolar oedema.
'.Then Py,> was raised there was a simultaneous increase in Pp;L, and
in Pp.p indicating a reduction in dynamic lung compliance (C^; Hauge,
Bo and T/aaler, 1975; see Section 3.)*
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Bioassay
To measure prostaglandin-like substances (PGL3) in "blood or lung
perfusate a modification of the superfusion technique of Gaddum (1953)
as developed "by Vane (1964, 19^9) was used. This is an on-line "bio-
assay in which organs are superfused with a stream of "blood (intact
animals) or perfusate (isolated organs).
Perfusate was assayed for its PG content "by superfusion over a
series of smooth muscle tissues and returned intravenously (fig. 2).
The choice of assay tissues depends on the substance to be estimated.
The assay tissue chosen must be sensitive to the particular substance
to be measured and relatively insensitive to other substances in the
bathing fluid. The combination R33, RC and CR was chosen for their
sensitivity to PGs. Sometimes a RbA was included to detect PG
precursors (p.47).
The specificity of the bioassay is increased by the use of
antagonists. The assay tissues rabbit aorta (RbA), rat stomach strip
(R33), rat colon (RC) and chick rectum (CR) were bathed for at least
1 hr before the start of the experiment in Krebs Ringer (KR) solution
(see Appendix p.189) gassed with 95^ O2 nnd 5^ CC>2» To this solution
was added 5 g/l of glucose and a mixture of antagonists of ACh
(hyoscine hydrobromide 0.15 ®g/l)» catecholamines (phenoxybenzamine
0,14 mg/l and propranolol hydrochloride 2.28 ng/l), 5-hydroxy tryptanine
(methisergide bimaleate 0.2 mg/l) histamine (H]_ receptor blocker,
mepyramine maleate 0.14 mg/lj and glucose (5 g/1) (Piper and Vane, 1971).
The blocker solution also usually contained indoraethacin 5 ng/1 to
prevent the intramural generation of prostaglandins (Vane, 1973)*
Rat stomach strip (R3S), rat colon (RC) and chick rectum (CR)
contract differentially to PGID2 and PGFpoc{ P33 and CR are more
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sensitive to PGE^ than the RC, while RC and RSS contract to PGP^ ^
(Palmer, Piper and Vane, 1973 ; Said, 1974).
However, these three assay tissues are sensitive to other
substances such as intermediates and metabolites in the conversion
of arachidonic acid, and to vasoactive substances against which
they are not blocked such as kinins and angiotensin II. When
assaying substances in tissue superfusate the effects on the tissues
must be compared with calibrating doses of that substance.
However, when the assay system is used for detection of unknown
substances, tissue patterns may be compared with calibrations but
the contributing effects of other active substances (if no suitable
blocker exists for them) to tissue activity must be considered.
The Rat Stomach Strip (RSS)
RSS is sensitive to PGE„, PGF„ , the PG endoperoxides and2 2 oo
thromboxane A0 (TxA^) (see p.150). The PG metabolites also
retain some activity (p.151).
The Rat Colon (RC)
The rat colon contracts to PGF„ (Regoli and Vane, 1966) andd 00
is also slightly sensitive to PGE^ (Said, 1974).
The Chick Rectum (CR)
The chick rectum is sensitive to PGE„, PGF„ and, to a lesser2 2oo
extent, to endoperoxides and TxA^ (Bunting, Moncada and Vane,1976)
Tissues cannot be blocked against TxAp or PG endoperoxides.
The Rabbit Aorta (RbA)
In several experiments a helically-cut strip of rabbit aorta
was included. The "rabbit aorta-contracting substance" (RCS;Palmer,
Piper and Vane, 1973), which is often released when PG synthesis is
stimulated, has been discovered to consist of TxA„ with small
amounts of the PG endoperoxides (Hamberg, Svensson and Samuelsson ,
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1974). HbA is very sensitive to i'xi^ and less sensitive to the PG
endoperoxides (PG&2 and PGH2), "but is insensitive to PGE2 and PGI?2a;
(Hamburg, et al 1975> Bunting, Moncada and Vane, 1976).
Thus the bioassay method gives a good qualitative measure of bio¬
logical activity in the convertion of arachidonic acid (AA; see fig.
1) although quantifive identification of each compound is difficult,
especially since synthesis and release probably involves a mixture of
substances.
Effects of Ron-Prostaglandin Substances on the Bioassay Tissues
Recently Said and Hutt have reported release of vasoactive and
spasmogenic lung peptides. These were found to contract RSS and RC
(Said and Mutt, 1977.) The rat colon contracts strongly to Angiotensin
II (Regoli and Vane, 19641 but is much less sensitive to other vaso¬
active substances such as 5HP and bradykinin. Gat jeunum (.CJj is
sensitive to bradykinin (.Ferreira and Vane, 1967b) and contracts to this
substance.
The Assay Svstem
. . 11 ■ 1 ■ .i M ■■ . — . -
A thread from the tissues was tied to a transducer which was
positioned immediately above the tissue bath. The tissue was suspended
in the plastic bath to protect it from temperature changes and the lower
thread was kept in place by a close-fitting plastic spout placed on the
V
base of the bath. This anchored the tissue in place and the tissue
tension could be altered manually by drawing the thread out or by moving
the vertical position of the bath. Isometric tension of the tissues
was measured by transducers (see figs. 3 snd 4 and P.49 ), and recorded
on a Grass polygraph (model 7B). Tissue superfusate was pumped through
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Fig. 5. The electronic design of the force transducers is
shown. The semiconductor transducer element consists of a
single crystal silicone beam (transducer beam), having one
diffused resistor (R) on each side. When the tip of the
beam is deflected (indicated by the arrow to the right),
the zones into which the resistors are diffused will be
stressed and their resistance changed. The resistor in
the compressed zone will decrease its value and vice versa.
The "active"resistors in the transducer beam were connected
to two "passive" (constant) resistors (R) to form a






Fig. 4-. The mechanical design of the force transducers
is shown schematically. The force to be measured displaced
a spring, as indicated by the vertical arrow on the far
right. The transducer element then measured the position
of the spring. Maximal deflection of the beam of the
transducer element (length Jmm) was 50pm. Due to the
selected rigidity of the spring this maximal deflection
was obtained when a weight of 7g was hung on the spring.
This corresponded to a deflection of 420 to 450 pm of the
tip of the spring. Further deflection of the spring was













2nm dism. silastic tubing and heated (37 C) hy a water jacket parallel
current heat exchanger surrounding the tubing for 40 cm (see fig. 2).
ihe tubing was arranged so that perfusate flowed down the thread which
suspended the first tissue without the thread actually touching the tubing
Perfusate was collected in the spout of the first tissue bath and
channelled over the upper thread of the tissue beneath.
The Assay Tissues : Preparation
1) Rat Stomach Striu
Hale or fenale Sprague-Dawley rats were either stunned by a blow-
on the head or lightly anaesthetized by ether and the abdomen opened.
The whole stomach was removed into Krebs Ringer solution. The rat
stomach strip was cut from the upper fundic part by the method of
Vane (1957). Two or three parallel cuts were made on the lesser
curvature and the resulting strip was about 6 cm long. The mucosa
was not cleaned away. Threads were tied at either end and the tissue
placed in Krebs Ringer solution (gassed with 95^ °2 an<^ 20°c
containing the antagonist mixture (see p.46 ) for at least 1 hour
before being placed in the cascade.
2) The Rat Colon
The ascending colon (4-5 cm long) was removed from the rat into
Krebs Ringer solution and the contents of the lumen were washed out.
Connective tissue and mesentery were removed and, using a needle, a
thread was tied through the wall of the colon at either end, thus
allowing the lumen to remain open, and the superfusate to reach and
drain from the lumen.
3) The -Chick Rectum
Chickens (1-2 weeks old) were killed by decapitation and the
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rectum was removed from the anus to the junction with the descending
colon, which has three "branches. A piece of rectum approximately 2-3
cm long with the three "branches (4mm) was removed. The tissue, in
cold Krehs Ringer solution, was cleaned of mesentery and lumenal
I
contents and tied at the anal end "by the same method as for the rat
colon. At the proximal end one "branch was tied and the others left
open. The tissue was placed in "blocked Krehs Ringer (gassed with 95^
02/5^ CO2) for at lea.st one hour.
4) The Rabbit Aorta
The thoracic aorta was cut from a rabbit which had been
anaesthetized with pentobarbitone (Nembutal ® 30 rag ip. A length
of approximately 1.5-2 cm was removed into Krebs Ringer solution which
had been gassed with 99^ O2 and 5}j OOg. It was cleaned of mesentery
and a spiral strip was cut which measured about 4-5 ram wide and 3 cm
long, tied at both ends and placed in blocked Krebs Ringer solution
(p. 46 ) gassed with 95^ O2 321(1 5$ ^2'
In some experiments the rabbit aorta was removed from the lung
donor animal and stored in Krebs Ringer solution overnight in the
fridge for use in the next experiment,
5) The Cat Jejunum
The cat jejunal strip was nrepared as described by Ferreira and
Vane (1967b). A piece of jejunum was taken from a cat which had been
anaesthetized with pentobarbitone (30-40 mg/kg ip) and was placed in
y
cold Krebs Ringer solution which had been gassed with 5^G0„ and Sp'Og•
The tissue was cut into a longitudinal strip about 4-6 mm wide and
5 cm long and placed in Krebs Ringer containing glucose and blockers
at 3°C until used (1-3 days).
The time between the perfusate leaving the lungs and reaching the
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first assay tissue v,ras 1-1.5 ®in. When the rahhit aorta was
included it was always the first tissue in the cascade, since the
half life of RC3 is short (p.150). In experiments where CJ was used
it was placed at the top. Otherwide the order of the assay tissues
in series was always 233, RG and CR, although no effect of changing
order has "been reported. According to Vane (1969) no significant
release of active substances occurs from tissues themselves, nor is
there modification of the substances present in blood.
Standard solutions of PGEg and PGP^ec 7761,0 Q2.de up daily in
isotonic saline from stock solutions in ICC^j ethanol, and calibrating
doses were infused into the superfusate upstream to the assay tissues.
RSS and CR were sensitive to as little as 0.5-1 ng/nl of PGE^, while
RG and R33 were sensitive to 1-2 ng/nl PGF„ , . Tissues were also
calibrated with angiotensin II (0.1-1.0 ng/nl) and bradykinin (1-4
ng/nl).
Upstream to the assay tissues superfusate was heated to 37cC by
neans of a surrounding water jacket. Tissue superfusate temperature
fell during superfusion by approximately 0.5°G at each assay tissue.
The tissues were mounted and superfused for approximately 2-3 hr with
KR solution containing blockers before superfusion with blood or lung
perfusate was begun. The basal tension of R33, RC and CR was set at
1-2 g while that of RbA and CJ was set at 3-4 g.
*
The Intact Cat Preparation: Elevation of PT.
n — ■ InA.
Experimental animals were tracheotomised and a muscle relaxant
(alloferine 0.5 mg/kg) was given. They were then ventilated with
positive pressure at constant volume (frequency 24/min) by a Starling
"Ideal" pump. End expiratory pressure, PK-;, was kept at 1.5 cnHgO.
Arterial pH was maintained at 7.35-7.45 by adjusting the tidal
volume. The thorax was opened by a sternum-splitting incision and
polythene catheters placed in both femoral arteries. A catheter
was placed in the pulmonary artery through the wall of the right
ventricle: using surgical sutures, four stitches were made in
the outer tissue of the muscle wall to form a circle about 5mm
diameter and the ends tied about 5mm above the wall. A piece of
fishing twine was inserted into a polythene catheter until it
protruded 2mm from the end. This end was inserted into the vent¬
ricle through the centre of the suture, the fishing twine removed
and the cannula was positioned in the pulmonary artery, as judged
by the pressure recording, and securely tied.
Femoral arterial (Pp^) an(i pulmonary arterial (Pp^) pressures
were recorded on a Grass polygraph (model 7B). An incision was
made in the left atrium of the heart and a saline-primed balloon
catheter (Folatex No. 8) was inserted for the recording of left
atrial pressure (Ft,) and infusion of PGs. P_, could be raisedy LA LA
by inflating a 1cm long balloon which lay in the outer circumference
of this catheter at the proximal end. This raised hydrostatic
pressure in the pulmonary circulation.
Cardiac output (CO) minus coronary flow was measured by an
electromagnetic flow probe placed round the ascending aorta.
Pulsatile and mean flow were recorded. Tracheal pressure (Ppp=
tracheal pressure in open-chested animals) was measured with a
pressure transducer connected to the tracheal cannula. The
signal was amplified (Sanborn 350 1000B DC preamplifier ) and
recorded on a Sanborn 320 dual channel DC amplifier-recorder.
Polythene catheters were placed in one carotid artery and an
external jugular vein for the removal and return of blood in the
extracorporeal circulation.
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Bioassay of PG-s and Angiotensin II
Thirty minutes after completion of the surgical procedures lungs
were hyperinflated (Pgp= 20 cmHpO for 3-5 sec). Cats were heparinized
(IGCOIU/kg) and "blood superfusion of the "bioassay tissues was "begun (as
described on p. 46 ) • lood (lOnl/nin) was pumped from a carotid artery
over the tissues and drained back under gravity into the external
jugular vein. The animals were transfused with 90-200 ml donor blood
and in all but 2 experiments also with 30-60 ml of dextran (i'acrodex ub
Pharmacia, Sweden) to compensate for blood loss into the extra¬
corporeal circulation.
When the extracorporeal circulation was started there was a small
increase in peak inspiratory pressure which showed that airway con¬
striction had occurred. This increase in peal: inspiratory pressure
declined gradually and hyperinflation of the lungs (Ppp-20 cmH^O for
3-5 sec) returned it to its previous value. An increase in Pp^ of
2-5 mmffg also occurred at this point in most experiments. This
increase often returned "by itself after 10-30 nin or after a hyper¬
inflation, hut was sometime irreversible. CO fell slightly (10-15ml/
min) when extracorporeal circulation began but returned on infusion of
blood and dextran solution. These changes were probably due to
activation hv the foreign surfaces of the extracorporeal circulation
of nicroaggregates of blood platelets (Tinnes and Wilson, 1973).
Tihen blood reached the assay tissues they contracted (often full
scale on the polygraph i.e. 4g tension) then gradually relaxed over
10-30 min. Tissue basal tensions were adjusted if required to l-2g
(RS3, RG and CR) and 3-4g (RbA and CJ). Exposure to blood decreased
tissue sensitivity to calibrating doses of PG-s, often by as much as 50£>
and the sensitivity of the recorder was increased if required. The
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spontaneous activity of the R3S and OR decreased when "blood superfusion
"began, often returning to previous levels of spontaneous activity after
about 1 hr of superfusion. Spontaneous activity of the colon usually
increased during blood superfusion. Seasonal variations in the
sensitivity of the bioassay tissues were noted, the tissues being more
sensitive to calibrating doses of PGs in Spring and Autumn and relative¬
ly insensitive in "Winter. Fig. 5 shows the experimental set up for
the bioassay of PGs in blood from intact cats.
Experimental Protocol
After blood superfusion of the tissues was started, there was a
time lag of approximately JO min before the haemodynanic parameters
and the tension of the assay tissues were stable. -Tissues were
calibrated with PGs (l-2ng/ml PGS2 ) and in some experiments
angiotensin II (O.l-l.Ong/ml). Lungs were hyperinflated (20cmH20 for
3-5 sec) and 5 mixi later P^ was elevated by inflating the balloon
catheter and was kept high (20-50mmHg) for a maximum of 10 min or for
as long as and 00 stayed at a stable but reduced level. In some
animals more than one pressure elevation was performed, with an
interval between then of at least JO min. Assay tissues were calib¬
rated between periods of pressure elevation.
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SECTION 1. PART 2. RADIOIMMUNOASSAY ESTIMATION 0? PGF„ .1
METHODS
In 4 lungs a series of plasma samples (5ml) were withdrawn,
via a needle inserted into the outflow cannula in the left atrium,
"before and during the induction of pulmonary oedema. Oedema was
caused by raising and maintaining P at 25 mmllg ( 2 cat lungs ),±jA
20 mmlig ( 1 rabbit lung ) and 15 mmHg ( 1 rabbit lung ) throughout
the experiment. Samples were collected on ice and stored at-20°C
until the extraction procedure was begun. This was performed
according to a modification of the method of Gutierrez-Cernosek,
Morill & Levine, 1972 and C-autvik, Teig, Y/iberg, Bronsted &
Christoffersen, in prep. 2.5 ml of each plasma sample was vortexed
for 15 min with 5 ml methyl alcohol:100;i ethanol mixture (4:1)
and left to stand for 1hr at 20°C. Tubes were centrifuged
(3000 rpm) for 30 min at 20°C and the supernatants drawn off
into test tubes. The precipitate was then washed with 1.25 ml of
the methyl alcohol:ethanol mixture and centrifuged as before.
The supernatants were combined, evaporated under nitrogen at 45°C
and the residue dissolved in 2.5 ml of 0.1 M Tris-HCl ( pH 7.4 ).
Aliquots of 50-100 ul were taken for radioimmunoassay. Before
the labled PGF^ ( New England Nuclear Corporation ) was used
it was purified on silicic acid columns ( 0.5g, 100 mesh ).
Lung tissue content of PGP^ was also measured. Seven rabbit
lungs were perfused with horse plasma, 3 of which served as
controls. Control lungs were perfused for 15-30 min without
elevating outflow pressure, and frozen during a period of
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decreasing or stable weight. In 4 lungs P^, was raised to 15 or
20 mmHg and maintained at that pressure until the lungs were
grossly oedematous.
Lungs were removed, from the perfusion circuit and rapidly
immersed in liquid DDM cooled to -155°C in liquid nitrogen in
order to halt PG synthesis. Tissue pieces from the outer parts
of the lower lobes were homogenized,( Dounce homogenizer, 2 min,
0°C ) in 5 ml 0.1511 NaCl and 0.1N HC1 (5:2) to give a wet weight
concentration of 200 ng/ml. 1ml of the homogenate was transferr
to tubes containing 2.6 ml ethyl acetate:isopropanol (1:1) and
mixed on a whirlmixer for 10 min. 3 ml 0.3% RaCl and 2 ml ethyl
acetate were then added and the tubes were centrifuged ( 50,000g
30 min, 4°C). 3 ml of the ethyl acetate phase was evaporated
under nitrogen at 45°C, the residue dissolved in 2.5 ml 0.01M
Tris-HCl ( pH 7.4 ) and aliquots of 50-150 ul taken for RIA.
The concentration of PG?^ in tracheal exudate was measured
in duplicate samples from 7 rabbit lungs using the method
outlined for plasma measurements.
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SECTION 2. INDUCED I INTRAVASCULAR PL '-TENET AGGREGATION
II! 'ii:I;I?ACT CAT FH4PARATI0I!
I.STH0D5
/
Cats weighing 3.0-5.1 kg were anaesthetized "by i.p. injections of
sodium pentoharhitone (30-40 mg/kg) and anaesthesia was maintained by further
injections as required throughout the experiment. Animals were
trachetoroized and an i.v. injection of the muscle relaxant alcuroniuxi
chloride (alloferine 0.5 ng/kg) was given, and constant volume positive
pressure ventilation was started (frequency = 24 strokes/nin). End
expiratory pressure (IVg) was 1.5-2 cm HpO and the tidal volume was
adjusted to give an arterial pH of 7.40-7.45 at the start of each
experiment. Tracheal pressure (equals transpulmonary pressure(Pq«p)
in the open chested animal) was recorded. Both femoral arteries and
a femoral vein were cannulated for measurement of femoral arterial
pressure ( PO, for blood sampling and for administration of drugs£ A
respectively. Blood was obtained from donor cats (see p. 40) for
infusion at the start of the extracorporeal circulation to compensate
for blood loss. ,
Bioassay A detailed description of the extracorporeal circulation is
given on p. 46 and will only be briefly outlined here.
Changes in arterial blood level of PGs were continuously monitored
by the superfusion technique of Vane (19^9)• Cats were given 1000 I.U.
heparin per kg, i.v. 30 nin after the surgical procedures were finished.
Ten nl/min of carotid arterial blood was pumped to superfuse the assay
tissues rat stomach strip (RSS), rat colon (RC), chick rectum (CR)S
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a rabbit aorta strip (RbA) (five experiments) and a cat jejunum (GJ)
in two experiments. Blood then drained by gravity "back to the cat
via a jugular vein. Prior to the experiment, tissues were bathed for
2-3 hr in Krebs Ringer solution containing 'combined antagonists'
(p46 ). Isometric contractions of the tissues were recorded (p. 48).
and calibrating doses of PC-B^, PGF^, bradykinin and, in four experi¬
ments, angiotensin II were given as constant rate infusions for 4 min.
In two experiments where the RbA was not included a strip of cat
jejunum (CJ) was used to detect kinins.
Platelet Aggregation A suspension of collagen fibrils (1 ng/ml,
' Sigma') prepared as described by Eolmsen, Day and Storm (19S9) was
infused i.v. at the rate of 0.2 ml/nin for 6 min. If the initial
collagen infusion caused only a small increase in peak inspiratory
pressure (Ppj), the infusion rate was increased to 0.3 ml/nin in each
subsequent infusion to that animal.
Platelet Counting and Changes in the Number of Circulating Blood
Platelets The number of circulating platelets was counted by the
method of Brecher and Cronkite (1950). One ml of venous blood wa.s
collected and a fraction was diluted x 100 with 1^ ammonium, oxalate
and examined under the ligjit microscope in a counting chamber at
magnification x 400. Ammonium oxalate haeaolyzed the red blood cells
and made the platelets more easily seen and identified. All platelets
in 5 blocks of small squares were counted after they had settled for
15 min. Both sides of the chamber were counted and the number multi¬
plied by 2,500 to give the number of platelets per cu. mm.
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Experimental Protocol
when "blood superfusion started, the cats were given a "blood trans¬
fusion to compensate for the blood loss into the extracorporeal circula¬
tion. Throughout each experiment further transfusions of blood and
Macrodex(Dextran T70 &jo with NaCl 0.9fe) were given whenever necessary
to maintain a stable blood pressure. Several collagen infusions were
given at 20-30 min intervals. Between infusions the assay tissues
were calibrated with standard doses of PGs. Five to ten min before
collagen infusions, the lungs were inflated for a few seconds to a peak
inspiratory pressure of 20 cmH^O by clamping the expiratory outlet
tubing.
In 3 experiments the initial i.v. collagen infusion was followed
by an infusion of collagen (0.05 ml/min) directly into the blood bath¬
ing the assay tissues.
In another 2 cats a series of collagen infusions were given until
no or negligible airway responses could be elicited as described by
Vaage, Band Hognestad (1974). At this stage blood superfusion of
the assay tissues was started. Repeated collagen infusions (0.3 ml/
min) were then given to the animals as described above.
Platelets
The number of circulating platelets was initially between 150,000
and 400,000 ner mm^ blood and always decreased during extracorporeal
circulation. During the first hour it was reduced to 30-50fj of the
initial level, then gradually decreased in the next 1-2 hours to less
than 50.00Q/mm- in most experiments. There was a further, temporary,
fall in the number of circulating platelets during the first one or
two collagen infusions. The fall in platelet count after later
infusions was not significant since severe thrombocytopenia was then
present. It was technically difficult to count platelets at this
stage, since the few that were present were found mostly in aggregates.
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section 3. hydrostatic pul::oit.iKy oedhia akd cea'tgss
in luitg- ccitii ahce
i.ie1h0d5
The isolated, rabbit lungs were prepared as described oil p.40
and perfusion was begun.. The perfusate was always heparinized horse
plasma, to which was added papaverine (7.5-10 nig in a perfusate volume
of 200-250 ml) immediately after the start of perfusion to prevent
active vasoconstriction and thereby any increa.se in vascular resist¬
ance. Control Pp^ was set at 10-15 nmHg and if, during an experiment,
]?PA was observed to increase steeply additional papaverine (5-7.5^g)
was added to the reservoir.
Experimental Protocol and fixation;
Lungs were perfused at control pulmonary vascular and tracheal
pressures. Peak inspiratory pressure (Ppp) was between 4.7 2^1 8.5
cmH^O (Ppe=0. 5-2.0 criH^O) , ^he length of the control period depended
on the pattern of weigit change which was measured continuously as
described (p.44 ). Alien the period of decreasing or stable weight
had been obtained Pp^ was raised by clamping the ladder of tubes at
the venous outflow to 10, 15 or 20 nmHg weight increased by 9 "to 18 g
in the first 30 sec, indicating an increase in blood volume. P increased
simultaneously by about 25Jj. A change in PPj during ventilation at
constant tidal volume end normal respiratory frequency is a measure
of the change in compliance of the lungs (Cp).
The initial steep decrease in Cp on raising Pp^ (primary fall in
Cp) is followed by a period of constant or slightly decreasing Cp
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(i.e. constant or slightly ('^creasing Ppj). After between 8-14 g of
fluid has accumulated in the lungs (p. 38) the change in "begins to
accelerate and this is called the secondary fall in (Eauge, Eo and
Y/aaler, 1975) .
The pattern of weight increase was described on p.45. There was
an initial steep rise for 30 sec to 2 nin after the incree.se in PT A<
which then decelerated until a constant rate of weight increase was
reached. This second rate of change is due to fluid filtraiion from
the exchange vessels. The rate of increase depended on the height to
which Pwas raised. When rate was slow (less than 0.05 to O.lg/min)
Pj-.A was raised hy a further 5 mmHg, causing a further sinilar pattern
of weight gain, find a faster rate of filtration. When Pleasuring
changes in weight in these experiments, the initial increase was
excluded and the difference between the final weight and the prepara¬
tion weight 30 sec after increasing PTA was used. In those experi¬
ments where a second increase in PjA was performed, the contribution
to weight gain of the increased blood volume during the first 30 sec
was also subtracted. The 30 sec point was chosen as a reference and
used in all experiments.
In experiments where filtration was very fast Pj A could be lowered
by 5 nnHg, causing a steep initial decrease in weight then a steady
rate of filtration which was slower than the previous one.
If filtration was allowed to continue it was usually constant but
in some cases was seen to accelerate. This was also noted in lungs
perfused for the measurement of PGs, and was seen to occur in all lungs
where gross oedema was allowed to develop.
To arrest the situation at a chosen point of weight increase in
order to quantify oedema, in these preparations, the lungs were fixed
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either by
a) perfusion with a solution of gluteraldehyde, or
b) rapid freezing in liquid arcton (dichlorodifluord-
methane, DIM).
a) Perfusion Fixation
The plasma perfusate xo the lungs was exchanged with a 2.7%
Krehs Ringer dextran (KRD) solution for a period of about 0.5-1.5 rain
until the perfusate was clear. The dextran solution usually had the
same osmotic pressure as plasma and thus did not change the pattern
of weight increase of the preparation. In some experiments the
osmotic pressure of the dextran solution was higher than that of
plasma and weight was stable or increased only slightly during this
period. However, KRD perfusion time was kept as short as possible,
and the weight increase during this time was included. Perfusions
with a solution of 1.7^ glutaraldehyde in Sorensens phosphate buffer
was begun, and the first 50 ral of fixative leaving the lungs was
discarded. Ventilation was stopped at end expiration and the perfus¬
ion continued for 15-20 min, during which period the lungs became stiff
and yellow. When fixative perfusion was begun,the flow to the lungs
was adjusted to keep the same Pp^ as before.
Lungs were then removed from the perfusion circuit and tissue
pieces about 1-2 cn^ were cut from 2 (or 5) regions of the fixed lungs
and dissected into 30 to 35 pieces 2x3x1.5-2 mm. Samples were
X
taken from:
1) bottom lower lobe
2) upper lower lobe or middle lobe (not always taken)
3) upper lobe.
Tissue was immersed in 3ft glut ?,raldehyde solution for one hour, placed
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in Tyrode solution for 15 min then in 1% osmium tetroxide in
Tyrode for 90 min in the refrigerator. Tissue was returned to
Tyrode buffer for 15 min and fresh Tyrode for 15 min. It was
then dehydrated by immersion in solutions of ethanol and propylene
oxide:
60% ethanol 60 min
96% ethanol 60 min
96% ethanol 60 min
100% ethanol 60 min
100% ethanol 60 min
propylene oxide 60 min
propylene oxide 60 min in filled air-tight plastic containers.
The tissue samples could then be stored in a 1:1 mixture of
propylene oxide and epon at 3°C until further use.
Samples were embedded in epon by evacuating for up to 12-18
hours in a vacuum pump until all the air had been removed. In order
to prevent hardening of the epon this was done in a cold room
(3°C). The tissue pieces were transferred singly into fresh epon
in individual plastic moulds, labled and allowed to harden by
placing in an oven at 65 +, 3°C for 36-48 hours.
Osmium Tetroxide Osmium tetroxide is highly volatile, is a strong
oxidizing agent and is reduced, by even small amounts of organic
material and exposure to light, to the hydrated dioxide. As this
is no longer a fixative, every care was taken to prevent this
process occurring.




Osmium tetroxide acts as an electron stain. Reduced osmium stains
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osnophilic structures such as proteins, which it stabilizes, and
prevents them being coagulated by alcohols during dehydration.
Osmium reacts with unsaturated fatty acids but not with DITA or IETA or
most carbohydrates.
Osaium/Sorensens Phosphate Buffer Solution An osmium ampoule
containing 0.1 g of oxnium tetroxide crystals was broken by a heavy
glass rod inside a glass bottle containing 10 ml Tyrode solution.
All glass surfaces were previously cleaned with nitric acid, rinsed
thoroughly in distilled water and dried in a warm oven. A tight
gla,ss stopper was placed on the bottle, the solution was shaken
vigorously and after half an hour the osmium tetroxide crystals
dissolved. The bottle was protected from light by wrapping in
aluminium foil, and the solution was always stored in the refrigerator.
All procedures involving the use of osraium tetroxide were carried out
in the fume cupboard,
— O
Tissue samples were small (max 3 ran x 0.5-1 mm) in order that
osmium stain would be uniform. Osmium stain is even to a depth of
0.5—1 ram and larger blocks did not stain uniformly by immersion.
Embedding of glutaraldehyde-osniun fixed tissue. Epon 812 is a
commonly used embedding medium (Kushida, 1959; Finch, 1950; and
Luft, 1961). Epon 812 is a light coloured, glycerol based aliphatic
epoxy resin of quite low viscosity (90-150 cps) and penetrates tissue
quite quickly due to its low viscosity. It hardens uniformly at
fairly low temperatures when mixed with acid anhydrides (dodencenyl
succinic anhydride (DDSA) and nadic methyl anhydride (1"1A) and an
amine accelerator, 2, 4,5 tri- (dimethyl aminonethyl) phenol (3IP-30).
'.Then the relative quantities of DD3A and NIIA are varied the hard¬
ness of the plastic changes and a suitable hardness to match the specific
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tissue tyoe can "be chosen.
The cutting quality of epon blocks is influenced by a combination
of 3 factors: anhydride/epoxy ratio, final block hardness and the
temperature and duration of polymerization. Cutting quality depends
on the ratio of anhydride chemical equivalent to epoxy chemical equiva-
/
lent in the mixture, therefore the exact content of epoxide in epon
must be known.
Epon 812 was of standard epoxy equivalent 155 (i.e. weight of Epon
in grams containing 1 gram chemical of epoxy). Luft (19ol) found that
easier sectioning results from a low anhydride/epoxy ratio in resin.
The ratio should be 0.7-0.6 for best cutting quality (Coulter, 1967).
The amount of accelerator (D*'P-30) is crucial for satisfactory
polymerization (setting). Too much causes the block to become dark
and brittle. Therefore this component was measured very carefully
(see Eayat, 1970).
Epon was stored in batches of approximately 20 ml in the deep
freeze at -20°C.
Preparation of Sections for Lifdit I'icroscopy Epon blocks were trimmed
until the tissue lay at the surface of the block and the four sides
were shaped inwards at an angle of about 45° "to this surface to prevent
blunting of the knife.
Semithin sections approximately 1 p thick were cut on a microtome
using 45° angled glass knives with a water-filled waxed metal foil
\
boat to float the sections. Sections were removed with a sharp stick
and placed on a drop of water on glass microscope slides. Slides were
heated on a hot plate at 55_60°C and allowed to dry at this temperature
for 20-30 min.
Staining To obtain an overall staining of tissue components sections
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were stained with toluidine "blue (Trump, Snuckler and Benditt, 1961),
A saturated solution of toludine "blue in Sorensens phosphate "buffer
7.2 ( see Appendix p. 190) was made up. Several drops of this
solution were placed on the slide (on hot plate at 60°) for 1-3 nin
"before "being rinsed with distilled water. "Depex" (1:1 mixture of
depex and xylene solution was used to permanently mount cover slips,
"b) Ratiid Freezing Fixation :
Freezing. Lungs were perfused and the weight gain measured exactly as
described for the perfusion-fixation experiments. At the required
point of weight gain, the perfusate inflow and outflow of the lungs
were clamped and ventilation was stopped simultaneously. The pre¬
paration was cut down and removed from the perfusion circuit and
immersed as quickly as possible in liquid DM cooled to about -150°C
by a jacket of liquid nitrogen (-180°C). To ensure that the freezing
process was as rapid as possible the DK1 was stirred continuously.
The frozen lungs were then transferred to liquid nitrogen and
pieces about 1 cm^ were removed from the outer edges of the upper part
of the lower lobes just below the hilum. Pieces were also taken from
the lower part of the lower lobes. Samples were not taken from the
upper lobes as these were often distorted in the clamping and freezing
procedure. Freezing is fastest in the outer 2 mm of the lungs (Staub
and Storey, 1962). However, light microscopic examination of the
samples taken showed that structure in the parts examined was preserved
in good condition for the observatibn of oedema (figs. 26 to 57).
Freeze Drying Two methods of freeze drying were employed,
l) Frozen tissue>approximately 1 cm2, was placed on a grid surrounded
by a heating element and suspended inside a "quick-fit" glass jar.
The jar was closed (sealed with silicone high vacuum grease) and
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immersed, in liquid nitrogen. The jar was evacuated to a pressure of
0.001 mmHg and the grid was heated to -30 to -35°C. As ice sublimated
from the tissue it condensed on the inside of the glass jar. The
/
tissue dried in 24-30 hours. The heater was then switched off and,
with the vacuum still functioning, the jar was allowed to heat to room
temperature until the ice crystals inside sublimated, A liquid -
nitrogen- filled flask in series between the jar and the vacuum pump
trauped the water. Tissue pieces could then be carefully removed by
forceps into a dessicator and stored in airtight containers with silica.
Macroscopic examination of dried tissue showed large bronchi end
vessels. Cuffs of interstitial fluid around the vessels and bronchi
could also be observed.
2) Tissue pieces were also dried in a freeze drier (Hetosicc, Hito
Birkerod, Denmark). Before drying tissue was stored for at least
24 hours at -70°C. The vacuum produced was approximately 0,1 torr.
Pieces were dried for 18-24 hours, and many samples could be
dried simultaneously.





Dried tissue was carefully cut into 2 mm cubes with a razor blade,
taking care not to pres3 or squeeze the tissue. Pieces viere evacuated
in epon for approximately 40 hours in a cold (3°C) room.
Cutting and Staining Tissue was embedded in epon blocks, as before,
but without osmium stain. Sectioning of the tissues was the same
although they were more difficult to section, possibly because they
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•were softer (osmium hardened the tissue). A modified epon mixture
T72,s used (see Appendix p.190) for the freeze-dried material. Blocks





Blocks of freeze-dried tissue (1 cm3) were placed directly into
moulds containing melted (58-62°C) "Paraplast" paraffin wax, and kept
in an oven at this temperature for 3 days, then cooled to room temper¬
ature. Sections 7-15 p think were cut on a microtome and placed on
a solution of albumin-glycerine in water on glass microscope slides.
This solution was allowed to eva.porate to dryness on a warm plate (40°C)
and. the slides were then placed in an oven (37°C) overnight.
Removal of Paraffin and Staining Procedure
Slides were dipped in beakers containing the following solutions
for the stated times to remove paraffin from the sections and to stain
them for light microscopy (LM).
xylol 2-3 min
xylol 2-3 min
100,0 ethanol 2-3 min
100;? ethanol 2-3 min
96,0 ethanol 2-3 min
70p> ethanol 2-3 min
distilled water 2-3 min
hematoxylin 5 min
distilled water 10 min
eosin 1 min














Coverslips were permanently mounted with dansaer xylene solution.
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SiSOTlON 1. THE RELEASE OI'1 PGs l-Hc-l, LUNGS
DURING lUGitEiSSD HYDROS'!ATI G PRSSSUnS' AHO OKDEil
RESULTS
Bioassay of Perfusate frora Isolated Lungs
A total of 22 rabbits, 6 cats and 3 guinea-pigs were used.
The results of the bioassay of prostaglandins in isolated lungs
are shown in Tables 1 and 2. The lungs were divided into two groups
according to the method used to induce pulmonary oedema.
Grout) 1
Group 1 contains those lungs where oedema was induced by raising
vascular hydrostatic pressure. Table 1 shows the results from this
group (.19 experiments). The species of lung donor, type of perfusate,
values to which Pj^ was raised and the total perfusion time (or time
to release of PG if this occurred) is shown. The inclusion of the
KbA and the addition of indomethacin to the lung perfusate are also
tabulated. Depending; on the values of P^A, group 1 is divided into
2 subgroups (A and B)s slow and rapid induction of oedema.
A) Gradual Development of Oedema
In 10 cat and rabbit lungs perfused with horse plasma (8 lungs)
or Krebs Ringer Dextran solution (KRD) (2 lungs) P^ was initially
raised to 10 (rt=6) or 15 (n=4) mmHg for between 5 and 20 min to induce
a slow filtration of fluid from the pulmonary exchange vessels into the
interstitium.
In 7 plasma-perfused lungs (No. 1-5 and 7 and 8, Table 1) PLA was
raised and maintained or further increased to a maximum of 25 mm Hg
until gross alveolar oedema was observed. At this stage more than
7 4
TABLE 1.
Duration of increased P-^A and release of prostaglandins
in isolated lungs.














































































































































50g of fluid had accumulated exfravascularly. In no experiment
could any contraction of the assay tissues be observed during
or after oedema development.
In one pair of lungs perfused with horse plasma (No.6, Table
1) P . was first raised to lOmmHg for 10 min then to 15mmHg for.LA
23 min and returned to control, normalizing blood volume and
starting fluid reabsorbtion. Repeated pressure elevations were
made (Table 1).
A total of 4 pressure elevations were performed in these lungs.
The third and fourth are shown in figs. 6 and 7 respectively,where
P was 15 and 20 mmHg. The end result was fulminant alveolar oedemaJjA
with fluid pouring out of the trachea to such an extent that vent¬
ilation had to be stopped. At this point the perfusate was gassed
with 5% C0^ in air. No contractions of the assay tissues were
observed during the period of increased PT„.
In this experiment tissue superfusion with the venous effluent
was temporarily interrupted and immediately replaced by the tracheal
fluid. This caused only a short-lasting contraction of the RSS
(fig. 7), and a similar contraction, which was also not maintained,
occurred when the venous effluent replaced the tracheal fluid as a
superfusate. These contractions may have been due to changes in gas
tension or pH in the superfusate. Basal tissue tension was the same
in tracheal fluid and plasma. When indomethacin was added to the
reservoir (lOpg/ml) it did not relax the assay tissues, showing that
X
no PG synthesis had occurred.
Two lungs were perfused with KRD solution (Table 1, No. 9 and
10) and P was increased. Lung No 9 was perfused for 60 min during
which time weight was stable. P^ was raised to lOmmHg for 12 min
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Fig. 6. Rabbit lungs perfused with horse plasma. The third
o'f four periods of left atrial pressure elevation is shown.
Left atrial pressure (Pp^) was raised to 15mmHg and maintained
at that value. The tracings show the isometric tensions of
the bioassay tissues: rabbit aorta (RbA), rat stomach strip
(RSS), rat colon (RC) and chick rectum (CR). Pulmonary-
arterial pressure (Pp^) an(l "the changes in weight (in grams)
of the preparation are shown (AWg). The sensitivity of the
assay tissues was tested by infusing PGEp and PGFp^ (DIR)
























Fig. 7. Shows the tensions (in grams) of the assay tissues
during the fourth (and final) period of pressure elevation
in the experiment also depicted in Fig.6. RbA= rabbit aorta,
RSS= rat stomach strip, RC= rat colon and CR= chick rectum.
Pulmonary arterial pressure (Pp^) is shown. The tissues
were calibrated with direct infusions of PGE2 and PGF2^.
Left atrial pressure was raised and maintained at 20mmHg
(P-^ 20mmHg). Tissue superfusion with venous effluent was
temporarily stopped and replaced with tracheal fluid for
a period of 8 min. Indomethacin (lOmg IR) was added to the
reservoir at the end of the experiment. Due to an electrical



































then raised to 15 mriHg and maintained at that pressure. Approximately
75 rain after the start of perfusion a progressive release of PGL3 "began.
Baselines and activity of RS3 and CR increased. i'his was assayed as
Ing/nl PGBg. Indomethacin (lOp.g/ml) was added to the lung perfusate
and the assay tissue tensions returned to "baseline, confirming that the
tissue activity had "been due to PG-LS.
Lung Ho. 10 was perfused for 72 min "before P^^ was raised (fable 1).
PG release was detected (during P-^ elevation) 80 min after the start
of perfusion and increased to a value of 0,5-lng/ml PGE^.
B) Rapid Development of Oedema
In a total, of 9 cat, rabbit and guinea-pig lung's perfused with
blood, horse plasma or Krebs Ringer dextran solution, Pj^ was initially
raised to 20 (n=3) or 25 (n=6) ramllg. In one experiment Pj^ was
increased further to 50 mmHg (fable l). These manoeuvres caused
marked pulmonary hypertension and rapid onset of gross alveolar oedema.
However, in the blood, plasma or KB perfused lungs contractions of the
assay tissues during vascular hypertension and lung oedema were never
observed, indicating that no relea.se of PGL3 had taken place.
Fig. 8 shows the results from one experiment (lung 18) where PLA
was increased to 20 mnHg for 5 rain and then returned to zero. V/ei^it
rose rapidly during the period of raised PLA* A net weight gain of
50 g remained after the vascular pressure was normalized, representing
irreversible extravascular fluid accumulation. The assay tissues
(RbA, RSS, R0 and CR) were calibrated before the after the period of
pressure elevation with doses of 0.5 snd 1 ng/ml PG&2 and PGF2K.
There wa,s no PG release detectable on the tissues due to vascular
distension or to pulmonary oedema. Indomethacin (50 ng) added to the
7 9
Fig. 8. A pair of rabbit lungs perfused with horse plasma.
The tracings show tracheal pressure (P^p), pulmonary arterial
pressure (Pp^) and the changes in weight of the preparation
(AW). Isometric tensions (in grams) of the following bioassay
tissues, superfused with venous effluent, are also shown:
rabbit aorta (RbA), rat stomach strip (RSS), rat colon (RC)
and chick rectum (CR). The scale of the RC recording was
changed during the experiment. Calibrating doses of PGFp^
and PGEp were infused into the superfusate upstream to the
assay tissues (DIR). P^A was increased to 20 mmHg for 3 aiin
then returned to control. Indomethacin (10, 20 and 20 mg),





























































Fig. 9. Shows an isolated cat lung perfused with cat plasma,
The tension of the assay tissues, superfused with lOml/min
of the venous effluent from the lungs, is shown. RSS= rat
stomach strip, RC= rat colon, CR= chick rectum. Pulmonary
arterial pressure (PpA) and the change in weight of the
preparation (aw) are shown. Assay tissues were calibrated
with doses of PGE2 an<i siven directly into the
superfusate. Left atrial pressure (EpA) was raised to 20













PLA Omm Hg 3(e- -PLA 20mm Hg-
2ng/ml Ing/ml 2ng/ml
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reservoir, did not relax the assay tissues. Fig. 9 shows the results
from a cat lung perfused trim cat plasma (fable 1, Ho. 11) where PLA
was raised to 20 (33 m±n) and to 25 nmSg (15 min). Ho release of
PG-1S was detectable.
In experiment Ho. 19» rabbit lungs were perfused v.uxh KRD for 53
lain, Pj.a was raised to 20 noHg for a period of 20 min and returned
to control. Perfusion then continued with control vascular pressures
for approximately 3 min "before release of PG-LS was detected. Release
was observed a,s a "Progressive increase in the baselines of the assay
tissues RSb end KC, end was assayed as up to 0.5ng/ml PG5?.
(from 2
The method of inducing oedema formation in this group of 12 rabbit
lungs was to perfuse the lungs with KRD solution, KR,plasma or KRD
containing histamine "blockers and monitor the changes in weight.
During extended perfusion in isolated lungs the weight of the prepara¬
tion "begins to increase slowly then progressively faster and eventually
alveolar oedema develops with fluid pouring from the trachea. ihe
results of these experiments are subdivided according to the type of
perfusate used:
(A) Perfusion with KRD Solution
fhree pairs of lungs were perfused and hyperinflatea to a P^p of
20 cm HpO for 3-5 sec at intervals of 10 to 20 minutes throughout the
\
course of perfusion. Lungs were perfused for 30 to 55 "before
weight increase "began. After perfusion for 100, 100 and 150 nin
respectively, a spontaneous release of PGSp-lilce substances (0.5-1 ng/
ml) occurred. I'oderate alveolar oedema was present in two of the
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3.6g. The results iron one lung (No. 3) are shown in fig. 10. The
assay tissues RSS, RC and CR were sensitive to calibrating doses of
0.5-1 ng/ml POE2 and 1-2 ng/ml PG^x* Tissue baselines were stable
a.t the start of perfusion (left hand column) and at this stage hyper¬
inflations did not release PG—like substances (PGLS). Ninety nin.
later there was relea.se of PGLS (right hand column), and stimuli such
as hyperinflation, raised left atrial pressure (PjjJ\=15 nnilg for 10 to
20 sec) or increased perfusion flow Q.0 sec) caused additional release
of PGLS corresponding to 0,5 ng/ml PGE2. There was also a gradual
increase in baseline of the tissues RSS and CR, which was reversed by
the addition of 12,5 pg/ml indonethacin to the lung perfusate.
(33) Perfusion with KR Solution or Horse Plasna
Two preparations were perfused with KR solution and one with horse
plasma for between 2-3.5 hr. V/eight in the KR perfused lungs began to
increase 15 to 20 rain after the start of perfusion and the lungs
rapidly becme grossly oedematous. Eventually perfusate poured from
the trachea and ventilation was stopped. ITo PG release could be de¬
tected throughout "perfusion, and periods of hyperinflation (at
intervals of approximately 20 nin) did not stimulate PG synthesis
(fig. 11). All lungs were oedenatous by the end of the perfusion
period (Table 2). That is,weight gains were large (greater than 50g).
(C) Perfusion with RPD Solution Containing Histamine and Hp Receptor
Blockers
In 2 pairs of lungs with nepyramine na.lea.te (2.5 ng/nl) and
metiamide (.75 ng/nl) in the perfusate, no release of PGLS was detected
during perfusion for 3«5 to 4.5 hn. Nor was there any release due to
hyperinf1ation.
8 4
Fig. 10. Rabbit lungs (Table 2, exp. 3) perfused for 3br
with KRD solution and hyperinflated(H) to a maximum P^p of
20 cm HpO for 3-5 sec at intervals of 10 to 20 min. Pulmonary-
arterial pressure (PpA) and the. isometric tension (in grams)
of the assay tissues: rat stomach strip (RSS), rat colon
(RC) and chick rectum (CR) are shown. Calibrating doses
of lng/ml PGEp and PGFp^ were given at the start of the
experiment and after 90 min of perfusion. Left atrial pressure
was raised to 15 mmHg for 10 sec Pncreased flow
of perfusate to the lungs (Flow) was caused by raising
pump speed for 10 sec until Pp^ was similar to that during































Fig. 11. Rabbit lungs perfused with horse plasma. (Table
2, exp. 6). Tracheal pressure (Ppp) and pulmonary arterial
pressure (Pp^) are shown. The assay tissues are rabbit
aorta (RbA), rat stomach strip (RSS), rat colon (RC) and
chick rectum (CR). Tissues were calibrated with 0.5-1
ng/ml PGEp and 2 ng/ml PGFp^• Periods of hyperinflation
(H) throughout perfusion did not release PGs either at
the start of perfusion ( left side of fig. ) or after 90


























































(D) Perfusion with KHD Solution Containing Histamine H-j Receptor
Blocker
Two pairs of lungs where mepyramine maleate (2.5 ng/nl) was added
to the perfusate did not release PG-s during perfusion for 5 hrs.
Stimuli such as hyperinflations, short periods of increased Pla or
increased Pp^ "by increasing flow caused no release of PGL5. Pig. 12
shows the results from one such experiment where lungs had already
heen perfused for 90 rain.
(E) Perfusion with KHD Solution Containing Histamine H9 -Receptor
Blocker
two pairs of lungs perfused with KKD during Hp receptor "blockade
released PGL3 (assayed as less then 0.5 ng/nl PGEp) "beginning 2 and
2-g- hr after the start of perfusion. At this stage hyperinflations
and elevations of vascular pressure caused additional PG—release
(about 0.5 ng/ral of PGSp) . One such experiment is shown in fig. 15.
Indoiaethacin added to the reservoir returned the tensions of the assay
tissues to baseline and a subsequent period of increased Pp^ had no
effect on the tissues, confirming that POLS had caused the tissue
activity.
Bioassay of Arterial Blood in Intact Cats
Pulmonary and Cardiovascular Effects of Raised PpA
IThen the balloon in the left atrium was inflated P^:, increased
together with Pp^ and remained elevated until tne balloon was deflated.
The pressure gradient across the lungs decreased markedly and pulmonary
vascular resistance also decreased although cardiac output was reduced.




Fig. 12. Rabbit lungs perfused with KRD solution containing
2.5 ng/ml mepyramine, a histamine (H-^) receptor blocker.
Pulmonary arterial pressure (Pp^) an<l the tension (in grams)
of the assay tissues RSS and CR are shown. This fig shows
the situation after 90 min of perfusion. Tissues are cali¬
brated by direct infusion of 1 ng/ml PGEp and 2 ng/ml PGF2^•
Hyperinflation (H), a period of increased flow (Flow) and
increased outflow pressure (Pp^) fail to release PGLS










































Fig. 13. Rabbit lungs perfused with KRD solution containing
75 ng/ml of the histamine (Hp^eceptor blocker, metiamide.
The fig. starts after 90 min of perfusion. Perfusion
pressure (Pp^)» tracheal pressure (P^p) and the isometric
tensions of the assay tissues: rat stomach strip (RSS),
rat colon (RC), and chick rectum (CR) are shown. The tissues
were calibrated with PGEp and PGFp^. Hyperinflations (H)
were performed at intervals of 10-20 min. Increases in
outflov; pressure (Pp^) an<3. perfusate flow (Flow) released
small amounts of PGLS before the addition of indomethacin
































































A total of 18 pressure elevations were performed in 9 cats.
The pressure elevations were in the range of 21-49 mnHg and lasted for
2-26 nin (Table 3). Changes in PjjA and. -FA are also shown in the
table. In 14 of the 18 pressure elevations contraction of assay
tissues occurred indicating appearance of PG—like substances (PGLS) in
arterial blood (fig. 14). In 4 of these 14 elevations the type of PG
could not be specified since it did not exactly natch, a calibrating
dose. In 10 elevations the assay tissu.es indicated release of PGIj^oc"
like substances. Estimated as PG?2oc» "t"ne concentrations ranged from
1 ng/nl to 4 ng/nl (mean 2 ng/nl). The tissu.es responded 2-3 nin
after Pp,A was elevated and remained contracted in all but one case
throughout the period of pressure elevation. When Pj— was reduced
after a period of high pressure the tissues returned to their pre-
• elevation tension level. Tissue baselines were stable during the
control periods between pressure elevations (usually about 30 min)
with Pj^ of 2-5 niriiig.
In 4- out of 18 pressure elevations release of PGL3 could not be
detected. These 4 elevations PLA were in 3 cats and in ea.ch of
these cats release of PGL3 could be mea.su.red during another Pp^
elevation (Table 3)• When no PGLS was detected the magnitude and
duration of the pressure elevations were not different from elevations
where release of PGLS occuri-ed.
During 2 pressure elevations gross alveolar oedema developed,
judged from foam pouring out of the trachea, and P.pp increased through¬
out pressure elevation and did not normalise afterwards. One of these































































































































During 4 episodes of elevated Pj^ with a definite increase in
PGLS, indonethacin (2 ng/kg) was injected slowly i.v. to inhibit
synthesis of PGs. Within 4-5 Qin the assay tissues relaxed to the
original "basal tensions end their tensions did not change when Pjj "as
reduced (fig. 14). Immediately after indomethacin was injected P-,^
fell about ic£> and remained at this reduced level.
In cats Ho 6 to 9 a RbA was included in the superfusion circuit,
in the 6 pressu.re elevations in these cats the KbA contracted in 4 cases,
whereas R33, RC and CR indicated release of PG-LS during 5 of "the pressure
elevations.
Release of Angiotensin
. ....... . , i
In all the cats a reduction in PpA occurred when Pj A was elevated
(Table 3) . Hypotension might stimulate the renin-angiotensin system
with subsequent release of angiotensin I into the circulation, which would
then "be transformed to angiotensin II In the lungs and might stimulate
systemic or lung release of PGs. To investigate this possibility six
infusions of angiotensin II were given into the inferior vena cava of
4 cats, giving z blood concentration of 0.25-1.25 ng/nl. Assay tissues
were also calibrated with angiotensin II. The tissues reacted similar¬
ly to equal concentrations of angiotensin II independent of the route
of administration. In two cats angiotensin II was infused i.v. twice.
Before the second infusion 3 mgA'g indomethacin was given. Angiotensin
II caused similar contractions of the tissues before and after PG
synthesis inhibition (fig. 15) showing that increased blood level of
angiotensin II entering the lungs does not give detectable PG-lilce
activity in carotid arterial blood. Angiotensin II itself might affect
9 2
Fig. 14. The effects of elevating left atrial pressure
in an anaesthetized, open-chested cat, ventilated at constant
volume. ( Pressure elevation no 2 in cat no 4 ). The tracings
are: pulmonary arterial pressure (Pp^)* left atrial pressure
(P^), cardiac output (CO), femoral arterial pressure (Pp^),
transpulmonary pressure (P^p), and the tensions of the
bioassay tissues continuously superfused with arterial
blood ( 10 ml/min) : rat stomach strip (RSS), rat colon (RC)
and chick rectum (CR). The assay tissues were calibrated
by direct infusion of PGF20t . H indicates hyperinflation
of the lungs. During the period of P^ elevation, indo-










































Fig. 15. Effects of infusing angiotensin II i.v. to an
anaesthetized cat ( cardiac output 400 ml/min ) on
femoral blood pressure and- 2 bioassay tissues
continuously superfuaed with arterial blood ( 10 ml/min ):
rat stomach strip (RSS) and rat colon (RC) before and after
1









the tension, ox the assay tissues, as the tissues were not blocked
against it. To investigate this possibility angiotensin II was
infused directly to the assay tissues in concentrations from 0.1 to
1.0 ng/ml. In these doses angiotensin II contracted the RC whereas
nc or only small contractions of the R3S and CR were observed.
This pattern is distinctly different from that of FG-E^ an!^
(fig. 16). Consequently angiotensin II cannot be responsible for the
observed tissue responses. On the other hand angiotensin II might
cause some of the effect observed on the RC and could, together with
release of PGEb,, give a picture of PG?2ec_ii^e activity.
Hematocrit (hct) and Osmolarity
At the onset of each experiment hct was in the range of 27-35 and
gradually declined to 15-28 during the experiment, probably due to
henodilution caused by transfusions.
Plasma osnolarity was unchanged at 320-528 n osmol/L throughout
each experiment.
Pulmonary Degradation of Prostaglandins
The effect of Pjj^ elevations on pulmonary degredation of prostag¬
landins was investigated in order to establish whether any systemically-
released PGs could have traversed the lungs without being degraded
during periods of increased P^A* Three cats (nos. 10-12, Table 4)
were pretreated with indomethacin (2ng/kg i.v.) before commencement
of the extracorproeal circulation. This dose was considered sufficient
to block systemic PG synthesis (Flower, 1974). 'Then indomethacin was
infused P-n, fell by about 10g and remained at this reduced level. , Ho
-D.fi.
definite change in mean GO was observed, while Pj-^ and PD^ fell slightly.
/ 9 5
Fig. 16. Effects of standard doses of PGE2 , PGF2o0 and
angiotensin II on 3 bioassay tissues superfused with arterial
blood ( 10 ml/min ) from an anaesthetized cat : rat stomach






































































When PGE2 was infused systenically (i.e. into the inferior vena
cava close to the heart or into the left atrium) the effect on Pp.
vras hiphasic. Within 2 rain of the start of infusion Pp. fell by
about 2% then rose to a value equal to or slightly greater than its
pre-infusion level. This increase in Pp^ was maintained throughout
the infusion. CO increased by about 15y during infusion and mean
^PA incres-se(i "by about 20^, thus pulmonary resistance increased during
infusion.
Intravenous PC must traverse the lungs and will be metabolized
(Perreira and Vane, 1967a) by enzymes present in the vascular endothel¬
ial cells (see p.17 ). PGE2 was infused into the inferior vena cava
during periods of control vascular pressures in concentrations of 15.A
-25.0 ng/nl/nin (Table 4) for periods of up to 23 min, until activity
on the assay tissues had reached a plateau. When compared with
calibrating doses infused directly to the tissues the activity was
equivalent to 2-3 ng/ral PGIiU, giving a value of Sl~92p degradation.
These values are in agreement with those of Perreira and Vane (1967a).
PGEg was infused for up to 25 nin. A plateau level of tissue activity
was reached and P^ was raised. Tissue activity was unaffected by the
elevation of left atrial pressure (8-10 nin) or the return to control
vascular pressures. One such experiment is shown in fig. 17.
9 8
Fig. 17. Vascular and assay tissue effects of an i.v.
infusion of PGEp ( 15 Ug/min ) in an anaesthetized cat.
Pp^= pulmonary arterial pressure, P^= left atrial
pressure and Pp^= systemic arterial pressure. The tensions
of the rat stomach strip (RSS), rat colon (RC) and
chick rectum (CR) are shown. Tissues were calibrated
with direct doses of PGEp (DIR). Left atrial pressure
(Pla) was and returned to control during the
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SECTION 1 PART 2. RADIOII.CUNOASSAY 0? PGF„
2a,
RESULTS
The antiserum did not distinguish between the F compounds
but showed no cross reaction with PGA, PGB, PGE^, PGE^ or the
dihydro- or keto-metabolites of PGF^^ and PGF^^ (fig. 20). The
RIA method is described fully by Gautvik, Teig, Wiberg, Bronsted
and Christoffersen (in preparation). The antibody was produced
in chickens. All determinations were carried out in duplicate
and differed less than 15%.
Fig. 18 shows the concentration of (ng/ml perfusate)
in the effluent, measured before and after pressure elevation and
induction of pulmonary oedema in one cat. lung preparation. The
concentration of the main pulmonary metabolite of PGF , 15-
c. OCc
keto, 13-14 dihydro PGF was also determined (by Dr. Hans Kindahl,£-00
Karolinska Institute, Stockholm ).
Table 5 and fig. 19 show the results from 4 experiments.
Neither the increase in P
^ nor the development of pulmonary oedema
in these lungs caused an increase in the PGF^ content of the
plasma, which remained constant or, in one cat lung, decreased
slightly during perfusion. There is a basal level of PGF^ in the
perfusate of these lungs of between 0.55 to 3.4 ng/ml before
PT, was raised.LA
Lung tissue content of PGF^ ' was also measured. Seven rabbit
lungs were perfused with horse plasma, 3 of which served as
controls. Control lungs were perfused for 15-30 min without
elevating outflow pressure and frozen during a period of decreasing
or stable weight. In 4 lungs P was raised to 15 or 20mmHg andliA
maintained until the lungs were grossly oedematous.
Lungs were removed from the perfusion circuit and rapidly immersed
Fig.18ChangesiplasmaPGFnd15-keto,13,14-dihydroPGF2(m asuredbRIA)before andfternincreasel ftatrialpressure(PLA)of25mmHg.
1 0 1
Fig. 19. Shows the changes in the amount of PGF0cL oc
(ng/ml) measured in plasma samples from the control
































































































in liquid DDM to halt PG synthesis.
The values for tissue content of PGF^ are shown in table 6a.
Tissue content of PGF^ was not significantly different in
oederaatous lungs from that measured in the control situation
(p>.429, Mann Whitney U-test one sided). These values are slightly
higher than the basal levels for PGF0 ( 8ng/g wet tissue weight )
c. 00
reported in rabbit lung tissue by Karim (1968).
The concentration of PGF
^ in tracheal froth is shown in table
6b. Duplicate measurements were made in samples of tracheal
exudate from 7 rabbit lungs by the same method used for plasma
PGF,^ determination. Values found were between 1.0ng/ml and 5.76
ng/ml (mean 2.73). Alveolar fluid in oedema probably represents
the outflow from the interstitium to the alveoli of fluid filtered
from the exchange vessels and as such is difficult to obtain
a control value for, since sampling of interstitial fluid from
normal lungs is impossible. However, the values for PGF&. in
tracheal froth are not different from those in the perfusate.
Thus in hydrostatic pulmonary oedema, PGF^ concentration
is not increased in perfusate from isolated lungs, or in
total tissue. Concentration in tracheal fluid is not signif¬
icantly higher than that of plasma.
X
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TABLE 6b. Tracheal fluid content of PGP,^ (ng/ml).









Fig. 20. amount of unlabled compound needed for 50#
3
displacement of H-PG-F2(^ from rabbit anti-PGF2^-serum,
_q
prostaglandin F2<& x ^ g
_q
prostaglandin ^lcC 0.3 x 10 g
-9
15 keto prostaglandin F2oC ^ ■L<^0 x 10 g
15-keto, 13,14- dihydro prostaglandin Flc^ >100 x 10~^g
_o
15-keto, 13,14- dihydro prostaglandin 30 x 10
prostaglandin E-^ >100 x 10-<^g
-9
prostaglandin E2 >100 x 10 yg
—9
prostaglandin A-^ > 100 x 10 g
—9
prostaglandin >100 x 10 7g
prostaglandin B2 >100 x 10~^g
Determined in 2 different assays where the results differed
by less than 20#.
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SECTION 2. RELEASE 0? PROSTASLAEDIITS
PURINE IIJLEOiTARY •R:GR0E.ECLISI!
RESULTS
Effects of Collagen Infusions
8.) Pulmonary and Vascular Effects' v n - ..... . ■ i i. ■. ■...
In total, 43 collagen infusions were given i.v. to 10 cats, each
animal receiving 3-7 infusions. Collagen infusion caused a narked
lung response as judged from the increase in Pp-j. (figs, 21 and 25)
during, and for a few minutes after the infusion. It has previously
"been shown (Vaage, So and Hognestad, 1974) that pulmonary arterial
pressure (Pp^) also increases in parallel with increase in Ppj,
although Pp^ was not measured in the experiments reported here. The
size of the lung response varied "between cats, although in individual
cats the response to the first 4-6 collagen infusions was similar.
During infusions there was a temporary decrease in systemic "blood
pressure ( in all "but 5 cases in 3 animals where no reduction in
P occurred, although the lung responses were present.
s* A
t>) Release of Prostaglandin-like Substances (PELS)
Three to four minutes after the start of each collagen infusion,
the Moassay tissues contracted, indicating release of PELS (figs. 21,
22, 23, 24 and 25). This release was assayed as 0.5 - 2 ng/ml of
PGE2 or PG?2K - like substances. However, the pattern of contract¬
ions could usually not "be exactly matched "by PGE2 or PGiV^* Tihen
KbA was included in the assay, collagen infusions caused contractions
of this tissue (figs. 21, 22 and 23) demonstrating release of 'rabbit
aorta contracting substance1 (RGS, see p.47 ). PELS were detected
during every collagen infusion where a lung response was present.
During 5 of the collagen infusions either the RC or the OR did
107
not contract. However, in these cases the non-responding tissue was
also insensitive to calibrating doses of 2-4 ng/ml PGEg and
Abolition of Assay Tissue Activity
Airway responses decline and finally disappear with repeated
collagen infusions (Vaage, 3/ and Hognestad, 1974). It was, there¬
fore, of interest to see if tissue activity also disappeared when the
lung responses were exhausted. However, the additional trauma to
the animal of the extracorporeal circulation during repeated infusions
prevented the use of bioassay throughout the experiment. Therefore
two cats without extracorporeal circulation were given infusions of
collagen at 30 min intervals until neither a lung response nor
platelet aggregation could be elicited. This procedure reduced the
number of circulating platelets to 25-30 per cent of the initial value.
At this stage blood su.perfusion of the bioassay tissues was started,
and each animal was given 3 more collagen infusions, to which neither
contractions of the assay tissues nor lung reactions occurred. A
further two animals were given an initial infusion of collagen which
evoked the usual lung response and release of POLS. Indomethacin
(5 ng/kg) was then infused i.v. This caused a maintained decrease
in PpA of 15 and 20 mmHg. Subsequent collagen infusions caused
neither lung reactions nor contractions of the bioassay tissues.
Platelet Aggregation ex vivo and in vivo
In 3 experiments one initial i.v. infusion of collagen (0.2 ml/
min) was given (in vivo aggregation), then platelet aggregation was
induced ex vivo by a smaller dose of collagen (0.05 ml/min) infused
directly into the extracorporeal circulation upstream to the assay
10B
tissues. In vivo and ex vivo platelet aggregation caused similar
contractions of the assay tissues, except the RC which showed a nuch
smaller contraction during ex vivo aggregation (fig. 23).
Release of Hinins and Angiotensin II
The assay tissues were not blocked against the action of kinins
and angiotensin II. Control experiments were therefore performed to
investigate whether release of these substances might "be responsible
for part or all of the tissue contraction pattern observed. In two
experiments a cat jejunum (CJ) was included as an assay organ and all
tissues were calibrated with bradykinin as well as PCs. Bradykinin
calibrations in the concentrations used (0.5-4 ng/nl), contracted the
CJ, but had little or no effect on the R33, RC and CR (fig. 24). Mo
significant contraction of the CJ was elicited by i.v. collagen infusions.
Release of kinins cannot be responsible for the contraction nattera of
the assay tissu.es observed during collagen infusions.
A fall in systemic blood pressure was observed during most of the
collagen infusions. Angiotensin II might be released secondary to
such reductions in blood pressure. However, during a total of 5
collagen infusions in 3 animals, there was no change in although
the usual lung responses and contractions of the bioassay tissues were
observed (fig. 21). Also calibrating doses of angiotensin II given
directly to the assay tissues (0,1-0.6" ng/ml) showed that the pattern
of tissue contractions occurring during induced platelet aggregation
could not be matched by standard doses of angiotensin II (fig. 25).
These doses of angiotensin II, however, caused contraction of the RC.
Release of angiotensin II might therefore be responsible for at least
part of the contraction of the RC observed during collagen infusions
 
110
Fig. 21. Effects of inducing intravascular platelet aggregation
by collagen infusions in an anaesthetized cat ventilated at
constant volume. The following bioassay tissues were continuously
superfused with arterial blood (10 ml/min) from the cat: rabbit
aorta (RbA), rat stomach strip (RSS), rat colon (RC) and*chick
rectum (CR). TP is the tracheal pressure and FAP femoral arterial
pressure. The tissues were calibrated with infusions of PGE^
and PG?2 directly into the superfusing blood. Isometric
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Fig. 22. Effects of 4 consecutive i.v. collagen infusions
( 0,2 ml/min ) to an anaesthetized cat. The bioassay
tissues are as in fig. 21. In this figure the scale of
the RbA is zero-suppressed. The asterisk in the tracing
of the RC indicates that the tissue touched its surrounding










































Pig. 23. Effects of inducing intravascular platelet
aggregation by collagen infusions in an anaesthetized
cat ventilated at constant volume. TP=tracheal pressure,
FAP= femoral arterial pressure, RbA= rabbit aorta, RSS=
rat stomach strip, RC= rat colon and CR= chick rectum.
:
The tissues were calibrated with standards of PGE2 and
PG^2cC • Collagen was infused either i.v. or directly














































Fig. 24. Effects of inducing intravascular platelet
aggregation by consecutive i.v. infusions of collagen
in an anaesthetized cat on femoral arterial pressure
(FAP), and on the following bioassay tissues continuously
superfused with arterial blood (lOml/min) from the animal:
cat jejunum (CJ), rat stomach strip (ESS), rat colon (RC)
and chick rectum (CR). The tissues were calibrated
regularly by infusions of PGE2 and PGF2^ and bradykinin
(BK) directly into the superfusing blood. Isometric
tension of the tissues is shown. At the arrow, the























































Fig. 25. Effects of infusing collagen to an anaesthetized,
cat on the following bioassay tissues superfused with 10
ml/min of carotid arterial blood : RSS= rat stomach strip,
RC= rat colon and CR= chick rectum. These effects are
compared with those of calibrating doses of PGE2, PGF20C
and angiotensin II (Agt. II) infused directly into the
superfusing blood. In this particular experiment systemic





























ssci'ioi! 3. hydrostatic Pulhoii-'je'.; oirsiia ;;;d chahc-ss in cl
RR3ULT3
Lungs Fixed "by Perfusion with g-lu.taraldehyde Solution
Samples of tissue from lungs fixed by glutaraldehyde perfusion
were taken fron three regions as described. 0edematous lungs showed
a vertical gradient in the degree of oedema: accumulation of oedema
fluid was most marked in the dependent parts of the lungs. Many
sections were therefore required to ensure representative sampling
and tissue samples from the three lung regions:upper, middle and lower
were usually talien.
Nineteen experiments were performed. Random samples of between
10 to 33 sections per experiment were taken from the upper, middle and
lower lung lobes in 15 experiments and from two lung regions in the
four others, and the sections were examined in the LM at magnifications
of xlOO and x250.
In appearance the cell nuclei stained dark blue and the cytoplasm
paler blue. Alveoli were observed in an irregular mesh formation and
alveolar sacs and ducts were seen. Larger vessels and airways were
sometimes seen. Filled alveoli were stained an even pale blue colour,
as were the contents of the venules and arterioles. Alveoli were
classified as either filled or empty. However, in contrast to the
results of Staub, Nagano and Pearce>(1967) some partly-filled alveoli
were seen, a concave meniscus stretching over the opening of the
alveolus from the alveolar sac.These were classified as filled
alveoli.
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Quantification of Alveolar Oedema
An attempt was made to quantify alveolar oedema by inspection.
A Leitz graticule with two crosslines at 90° to one another was
inserted into the eyepiece of the leitz orthoplan microscope. Random
areas of the sections were examined at magnifications of xlOO to x250
and the number of filled or non-filled alveoli scored. The results
are shown in Table 7a. Between 400 and 800 alveoli were scored in
each experiment and the percent of filled alveoli calculated.
Experiments where weight increase was 10g showed a fall in C^.
Lungs Fixed by Rapid Freezing
In 22 experiments lung tissue samples were taken from the upper
region of the lower or middle lobes - i.e. approximately on the
horizontal level of the hilus - and from the lower
part of the lower lobes about 0.5-1 cm from the lobe tip. Ho samples
were taken from the upper lobes as they were often distorted in the
clamping and freezing procedure. Tissue from these two regions was
cut and embedded in epon (p. 67), sectioned by microtome and stained
as described (p.68 ). A random sample of 6-12 sections from both
areas were examined under the light microscope.
In experiment 2, only epon-embedded sections were examined and
no samples were taken for paraffin-embedding. In experiments 3-23
tissue samples were embedded in paraffin for sectioning: in all but
3 experiments samples were taken from the upper part of the lower lobe,
while in the remaining 3 lungs samples from the lower part only were
embedded. In 8 experiments blocks from both areas were embedded and
in 2 experiments (17 and 18) two blocks from the same area were used.
Initially sections were cut from the surface of the prepared
block, then serial sections were cut between 1 and 2 ram deeper in the
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block. Two or three horizontal areas of 1 cnr from each block -ore
then available for quantification of oedema enabling a large area of
the lung to be seen.
Sections were examined at magnifications of x25 to x250 under the
light microscope. In appearance the nuclei of cells stained purple
while plasma stained pink. The freeze-drying process causes ice
crystals to sublimate leaving "strings" of coagulated protein which
stained pink and could be clearly seen in the lumen of the larger
arteries end veins (fig. 26). At the pleural edges of the lungs,where
freezing was fastest and the ice crystals formed smallest,the protein
"strings" were close (fig. 27a) while deeper in the lungs larger ice
crystals were formed and the "strings" more clearly visible (fig. 27 ).
Lymphatics lay in the perivascular interstitium of the arterioles
and were often very distended in lungs where several grams of fluid
had been filtered (fig. 28). They were narrow or not visible in
control lungs,although occasionally large lymphatics were observed
(figs. 29,30,31 and 32). In control lungs the capillaries in the
alveolar walls were of a narrower diameter than in congested lungs
(fig. 33). Interstitial areas around the larger vessels and bronchi
were stained purple and the tissue was fairly dense. In control lungs
the interstitium in that area was usually a very narrow perivascular or
peribronchial cuff although distended interstitium was observed in one
interstitial area in lung 2 (fig.31). Alveoli were an open meshwork
and had no contents.
In tost lungs where fluid filtration had occurred, interstitial
oedema was visible as largo cuffs around the arterioles or bronchi.
as described in the introduction, the pulmonary arteries run close to
the bronchi, while the veins lie in the area between two arterial trees
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(fig. 34). Distended interstitium consisted of interstitial tissue
(collagen matrix as described in the introduction) filled with the
exudate from the exchange vessels. In many experiments cells were
seen in the interstitium, often clustered in the area between the
arteriole and bronchiole ( see figs. 35, 36 and 37) and were'probably
leucocytes. Large vessels were observed which did not possess cuffs
(while others in the vicinity of airways did) and these were consid¬
ered to be veins (see fig. 34).
Alveolar flooding was often observed in the alveoli in the area
close to perivascular and peribronchial cuffs ( fig. 38). Otherwise
flooding was often patchy .and a picture of filled or non-filled
alveoli was seen (figs 39 and 40). In areas where the alveolar sac
was sectioned transversely a pattern of partly-filled alveoli radiating
from the alveolar sac could sometimes be seen (figs. 41-44). There
was a concave meniscus over the entrance to flooded alveoli and in
severe oedema, often over the entrance to the alveolar sac. Alveolar
ducts were usually empty even in quite severe flooding (fig. 45).
In very severe oedema bronchiolar flooding was very occasionally
observed (fig. 46). Alveolar flooding was often seen to occur in
the alveoli in the areas surrounding the larger arterioles and
bronchioles in lobes where little flooding otherwise existed(fig.47).
Quantification of Alveolar Oedema
Quantitative morphometry was based on the method of Weibel(1963)
as used by Caldini, Leith and Brennan (1975). A 25 point reticle
(integrating eyepiece 1 of Zeiss, according to the design of Hennig
1958) was inserted in the occular of the Leitz "orthoplan" microscope
and the epon and paraffin embedded sections from rapidly frozen lungs
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were examined at a magnification of xlOO or x250. For each field of
25 points the number which overlay filled and empty alveoli (and
alveolar walls) were scored. Points overlying alveolar ducts or
sacs were not scored, nor were arterioles, bronchioles, perivascular
or peribronchial interstitium or lymphatics.
Between 13bl and b602 points overlying alveoli were counted.
In most experiments over 2500 points were counted to improve accuracy
of the results (Caldini, Leith and Brennan, 1975). 'the fraction of
points over filled alveoli was calculated and expressed as a percent¬
age of the total counted (Table 7b). A3 this is a ratio, and can be
compared between experiments, it was not necessary to correct for
section thickness (Weihel, 19fc>3) • However, since filled alveoli have
a smaller volume than non filled alveoli this method may underestimate
the proportion of filled alveoli. All lungs were fixed at end
expiratory pressure. Table 7b snows the results from 22 experiments
in rapidly frozen lungs where the percentage of filled alveoli of the
total number of alveoli counted is shown. The number of points
counted is also shown.
Fig. 48 shows the percentage of alveolar flooding and weight
at the point of fixation for each lung. The percentage change in
PTpfrom the initial (30sec after raising ?LA) to PTp at the
point of fixation is also plotted. The results show that at low
weight gains ( that is 3.5— lOg ) there is some alveolar flooding:
a progressive increase in flooding of up to 10% of alveoli occurs.
Also at weight increases of 10-12g, where the 2° fall can he expected
to start, there is an increase in the amount of flooding (10-20$)
and in lungs where the 2° fall had clearly occurred there is a sharp
increase in the amount of alveolar flooding (48-88% at 15-17.9g).
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Point Counting Method for the Quantification of Interstitial Oedema
The major accumulation of interstitial liquid during oedema
formation rras around the larger arterioles and bronchioles (diameter
ahout 100 pi to 1 ram), and was visible both within and outside dilated
lymphatics (figs.49» 50 and 51). Photomicrographs were taken with a
35 nun camera attached to the microscope at magnifications of >:5 to x20
of the areas of the sections where these vessels and airways were
present. The slides were projected onto a screen of (40 x 60 crap
with a grid of points 0.5 cm apart (method of Bland, personal communi¬
cation to Br. G. Nicolaysen). Sometimes slides "were projected onto
graph paper (40 x 6Q cmp ana the outlines of the arterioles, bronchioles
and interstitial cuffs were drawn, and the numuer of points 0.5 cm
apart counted. A micrometer scale photomicrograph of the same
magnification was also projected.
She number of points within vessels and the number in the peri¬
vascular cuffs were counted and a ratio of cuff to vessel lumen was
obtained. Mainly arterioles and their perivascular cuffs were counted
since they possessed the largest interstitial areas (figs. 52 and 33).
Peribronchial cuffs were often smaller (figs. 54 and 35) and only
those witn large cuffs were counted. Bronchial arterioles when seen
nad. large cuffs (figs. 56 and 57). In these areas wnere vessels and
bronchi shared interstitium the area round the vessels was point-
counted taking a demarcation line for the perivascular cuff by extra¬
polation if necessary. The ratio of cuff to vessel (bronchus) sizes
for each experiment is shown in 'l'able 8 along with the number of vessels
(or hroncni) counted per experiment
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TABLE 7 a.



















































































Weight (in grams) and percentage of alveolar flooding in lungs
fixed by gluteraldehyde perfusion.
TABLE 7b
Percentage Alveolar Flooding in Rapidly-Frozen Lungs
Experiment Weight at Precentage Number of
number Fixation Alveolar flooding Alveoli counted
20 0 1816
18 0 0 6173
19 o o 2329
3 2.7 2.21 5242
4 4.0 6.53 2877
5 5.0 21.3 4036
10 5.5 9.16 3397
23 7.5 9.81 2936
11 9.0 9.1 2757
12 9.3 10.13 2102
14 9.7 16.03 3041
9 10.2 9.4 2093
6 10.6 13.85 3387
7 11.0 28.3 4405 ■
16 11.2 23.7 3078
17 11.2 8.1 3815
8 11.7 20.0 3140
20 13.4 76.0 2457
15 15.0 47.9 4184
*
21 15.0 85.16 6602
22 17.9 48.83 2511
1 2 2
TABLE 8 .























Ratio of cuff to vessel size (from point counting method)
in rapidly-frozen lungs, and the number of vessels or airways
counted per experiment.
1 2 3
Fig. 26 shows a section of a pulmonary vein (experiment
3). Large protein "strands" have been formed during the
freezing procedure, and can be clearly seen.
1 2 4
Fig. 27 Experiment 23, lower lobe. A transverse
section of the lobe specimen, beginning from the septum,
is shown. Contents of the peripheral venules and arterioles
are homogeneous, while those of deeper vessels show
clear strands of protein.
 
1 2 5
Fig. 28 Experiment 4-. A perivascular cuff and distended
lymphatics are seen in this experiment, where A grams of
fluid was filtered.
1 2 6
Figs 29 and 30. Experiment 2. No perivascular or
peribronchial oedema was visible in these control
lungs, although some filled lymphatics are seen.
1 2 7
Fig. 31. Considerable perivascular oedema is seen. L
Lymphatics are distended, and flooded alveoli are absent.
(Experiment 2).
Fig. 32. No peribronchial oedema is visible, and the
alveoli are empty.
1 2 8
Fig* 33. Experiment 18,control. No contents in the alveoli
and alveolar walls are narrow when compared with experiments
with raised Pj-a.
Pig. 34-. Relative positions of pulmonary arteries, veins
and bronchi.
*









Fig. 35 and 36. Leucocytes in the peribronchial area in experiment 3.
Fig. 37. Leucocytes close to a pulmonary vessel in experiment 16.
Fig. 37.
1 3 2
Fig. 38. Alveolar oedema in the area near a vessel with
perivascular oedema. (Experiment 4-).
3 3
Fig- 59. Alveolar flooding is "patchy". Flooded areas
are interspersed with partly-filled or empty alveoli.
The partly-filled alvaoli are seen radiating from a single
alveolar sac. (Experiment 15).
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Fig. 40. Alveolar flooding is not uniform in this area.
Also note the presence of bubbles of trapped gas (arrow).
(Experiment 15).
1 3 5
Fig 41, Experiment 23. Area near septum showing filled
and partly-filled alveoli. Note filled alveoli with a
concave meniscus over the entrance from the (empty) alveolar
sac.
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A pattern of filled and partly-filled alveoli
(Experiment 23).
1 3 6
Figs. 4-3 and 4-4-. Partly-filled, filled and empty alveoli
are seen. (Experiment 23).
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Fig. 46. Experiment 11
1 3 8
Bronchus containing some fluid.
J
1 3 9
Fig. 4-7. Areas of alveolar flooding predominantly in the







































Fig. 4-9. Perivascular oedema is clearly visible as a cuff
around this artery. (Experiment 8).
Fig 50. Perivascular oedema surrounds this artery, and
the lymphatics are distended. (Experiment 7).
1 4 2
Fig 51. Oedema fluid is present in a perivascular cuff
with filled lymphatic vessels.
1 4 3
/ hlA
Fig. 52. Experiment 8. Fluid collects predominantly in
periarteriolar not beribronchial cuffs.
Fig. 53• Periarteriolar oedema is greater in the area
«
between the artery and bronchus. (Experiment 8).
1 4 4
Fig. 54. Little peribronchial oedema is visible (exp.5)
1 4 5
146
Pig. 56. A bronchial arteriole v/ith a muscular wall and narrow
lumen is shown. This is surrounded by considerable perivascular






Fig. 57. A bronchial arteriole with thick muscular wall is shown.
The perivascular fluid cuff is large and lymphatics are distended.
(Experiment 10)
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SECTION 1, PART 1. THE RELEASE OF PGS FnOH LUNOb
DURING INCREASED HYDROSTATIC PRESSURE AND Q5335JTA
DISCUSSION
The Hethods Used
(a) The Bloassay System
The aim of the hioassay system was to detect a variety of substances
released into the blood or perfusate from lungs in vivo and in vitro.
In particular the occurrence of prostaglandins, their precursors and
metabolites was of interest since they were considered likely to be
released.
The three main assay tissues RSS, RC and CR were chosen for their
characteristic response to prostaglandins E and P, for which they are
particularly suitable, although they are also somewhat sensitive to
other active substances.
RSS is considerably more sensitive to prostaglandins of the E
series than to P prostaglandins, while PGFr^ and PGE are equipotent
on the rat colon (Gilmore, Vane and Wyllie, 1968; Said, 1974). In
the present experiments calibrating doses of PG?20C contracted the RC
proportionately more than did PGS2, but PGP2^ was usually much less
active than PGEp on the RSS (see fig. 9 and 11). The chick rectum
was always much more sensitive to the effects of PGEg than PGP^,
confirming the observations of Said (1974).
Simultaneous contraction of the chick rectum and rat stomach 3trip
demonstrates the presence of PGE-like material, while contraction of
the rat colon with little or no contraction of the rat stomach strip
would indicate the presence of PGP^, (Piper, Vane and '.Vyllie, 1970).
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That this pattern of response correlates to the presence of PCS and
P has "been verified "by chromatographic, chemical and inmunological
methods (Gilnore, Vane and Vyllie, 1968; LIcGiff, Crowshaw, Terragr.o,
Lonigro, Strand, Y/illianson, Lee and !Tg, 1970; Davis and Horton, 1972;
Douglas, Johnson, liarshall, Jaffe and Heedlenan, 1973). The specific¬
ity of the hioassay system is, therefore, the "basis for the qualitative
identification of prostaglandins although confirmation cones from the
disappearance of activity after indonethacin, a specific inhibitor of
PG "biosynthesis (Perreira, I'oncada and Vane (1971).
The perfused organs were nade more specific by pretreatment with
the •'combined antagonists", (Gilnore, Vane and uyllie, 1968). This
meant that the tissues were blocked againsx the actions of ACh, 5-ET
catecholamines and histamine which night have been released in the
intact animal due to systemic hypotension (catecholamines) platelet
aggregation (5-HT and ACh, see p.175)» or in the isolated lungs
(histamine) by dextran.
Indonethacin (5 ng/l) was added to the tissue bathing fluid in
nost experiments, prior to superfusion to prevent intramural genera¬
tion of prostaglandins (Eckenfels and Vane, 1972). It did not appear
to reduce the sensitivity of the tissues to calibrating doses. In
fact the effects of calibrating PGs were often more clearly defined
since the spontaneous activity of the tissues was decreased after
indonethacin treatment. This was especially important in the rat
colon, where spontaneous activity was particularly pronounced, often
masking the effects of small calibrating doses.
Vane (1971) showed 100;* inhibition of PG synthesis i:i honogenates
of guinea-pig lung with 2 p.g/nl incomethacin. The concentration
required to inhibit synthesis varies with species and with the pre-
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paration tested (Flower, 1974). In the present experiments the
assay tissues were pretreated with up to 5 ug/ml which could he expected
to inhibit PG synthetase. Doses of up to 12.5 P-d/ml in isolated lungs
and 5 ng/kg in intact cats were given and could he expected to inhibit
synthesis. Only with very much higher doses (20 pg/ral; Horthover,
1971) would smooth muscle activity he depressed. This did not occur
in the present experiments.
The assay tissues may also detect precursors and metabolites of
the prostaglandins, and the rabbit aorta strip was included in several
experiments. Rabbit aorta contracting substance (RCS), which is a
mixture of fx&2 with small amounts of. PG enaoperoxide (Hamberg,
Svensson and Samuelsson, 1976) has a half life of 1-2 min in Krebs
Ringer solution (Palmer, Piper and Vane, 1973). This is probably longer in
plasma, however, since the half like of Tsdu? is about 3 min in plasma
but only 30 sec in artificial media (Granstron, Kindahl and Samuelsson,
1976; Smith, Ingerman and Silver, 1977). This means that RCS would
be detected despite the delay of 1-15 min before the venous effluent-
reached the assay tissues.
The RbA and RS3 are reported to be equally or even more sensitive
to the PG endoperoxides and TxA^ than to PGB2 and PGPgcc* Hamberg,
Hedqvist, Strandberg, Svensson and Samuelsson (1975) have shown that
the RSS is equally sensitive to the PG endoperoxides as to PGS2 and
PGP^j-c while the RbA is very much more sensitive to the endoperoxides
than to E_ and F0 . Bunting, Hone ada and Vane (1976)» have found
2 2x
PGBg to be more potent that the endoperoxides (factor of 2-3) or TxAg
(factor of 10) on the RSS, and P'GFjvjc Kore potent than all these sub¬
stances on RC, whilst on the RbA TXA2 was more potent than the endo¬
peroxides, and PGs and ?2Cc were inactive.
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Prostaglandin metabolites retain some biological activity
(Anggard, 1966). Cruxchley and Piper (1975b) have shown that the
three pulmonary metabolites formed by the action of PG1>H and/or PG
reductase rere active on the bioassay tissr.es rat stomach strip, rat
colon and chick rectum. The 13-14 dihydro metabolite was 0.2 times
as active rhile 15 - keto PGfi2 and 13-14 - dihydro - 15 keto PGIPj rere
only 0.1 and 0.01 times as active as PGEg.
The bioassay is therefore a good method for detecting ongoing
PG synthesis.
The assay tissues rere not blocked against bradykinin or angio¬
tensin, rhich might be expected to be released during platelet aggre¬
gation (see Section 2, p. 172$ and systemic hypotension (see Section 1,
P. 1621 respectively.
Calibrating doses of angiotensin II (p. 91 ) shored a distinct
pattern of tissue activity for this substance (figs. 16 and 25).
The pattern of assay tissue contraction to bradykinin is shorn in
fig. 24. The RSS contracts to bradykinin (4 ng/ml), the chick rectum
is less active and the rat colon is insensitive. This pattern of
contraction differs only slightly from that of PGx^ and in order to
ensure that significant amounts of bradykinin rere not released during
pulmonary embolism (see Section 2 , p.172) the assay tissue, cat
jejunum, which contracts specifically to bradykinin, was used.
(b) The Radioimmunoassay
The specificity of the antiserum to PGEpx 4s discussed in Section 1,
part 2. Radio immunoassay methods and conclusions are discussed
on p. 170.
(c) The Intact Cat Preparation
Extensive open chest surgery and an extracorporeal circulation
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were required in this preparation. These inposed a considerable
strain on the animal causing progressive arterial hypoxemia end
systemic hypotension. Although, the animals were heparinized, the
foreign surfaces of the extracorporeal circulation nay have activated
platelets causing them to aggregate and become trapped in the pulmonary
microvasculature. This caused a tendency to hypotension which was
difficult to prevent with transfusions of blood or dextran, and only
a limited number of pressure elevations could be performed in each cat.
Infusions of indomethacin caused a fall in systemic blood pressure
(fig. 15) which often prevented further pressure elevations being made.
The prostaglandins released during pressure elevation may affect the
tone of the systemic arteries. Probably the unstable precursors are
also important and these are mainly pressor(' Rose, Kot, Ramwell, Doykos -
and O'Neill, 1976). This may explain why the animals experienced
grave hypotension when the balloon was inflated after indomethacin
treatment, since the systemic pressor effects would be eliminated.
In retrospect, the infusion of nacrodex to the animals to maintain
blood volume and systemic pressure was inadvisable, since subsequent
experiments showed that dextran stimulated PG- synthetase in isolated
lungs. In fact, only small volumes were infused (up to 50 ml), and
in two cats no dextran was infused5 and no difference in PC- synthesis
was observed.
(a) The Isolated Lung Preparation
The isolated lung preparation has been used by many investigators
to detect the release of active substances to chemical and mechanical
stimuli. Despite the extensive degrading capacity for prostaglandins,
they have been reported to occur in the venous outflow of the lungs
after a variety of stimuli.
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Every attenpt was made in these experiments to prepare the tissue
with the minimum amount of handling. If the lungs were damaged in
any vay, if perfusion of the tissue was uneven (i.e. colour was patchy),
or If atelectatic areas were observed when the lungs were ventilated,
the preparation was discarded. If, as occu.rred In rare cases, the
perfusion pressure increased progressively at the start of perfusion,
the preparation was also discarded and a fresh one talien. It was
desirable to study PG release during, as far as possible, physiological,
not pathological conditions, since only in this way can a,ny findings
pertain "to the in vivo situation.
The main advantage of using an isolated, instead of intact, lung
preparation is that the possible contribution of, for example, release
of substances from other organs, or the effects of reflexes can be
avoided.
All animals were heparinized fully before removal of the lungs
during surgery. This will probably reduce the trapping of platelets
in the pulmonary circulation. Also, at the start of perfusion the
initial perfusate was discarded after it washed the remaining blood
from the tissue; and capillary beds were "recruited" by a short period
of elevation of left arterial pressure, which also facilitated washout.
Other workers who stun the animals before removing the lungs may have
considerable pulmonary trapping of formed blood elements.
ITature of the PC-IS and Other Substances') Releasor!
Inflation of the balloon catheter in the left atrium of anaesthet¬
ized cats caused pulmonary hypo tension end congestion, as well as
systemic hypotention. This has been described previously in the same
experimental model by Hauge, Bo and Aarseth (1977)» -bo showed a
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relatively snail increase in extravascular lung water in spite of a
raised of more than 30 mmHg. Only in a few cases was narked
fluid accumulation oh served, which they suggested represented alveolar
flooding. This corresponds well to the present findings where the
P.jip appeared to return to normal when Pj,/\ was reduced (suggesting re-
estahlishnent of the initial intravascular volume and reabsorption of
filtered fluid), except in 2 cases where alveolar oedema occurred.
In all 9 cats (Table 3) one or more periods of Pjelevation
produced detectable activity on the bioassay tissues, which probably
represents PG—like substances, since the tissues were blocked against
the action of histamine, 5 HT, ACh and catecholamines (I'ethods p.46)„
However, the tissues were not blocked against the effects of angiotension
II. The occasionally grave systemic hypotention produced when the
balloon was inflated probably stimulated the renin-angiotensin system
with subsequent release of angiotensin X. This would then have been
converted to angiotensin II in the lungs (p. 8 ) and released into the
arterial blood.
The effects on the tissues themselves of angiotensin II infused in
doses up to 1 ng/ml into the superfusate were studied. The RC contract¬
ed strongly to angiotensin II while almost no activity was observed on
the RSS or CR. However, this pattern of tissue contraction differs
substantially from that due to calibrating doses of PGE, and PCPV,„
(fig. 16) or during periods PLA elevation (fig. 14). Indeed the
contraction of RC during P^ elevation may be completely explained by
the effect of angiotensin II. nevertheless, release of angiotensin
II alone is not sufficient to explain the contraction of RSS and CR
observed, nor would the release of angiotensin II be inhibited by
indonethacin. The return of these tensions to baseline on infusion
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of indonethacin in four cats (fig. 14) proves that the substances
released were prostaglandins.
Identification of the exact type of PG released is not possible.
Tissue contractions matched those of PGIV most closely, hut when the2cc
contribution of angiotensin II is taken into account, the substances
released may have been PGS2 Plus angiotensin II. However, since
prostaglandin intermediates and metabolites are also active on the ESS
EG and OR to different extents, and since the contractions of the RbA
proved that thromboxanes and possibly endoperoxides were released,
it is only possible to say that PG systhesis was stimulated by' the pressure
increase. The identity of the PG-like compounds released cannot be
ascertained.
In 4 out of the 18 pressure elevations no release of PGLS was
detected. . This might indicate that release is not a constant pheno¬
menon, or rather that the amounts released mere too small to be
detected. Since the lover level of possible detection in the bioassay
mas 0.5-1 ng/nl PG32 and. 1-2 ng/ml of PO?2K (figs. 14 and 16), and
the amounts released during pressure elevation were of this order of
magnitude, a minor reduction in PGLS released would not be detected.
Release of PGs appears to be due to de novo PG synthesis, as
little or no PGs are stored in the tissues (Piper and Vane, 1971).
Although angiotensin II in severa.l tissues and cells is reported to
stimulate PG synthesis and release (HcGiff et al. (.1970), Gimbrone
v
and Alexander (1975)> see ?. 173) infusion of angiotensin II to cause
increased levels in blocd entering the lungs did not release PGLS into
arterial blood (fig. 15). The increase in the blood level of angio¬
tensin II was higher than the maximal increase during hypovolemia
(0.35 ng/ml5 Hodge, Lowe and Vane (i960), Hall and Hodge, 1971); but
no release of PGLS was observed since the tissue patterns to infused
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angiotensin II before and after indometbacin treatment were identical.
Stimulus to Release PGLS
The mechanical stress due to increased -vascular hydrostatic
pressure may well stimulate PG synthesis. Piper and Vane (1971) have
indirect evidence that leakage of fluid into the extravascular space,
rather than stretching of vessel walls, releases prostaglandins:
isolated perfused guinea-pig lungs sensitised to ovalbumin released
PGs only when an irreversible increase in weight of the lungs occurred.
In lungs where pulmonary venous pressure is increased there is an
initial rise in pilmonary blood volume due to distension of vessels and
recruitment of new capillary beds (Section 3> p.181). There follows
a net outward filtration of protein-containing fluid from the exchange
vessels into the interstitial space, considerably distending it.
Lymphatic drainage increases, and, if filtration continues, fluid
enters the alveolar spaces of the lung (Staub , Nagano and Pearce,
1967).
It is possible then that PGs could be released from the lungs
in pulmonary oedema, perhaps as the tissue extracellular space is
filled with?and expanded by,fluid filtering from the exchange vessels.
In fact, Said and Yoshida (1974) report that pulmonary oedema
released PGs. Apparently fluid extravasation may be a stimulus for
PG release. However, fluid accumulation in the interstitium is usually
rather scarce when P is elevated in intact cats (Hauge, BC and Aarseth,IjA '
1977) and in one of two cases where fulminant alveolar oedema developed
no PGLS were released. Also in the isolated lung experiments where we
induced a slow filtration of fluid into the extravascular space by
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means of a moderate rise (10-15 mmHg) in left atrial pressure in plasma
perfused cat and rabbit lungs (Table 1, Group A and fig. 6) there was
clearly no release of prostaglandins, nor were PGLS detectable in
f
tracheal fluid bioassay (fig.7).. This would indicate that release
of PG-s in intact cats was a result of the very considerable elevation
of hydrostatic pressure and not due to fluid filtration from the
exchange vessels.
In isolated perfused lungs (Table 1, Group B; outflow pressure was
raised to 20, 25 and in one case 30 mmHg, with no observed release of
PGLS, although pressure elevations of similar magnitude in intact cats
did cause release (figs. 8 and 9)• This would imply either:
(a) that release in isolated lungs was below the limit of detection of
hioassay (see p.26 ) or
(h) that the lungs are not responsible for the observed release, or
(c) that inflating the ballodn activated some mechanism in the intact
cat which released PGs from the lungs. This mechanism must not have
existed in the isolated lung.
Another possible explanation for the discrepancy between the results
from isolated perfused lungs and intact animals may have been due to the
species difference, since initial experiments were performed on isolated
rabbit lungs. This could also have explained the discrepancy observed
between these results in isolated lungs where no release was observed,
and those of 3aid's group where PG release was detected in cat lungs ,
and this was a strong argument for the importance of species variation
in causing the apparent anomalies. In fact even differences in strain
within a soecies have been shown to cause marked differences in biological
responses to pharmacological stimuli. Accordingly, two isolated cat lungs
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were tested. (Table 1) under identical perfusion conditions as for ralibit
lung preparations, with liorse plasna as perfusate. In one pair of cat
lungs slow filtration of fluid was not acconpanied "by detectable PG
release (Table 1, Group A, experiment 7) while in a second pair of
cat lungs (Table 1, Group S, experiment 12) perfused with horse plasna
induction of hydrostatic pulmonary oedema was rapid (P^-^20 mmHg),
causing considerable sudden increase in blood volume and distension of
vessels. These lungs also failed to release prostaglandins.
The importance of perfusate characteristics and the role of
platelets in PG release was then considered. Platelets "are found in
large numbers in the pulmonary microvascu.lature (Kaufman, Airo, Pollack
and Crosby, 1965) and- nay be trapped there in microaggregates, or
adhere to the capillary walls, and night have been the source of at
least part, of not all, of the PGLS detected from the intact cats.
Platelets are capable of releasing large amounts of prostaglandins
during aggregation (Smith and Willis, 1970; Hamberg and Samuels son,
1973), aud their importance in pulmonary embolism is discussed in
Section 2 ( p. 172 ). The extracorporeal circulation may
aggravate the formation of microemboli when blood comes in contact
with foreign surfaces and these emboli will be trapped in the vast
pulmonary microvasculature and may release PGL3. Increasing hydro¬
static pressure may then 'wash out' PGLS from previously occluded
capillaries, which would then be detected on the assay tissues. This
\
is unlikely for two reasons. The release of PGL3 was maintained
during periods of Pr ^ elevation of up to 10 minutes duration (in all
but one case) an unlikely occurrence if the prostaglandins were pre¬
formed and simply entering the systemic arterial circulation. Also
the effect of indomethacin and the activity on the RbA must strongly
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suggest de novo systhesis. The origin of these nevdy synthesized
PGs may have "been the platelets. However, in two cat lungs perfused
with heparinized cat whole "blood no PG release was detected during
grave vascular distension and subsequent pulmonary oedema (Table 1,
Group B, experiments 13 and 14). Therefore the lack of pla.telets in
artificial perfusates is not the factor responsible for lack of PG
release in the isolated lungs, and it is extremely unlikely that PGLS
released in intact animals originated from the platelets.
Recently attention has been focused on the role of PGs as local
hormones or intracellular messengers rather than circulating hormones
(Silver and Smith, 1975) this is consistent, in the case of PGs of
the B and B series, with their short life in vivo (see p.15 ). Mathe
and Levine (1973), using radioimmunoassay, reported release in anaphy¬
laxis of the pulmonary metabolites of prostaglandins, the 15 - keto
13, 14-dihydro - prostaglandins, with little or no release of parent
prostaglandins. Also Liebig, Bernauer and Beskar (1974) have detected
high amounts of the 15-keto 13, 14-dihydro metabolite of PGFp^. amongst
the other active substances released during anaphylaxis. One explana¬
tion is that an active PG degradation mechanism downstream from the site
of PG release may metabolize part or all of the prostaglandins, which
have been synthesized and have acted as local hormones within the tissue
or vessel walls, before they leave the lung via the pulmonary circulation.
If this is indeed the case it is of importance to try to detect not
only parent prostaglandins but their pulmonary metabolites also.
The site of pulmonary degregation of PGs is the capillary endo¬
thelial cells (Ryan, Jfiemeyer and Ryan, 1975) • Although no PG release
into arterial blood was detected, there nay have "been stimulation of
synthesis in the.tissue itself, which would be detectable as an
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increasec(tissue content of PG or as high levels in the tracheal fluid.
In "both these instances PGs would probably have escaped degradation.
However, the concentration of PGF^ in homogenized lung tissue
was not significantly different in ©edematous than in control lungs. (Table
Also ria measurement of PGF2jc in tracheal froth detected only snail
amounts of this substance (1 - 5*56 ng/nl) which did not differ from
that detected in perfusate samples (0.7-3.58 ng/ml), and was considerably
lower than the concentration of pg (20 ng/ml PgF reported by
Chijimatsu, Kara and Said (197&). In the single experiment where 15 -
keto 13, 14"~dihydro PGF in the perfusate was measu.red, the concent-' v 2cc
ration of this metabolite more than doubled during 45 minutes of per¬
fusion, increasing from 1.35 to 3.3 ng/ml (fig. 18). In the same
experiment there was a corresponding decrease in the plasma concent¬
ration of the parent prostaglandin, PGF^. It must be noted that the
lungs were perfused in a recirculating system. Possibly the high
initial plasma level of PGF?<y was due to the effect of removal end
perfusion of the organ on stimulation of PG synthesis, and subsequent
breakdown of this to 15"keto 13,14~dihydro PGF^ in the circulating
plasma would be sufficient to account for this substance's increase.
These experiments with radioimmunoassay, which is capable of
detecting much lower concentrations of pg than is possible by bioassay,
show that no increased synthesis of pgf occurred during hydrostaticCO
pulmonary oedema.
Localization and Cause of PG Synthesis
It was important tc ascertain whether the PGLb "released from intact
cats were from the lungs or not. It is known, for example, that
PGs are released into blood during haemorrhagic shock (Jekschik,
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Marshall, Kourik and Needleman, 1974). If PGLS are released from
extrapulmonary tissues they would have to traverse the lungs to
appear in arterial blood. Since the catabolism and inactivation
of PGs in the pulmonary circulation is extremely efficient
(70-90fo ; Perreira and Vane, 1967a; Piper, Vane and Wyllie, 1970
see p. 94 ) it would require very high levels of PGs in the mixed
venous blood reaching the lungs to produce activity equivalent
to 1ng/ml in carotid arterial blood.
It might be argued that the increased PG-like activity in
arterial blood of intact cats is due to decreased pulmonary
inactivation of PGs. Whether increased vascular hydrostatic
pressure will influence PG degradation in endothelial cells
is unknown. However, some factors might actually tend to increase
PG inactivation : increased vascular surface area due to distension
in the microcirculation, as well as reduced cardiac output will
increase the exposure time of the pulmonary endothelium to blood.
In fact fairly extensive damage to the pulmonary endothelium has
to occur before inactivation is impaired ( Jose et al, 1976)
during pulmonary hypertension in man. Jakschik et al (1974),
who report peak arterial concentrations of 2.6ng/ml of PGE2-
like material in carotid arterial blood of dogs after severe
haemorrhagic shock,have suggested either that the pulmonary
degradation of PGs must be impaired or that the lungs are the
source of these PGs, perhaps as an autoregulatory readjustment
of blood flow as occurs in the kidney ( Herbaczynska-Cedro and
Vane, 1973), and the heart ( Alexander, Kent, Pisano, Keiser and
Cooper, 1973). To ascertain whether pulmonary degradation of PG
was altered during pressure elevation, exogenoxis PGE2 was infused
at normal pressures. A value for pulmonary degradation of about
80fJ was found and this was unaffected by elevation of P ^ ( fig.
17 ; and Table 4 ).
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On the other hand the assay tissu.es are somewhat sensitive to the
pulmonary metabolites of PGs (Cru.tchley and Finer, 1976) although
sensitivity is only 1/10 to 1/100 of that of the parent PGs. Consequently
percentage pulmonary degradation nay have "been even higher than 80Jj,
since the effects of the metabolites on the tissues might give a
falsely high estimate of the amount of unchanged PGS2.
Whatever the actual value for the pulmonary degredation of pro¬
staglandins it remains the same during alterations in vascular pressure.
It is therefore very likely that the PGs were released from the lungs
themselves, probably distal to the site of destruction.
The systemic hypotension caused when pulmonary hydrostatic pressure
was raised (Table 3) aay activate the sympathetic nerves to the lungs
ana cause PG release (see p. 19). Increased sympathetic activity is
known to cause PGE synthesis in several other organs (Hedqvist, 1976)
and may have been the stimulus for release here, since stimulation of
sympathic nerves to the lungs has been reported to release PGs (Mathe'
et al, 1977).
The Effect of Perfusate Character!sties on 5tlmu.la.tion of Prostaglandin
Synthesis in Isolated lungs and Its Significance
When studying which stimuli release PGLS from isolated lungs most
investigators have used Krebs Singer solution (Palmer, Piper and Yane,
1973; Lindsey and Wyllie, 1970), or Krebs Ringer dextran (Said and
Yoshida, 1974) as perfusate. Also,>in cases where this is reported,
the flow rates used were very low, for example 8 ml/min in rat lungs
(Alabaster and Bakhle, 1970; 1976) or 5 ml/min in guinea-pig lungs
(Mathe and Levine, 1973). This may faclitate the detection of relative¬
ly low quantities of prostaglandin, although it nay be disadvantageous
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in that it could be insufficient to maintain the viability of the
lung preparation and cell damage may occur. The principal reason
for using such a low flow rate might be to delay the development
of oedema, and this could also account for the fact that most
investigators do not ventilate the lungs, although another reason
for not ventilating guinea-pig lungs is their high airway resis¬
tance (Table 1, Group B, experiments 15,16 and 17). Egan (1976)
has shown that the solute permeability of the alveolar epithelium
is a dynamic function of the inflation of the lungs. That is,
the calculated equivalent pore radius varied from 0.5 nm at low
levels of inflation to large leaks at high levels. Y/hen isolated
lungs are perfused over a long period of time, pulmonary oedema
develops spontaneously, the actual length of time varying between
lungs and depending on the type of perfusate used ( Nicolaysen,
1971a). Release of vasoactive substances into the perfusate may
contribute to this change in capillary permeability.
In the experiments of groups A-E ( Table 2) the effects
of various perfusates in oedema formation due to extended
perfusion were investigated in twelve isolated, ventilated
rabbit lungs. In two lungs perfused with Krebs Ringer solution,
oedema development was fairly rapid ( 15 min after the start of
perfusion). Despite perfusion of these lungs for up to 3-5 hr
( Table 2, Group B ) no tissue contractions were observed.
Apparently PGs are not released in the general pathological
decline in viability of the lungs during extended perfusion.
This suggests that PGs probably do not contribute to the non¬
specific damage causing oedema in isolated perfused lungs although
more direct studies, for example with synthesis inhibitors, would
be needed to prove this. Similarly, in horse plasma perfused
lungs ( Table 2, Group B) where plasma colloid osmotic pressure wa
approximately normal there was no release of PGs, although lungs w
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perfused until gross oedema, was observed (fig. 11).
Krebs Ringer Dextran solution has heen used as a perfusate in
isolated organs since the osmotic pressure closely approximates that
of plasma, and oedema formation is delayed. In three KRD perfused
lungs a spontaneous release of PGE-like substance was observed 100-
150 min after the start of perfusion (fig. 10). In one lung little
fluid filtration had occurred (3-6 g). Thus the release of PGs must
have been due to dextran, since a) oedema does not release PGs during
prolonged perfusion in plasma or Krebs Ringer perfused lungs, and b)
if oedema were the stimulus for PG release in KRD perfused lungs, it
would be difficult to account for release in lungs where very little
fluid filtration had taken place (3-6 g filtered in lung 1, Table 2).
Moreover, no PG release was seen in plasma or Krebs Ringer per¬
fused lungs during development of hydrostatic pulmonary oedema (Table 1
Groups A and B) while PG synthesis was stimulated during increased PLA
in KRD perfused lungs (Table 1, lungs 9> 10 and 19).
The addition of indonethacin to the perfusate (50-125 ng/ml)
abolished the gradual rise in tissue baselines, which occurred in the
KPD perfused lungs approximately 90-150 min after the start of perfus¬
ion, confirming that tissue activity was due to PG release (figs. 10
and 13). However, plasma perfused lungs did not release PGLS and
indonethacin added to the perfusate (fi§& 7 and 8) had no effect on
tissue tensions.
One very interesting finding in dextran perfused lungs was the
release of small amounts of FGLS (0.5 - 1 ng/ml)pabout 90 min alter
the start of perfusion?xo short lasting stimuli such as hyperinflation,
short periods of raised outflow pressure and of raised flow to the
lungs (figs. 10 and 13). None of these stimuli produced equivalent
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responses on the assay tissues when they were performed in plasma or
KR perfused lungs (fig. 11), which would suggest that dextran has a
facilitating- effect on PG synthesis in lungs. Interestingly Eynan,
Rennet, Joiner, Chapnick, llathe and Kadouitz (197^), and Hyman, ffiathe,
Spannalte and Kadowitz (197^) have reported enhanced PG synthetase
activity in dextran-perfused dog lungs.
Dextran has "been reported to release histamine from mast cells
3-5 min after exposure (Rowley and Benditt, 195&) and a similar dextran-
induced release of histamine occurs from lung tissue strips (Gryglewski,
Dembiska - Kiec, Grodzinska and Panczenko, 197&)• Ro reports have
"been published which show the time taken for dextran to release pro¬
staglandins, hut the responses seen here to hyperinflation and raised
vascular pressure were immediate (figs. 10 and 13) when the delay time
for the perfusate to reach the assay tissues is taken into account,
nevertheless, at least 90 mih lapsed from the start of perfusion
before the gradual release of PGLS was seen and it was only then that
raised pressure or hyperinflations stimulated release. , Similar
stimuli at the start of perfusion had no effect. It is tempting to
speculate that dextran must cross from the pulmonary exchange vessels
into the interstitial space before it can affect PG synthesis.
Accordingly, in the three pairs of KRB perfused lungs where outflow
pressure was raised and net outward fluid filtration enhanced, the
time taken to release PGs was less than in those lungs where perfusion
at normal vascular pressure was extended. Since the mean molecular
weight of Dextran T 70 is 70,000, its equilibration with interstitial
proteins may be slow.
Blocking either receptors alone, or In combination with
receptor block (but not H2 i^eceptor block alone) abolishes PG release
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(fig 12). Release still occurs in lungs perfused with KRD contain¬
ing H2 receptor blocker (fig. 13). The simplest explanation for this
would be that dextran causes histamine release with subsequent stim¬
ulation of the H^receptor which then leads to the synthesis and release
of PGs. Dextran might release both compounds from mast cells, but the
finding that PGs were not detectable during H^receptor blockade
is then difficult to explain. It would appear that PG release is
secondary to the release of histamine and its action on receptors.
Substantiating this are reports that histamine infusions cause PG
synthesis in isolated lungs ( Gryglewski et al, 1976; Leibig, fiernauer
and Peskar, 1974) and in lungs of intact animals (Yen, Mathe and
Dugan, 1976).
Mathe, Volicer and Puri (1974) reported that previous H receptor
blockade diminished the output of PGF2ac while H2 blocker pretreatment
decreased the liberation of PC-E2 but not PGF^ from lungs. In exper¬
iments using bioassay it is , of course, not possible to identify
conclusively either of these PGs. Also stimulation of PG synthesis
may lead to the release of a variety of intermediates and chemically
related compounds, for example endoperoxides and thromboxanes, and
these would also be active on the tissues (p.148). The PG pattern
detected, however, resembled PGE2 calibrations more closely than
PGF^although all release could be prevented by receptor blockade.
If the PG released during perfusion with dextran is predominantly
PGE , which is a vaso- and broncho-dilator in most species (Bergstrom,
Duner, von Euler, Pernow and Sjovall, 1959; Bergstrom, Carlson,
Ekelund and Oro, 1965; Carlson, Ekeluna and Oro, 1969; Rakano, 1973),
it will have the effect of lowering systemic blood pressure and may
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contribute to the hypotension observed when an anaphylactoid reaction
occurs during infusions of dextran in man (Lorenz et al, 1976). It
may also have a beneficial effect of improving the microcirculation
and tissue perfusion during infusions of dextran.
The Possible Significance of the PC- Release in Intact Animals
Infusion of arachidonic acid increases pulmonary vascular resis¬
tance in dog lungs in vivo, probably through conversion to the endoper-
oxides, PG-£*2oc anh is a more potent vasoconstrictor than
AA (1,000 times more potent; Hyiaan Bennet, Joiner et al, 1976).
Pulmonary bronchial infusion of PG?2k has been shown to increase lung
vascular resistance and decrease compliance (Gold, Lapierre, Levison,
Bryan and Orange, 1976). PC-E^ increases pulmonary arterial pressure
and vascular resistance in intact dog, swine and lamb lungs (Kadowitz,
Joiner and Hyman, 1975)» while in isolated lungs PGEj causes vasodilata¬
tion (Hauge, Lunde and Waaler, 1967).
Intermediates in the biosynthesis of prostaglandins possess much
greater biological activity than the natural prostaglandins. The
cyclic endoperoxides have a short half life; when endoperoxides, or
their stable analogues, are injected intravenously they are highly
potent pulmonary vaso- and broncho-constrictors (Kadowitz, Chapnick,
Joiner, Ilatthevs and Hyman, 1976; Wasserman, 1975). In fact, the
endoperoxides are probably the biologically active form of the pro¬
staglandins in the lung, and PGE2 and PG-P^. nav be the less active
metabolites. Indeed thromboxane Ap, an important product of PG-
conversion in t'~e lungs (Hanberg and Sanuelsson, 1974; Hamberg,
Svensson and Sanuelsson, 1976), is an even more potent broncho-con¬
strictor than PGH2 (Svensson, Strandberg, Tuvemo and Hamberg, 1977).
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Prostaglandins also have potent effects on airways, which nay he
very important if Pffs are released from lung tissue for example during
sympathetic stimulation. Injections of PGI'^ into pulmonary lobar
arteries increase airway resistance "by constricting airway smooth
muscle (Kadowitz, Joiner and Kyman, 1974). Hirose and Said (1971)
have injected PG-E^, F2cc and At into the jugular vein of anaethetized
dogs. caused vasoconstriction while PGB^ and A-j were vasodila-
tors. The PG-s were also active on the airways, PGFocc causing peri¬
pheral and central airway constriction. Similarly, Brazen and Austen
(1974) have measured an increase in respiratory resistance and a
decrease in compliance after i.v. infusion of PG-F^t histamine and
hradykinin in the unanaesthetized guinea-pig.
The sensitivity of the pulmonary vessels and airways to the pro¬
staglandins and the huge synthetic capacity of the lungs would suggest
that they play some regulatory role, perhaps in maintenance of the
ventilation perfusion ratio.
Prostaglandins and their intermediates also have potent cardio¬
vascular effects (Emerson, Jelks, Daugherty and Ilodgman, 1971? Rose
et al, 1976). Thus the function of the systemic and pulmonary
circulations and airway tonu.s may he directly altered by release of
PGLS and, indirectly, through modulation of function in the autonomic
nervous system.
Another possible consequence of the release of prostaglandins
from lungs during increased hydrostatic pressure and pulmonary con¬
gestion is their possible effect on the kidneys, PGE has been shown
to be a potent renal vasodilator and stimulator of natriuresis (McG-iff
and Itskovitz, 1973; Johnston, Herzog and Laulei> 1967? Martinez-
Maldonado, Tsaparas, Sknoyan and Sulci, 1972; Strandhoy, Ctt, Schneider,
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Willis,Beck, Davis and Knox, 1974) "by its direct effect on the kidney.
(Wander, 1968.) This would suggest a possible physiological role for
PUB released fron the lungs acting intra-renally to alter the sodium
and water "balance and alleviating pulmonary congestion.
Conclusion
In intact cats during increased pressure in the pulmonary circula¬
tion PS-like activity, measured in arterial blood by bioassay, is
elevated as long as the pressure is increased, or until indomethacin
is given. This indicates prostaglandin release, probably from the
lungs since PG-degrading capacity is not altered although extremely
high concentrations released systemically might have been detected.
However, release does not occur in isolated lung3 of cat, rabbit and
guinea-pig, when perfused with plasma, whole blood or Krebs Ringer
solution. Neither stretching of the vessels nor fluid filtration
cause release into the perfusate or the tracheal fluid of isolated
lungs. Release is dependent on the intact state of the animal and
is 'probably due to reflex sympathetic stimulation of the lungs when
vessels are stretched, or when systemic hypotension occurs. The
ability of dextran in the perfusate of isolated lungs to stimulate PG
synthetase whs shown and this ccu.ld be prevented by histamine (H^)
receptor blocker. PG release into arterial blood will influence
smooth muscle tone in both the pulmonary and systemic circulations.
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SECTION 1, PART 2. DISCUSSION AND VALIDITY"
OF RADIOIMMUNOASSAY OF PSFr
H1A has "been used extensively to measure PGF and PGE in vivo,
Ct '
especially in human plasma and serum (Caldwell, Burste.in, Brock and
Speroff, 1971» Jubiz, Frailey, Child and Bartholomew, 1972; Gutierrez-
Cemosek, I.Iorill and Levine, 1972) and the values published vary con¬
siderably. (200 pg/ml to 1.5 ng/ml for PGF^).
Samples for radioimmunoassay of PGF^ were extracted as described
and dissolved in Tris buffer. Several samples were purified on a
silicic acid column and the fraction containing PGF^ was collected.
These samples showed values of PU-F^ approximately 20(1. lower than those
obtained in samples not extracted on the column.
The specificity of the assay (i.e. of the antiserum to was
tested by assaying known concentrations of PG metabolites. The
results are shown in fig. 20 as the amount of unlabled compound needed
to displace 50fo of ^H-PGH^ from rabbit PGF^ antiserum. The antiserum
is equally specific to both PGF^ and hence the use of the general
term, PG^, while it is lOOx less specific for 15 keto 15-14 dihydro
PGP,., . All other PGs and metabolites have much loweraffinity for the
2oc
antiserum.
The high values reported here are not entirely due to the cross-
reaction of the antiserum with other non-specified compounds, since
this accounts for at most 2Cf, of the observed activity. However,
values as low as 2 pg/ml have been reported by Samuelsson, (1973) when
calculated from production rates measured by combined gas chromato¬
graphy and mass spectrometry. When urinary metabolites are measured
after i.v. administration of labled PGE and PGP, the true concentration
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of these PG-s may "be less than 20 pg/nl (Samuelsson, 1973). Also
other studies report values of 12-84 ngAal in nomal human plasna
(Jaffe, Berhman and Parker, 1973; Dray, Charbonnel and Kaclouf 1975).
This latter group, in a careful methodological study, have emphasized
the importance of chromatographic separation "before assay. Also a
large volume of miasma was used (10 ml) and care was taken to remove
all "blood cells, especially platelets which are a rich source of
prostaglandins. A combination of these factors may account for the
high values observed in the experiments reported here. However, the
values measured here may be correct, and the content of PG in perfusate of
isolated organs may well be higher than that in plasma of intact animals.
Since isolated, perfused lungs are capable of degrading over 9
of exogenous DGPg^ (Piper, Vane and byHie, 1970), the detection of up
to 3.4 na/ril in the perfusate during perfusion suggests that there is a
continuous output of PGF?^ from these lungs. Substantiating this is
the increase from 1.3^ to 3.28 ng/nl in the concentration of the 15-
keto 13-14 dihydro metabolite of PGI^ during 44 minutes of perfusion,
while the concentration of PGP fell over the sane period of tine ("fig.
18).
Hijkamp, lioncada, Ydiittle and Vane (1977) have reported a continu¬
ous basal release of ara-chidonate from sensitized Krebs Ringer-perfused
guinea-pig lungs, and Ferreira, Iloncada and Vane (1971; 1973) have
suggested that there is a "basal release of PGs from isolated kidney.
Similarly Kadowitz, Chapnick, Joiner and Hyman (1975) showed PG release
in isolated, perfused dog lungs. This nay be due to cell damage, or,
more likely, to the effect of handling the tissues on PG synthesis.
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SECTION 2. RJIjV.ONARY MICROaBOLISil /HP PG RE.jj3AS5
DISCUSSION
Type of Smooth Huscle Active Si7.~bstr.nces Released
In the present experiments, whenever a collagen infusion caused
transient increases in peak inspiratory pressure the assay tissues
RbA, RSS, RC and CR contracted. This would indicate a release of
PGLS (Piper and Vane, 1971) hut the "bioassay method does not enable
positive identification of any specific PG. It is unlikely that the
PGLS released were purely PC-S2 or PGP^x since standard doses could not
duplicate the responses after collagen infusion, and since contractions
of HbA were observed: this tissue is sensitive to TXA2 and to the PG
endoperoxides (p.150). Probably a variety of products in the convers¬
ion of arachidonic acid were released.
PG synthesis is "blocked by indomethacin (Vane, 19&9) and in 2 cats,
assay tissue activity was abolished after i.v. doses of indomethacin,
confirming that PG release had occurred. However, indomethacin has a
dual action in this situation. The aggregation of platelets is also
prevented when PG synthesis is inhibited (Hamberg and Sanuelsson, 1974),
since mediators produced from arachidonic acid are involved in collagen-
induced platelet aggregation. The formation of emboli will therefore
be prevented.
Other non-PG smooth muscle active substances nay have contributed
X
to the tissue activity observed. Tissues were not blocked against
bradykinin, and collagen is known to activate Hageman factor
(Niewiarowski, Bankowski and Regowiska, 1965), which in turn may act¬
ivate the kallikreih-kinin system (Cochrane, Revel:, Ruepper, Johnson,
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Morrison and Ulevitch, 1974). The resit lis obtained with the CJ as an
assay tissue demonstrated, however, that measurable amounts of kinins
did not reach the bioassay tissues (fig. 24) although kinins might
still have been generated during collagen infusions: bradykinin; with
a half like of less than 20 sec in blood (Ferreira and Vane, 1976b)
cou.ld have been inactivated before reaching the assay tissues and thus
have escaped detection.
The transient hypotention observed after collagen infusion might,
have activated the renin-angiotension system causing release of angio¬
tensin II. This could explain most of the contraction of the HC, and
thus the difference between the patterns of contractions, during ex
vivo and in vivo platelet aggregation (fig. 23). Therefore, although
angiotensin II and possibly bradykinin may have contributed slightly to
the tissue activity detected, the ma;'or part of the activity was due to
PGLS.
Site of Prostaglandin Systhesis
The present experiments allow no definite conclusion as regards the
origin of the PGLS released. Platelets are known to synthesize and
release PGs during their aggregation (Smith and "Jillis, 1970; Willis
et al, 1974). 'Then platelets were aggregated 'ex vivo' by infusing
collagen into the extracorporeal circulation PGLS were released from the
platelets, giving a pattern of tissue activity not very different from
that during in vivo aggregation. Apparently PG release from platelets
is sufficient to account for the observed tissue responses without having
to postulate any release from the lung itself. However, the concentra¬
tion of collagen infused over the tissues was four times greater than
that given in vivo to produce the same contractions. Some PG release
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from the lung tissue itself, possibly stimulated "by the presence of
microemboli lodged in snail vessels, cannot be excluded.
On the other hand, rhen platelet aggregates are trapped in the
pulnonary microcirculation their release of PGs probably takes place
close to reactive smooth muscle cells. In the immediate vicinity of
the aggregated platelets and pulmonary smooth muscle cells, the con¬
centration of PGs is probably higher than in mixed blood -from the lungs.
The PG—like activity in arterial blood might also be reduced by
pulmonary inactivation of the PGs released (Ferreira and Vane, 1967a),
and the -activity detected in the tissues after i.v. doses may have been
mainly dueto metabolites. A.direct comparison of the two collagen
doses can therefore not be made.
Evidence from non-biological embolisation of isolated lungs per¬
fused -,7ith blood free medium shoos that PG release from lung tissue
occurs at least occasionally (Palmer, Piper and vane, 1973). Houever,
pulmonary microembolisn in platelet free animals caused only veak pul¬
monary responses (Bp,h ognestad and Vaage , 1974).
It trould seem that platelets are the likely source of PGs in the
experiments reported here possibly vrith some additional PG release from
the lungs.
• --"hj
The Relationship Between PG Release, Platelet Aggregation and Ling
Responses
Badegran, et al (1977") have shorn by radioimmunoassay techniques
that PGF^. is released during prothrombin, and thronbin-induced platelet
aggregation in dogs. PG activity in blood is increased during intra¬
vascular platelet aggregation (Radegran, 1971; Vaage and Piper, 1975)
and PGs have been suggested as possible mediators of the lung responses.
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In the present experiments PGLS were detected only whenever lung
responses were elicited. "No PG release occurred when lung responses
and platelet* aggregation were "exhausted" "by repeated collagen
infusions. Undoubtedly a relationship exists between the release of
PGLS and the lung responses to platelet aggregation. Whether the
PGLS caused the lung response has not been ascertained. Several
factors suggest that PGLS, in the amounts detected, could have caused
the pulmonary broncho- end vaso-constriction. Some of the PGLS (for
example PGP?<y , thePG endoperoxides and TxA^) formed during the conversion
of AA are smooth muscle constrictors in the lung (Kadowitz, Joiner and
Hyman, 1975? Kadowitz, Chapnick, Joiner and Hyman, 1976) and there is
pulmonary vasoconstriction during infusion of AA into isolated lungs
(Wicks, Rose, Johnson, Ramwell and Kot, 1976). Although in the present
experiments only low concentrations of PGs were detected in blood
leaving the lungs, concentrations in the immediate vicinity of the
trapped platelet aggregates may have been much higher, and capable of
causing constriction of the surrounding vascular and bronchial smooth
muscle; and some may also have been degraded before reaching the
mixed pulmonary venous blood. It is reasonable to suggest a causal
relationship between the PGLS and the lung responses observed, although
there is no direct evidence for this from these data.
During the platelet aggregation and release reaction other active
substances are discharged which may contribute to smooth muscle con¬
striction (Kobayashi, liashino, Herther and Didishein, 1974). Among
the substances released from platelets are adenine nucleotides, serotonin
and histamine. Experiments using pharmacological blockers have shown
that serotonin and histamine contribute to the pulmonary effects of
induced intravascular platelet aggregation (Radegran, 1971;
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Swederiborg, 1971? Hageman, Gentling and Pruss, 1973) •
Tucker, Weir, Reeves and G-rover (.1976) suggested that prostagland¬
ins are the primary if not the sole mediators of the airway responses
they observed to microembolism. They have shown that the increased
pulmonary vascular resistance caused by particulate microembolism is
attenuated but not abolished by combined PU and histamine blockade,
while the alveolar hypoventilation observed was mediated by prosta¬
glandins alone.
There is some disagreement as to whether ADP and ATP are vaso¬
constrictor or vasodilator (Hauge, Lunde and Waaler, 1966, Swedenborg,
1971; Taage, Bj6 and Hognestad, 1974). It is unlikely, therefore,
that adenine nucleotides, serotonin and histamine could be the
principle mediators of the lung effects reported here, although they
may have contributed to them.
Conclusion
Intravascular platelet aggregation due to collagen infusion in
intact cats is accompanied by PG- synthesis and release whenever platelet
aggregation and pulmonary vaso- and broncho-constriction occur. It is
likely that the various substances formed during conversion of AA to
PGs produced the assay tissue responses observed. Release of these
substances, either from platelets, lung tissue, or both, is probably
sufficient to explain the pulmonary smooth mu.sele constriction, although
the Involvement of additional vasoactive substances cannot be excluded.
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SECTION 3. HYDROSTATIC PULMONARY OEDEMA AND CHANGES IN LUNG
COMPLIANCE
DISCUSSION
Validation of the methods used;
1. Fixation Procedures
Both the fixation procedures used produced good results
for light microscopy. However, for the present purpose, the
epon-emhedding method was less useful than the paraffin-
embedding method of the rapidly-frozen lungs, in that the former
gave blocks of a very much smaller size for sectioning and many
blocks had to be sampled. The osmium penetration into the tissue
and the cutting of epon limits block size (Hayat, 1970). On
the other hand, fig. 27 ( cross section of a block from the
lower lobe of one experiment ) shows the area v/hich is seen in a
paraffin section. Usually 2 or more blocks were made from each
experiment, and thence sliced to ensure that large areas were
viewed and sampling was representative.
Gravity has a profound effect on the pulmonary circulation
(West, 197°). West has proposed a division of the lungs into
3 functional zones dependent on the effective circulatory
pressures. At the apex of the upright lung ventilation
exceeds perfusion since the hydrostatic pressure is inadequate
to force the blood so high (Zone 1). At the base of the lungs
perfusion exceeds ventilation (Zone 3). Between these zones,
ventilation and perfusion are relatively well matched (Zone 2).
The major part of the normal lung lies in this zone. However,
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elevating P^A means that more of the lungs are under Zone 3
conditions. This uneven distribution of oedema will affect
the distribution of blood flow and ventilation, causing arterial
hypoxemia under clinical conditions.
Lungs showed a marked vertical gradient of pulmonary
oedema. This was noted both for interstitial oedema, since
the pulmonary interstitium is a contiautua and for alveolar
oedema, which was greatest in the dependent part of the lungs.
Because of this, care was taken to examine sections from both
middle and lower lobes in all experiments. In addition, in
glutaraldehyde perfused-fixed lungs sections from the upper
lobes were also examined, although this was not possible in
rapidly frozen lungs.
2. Light Microscopy and the Point Counting Methods
i) Light Microscopy (LM):
Both perfusion- and rapid freezing-fixed lungs showed
good preservation of tissue structure for LM, although this
was very much better in perfusion-fixed lungs. In fact, samples
from lungs fixed by glutaraldehyde perfusion also showed
preservation of normal lung structure on electron microscopic
examination (unreported observations). Although this was not
so for freeze-fixed lungs, in the present experiments they
\
had a greater advantage: the freezing procedure is rapid,
and mechanical changes in the living lung are stopped in 0-10
sec (Staub and Storey, 1So2). This is important when studying
oedema, since delays in the prefusion fixation method, perhaps
coupled with changes in the intravascular osmotic pressure,
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might alter the fluid balance and create artifacts.
With rapid freezing, true tissue dimensions are preserved to
at least 0.4 cm below the pleural surface (Kulka, 1961). Although
much deeper areas were examined in the experiments reported here,
this was considered valid since no actual measurments were made.
Only the ratios of filled to non-filled alveoli and of interstitial
cuff to vessel or bronchial lumen were of interest. In fact,
since the area of interest for the quantification of interstitial
oedema was the loose connective tissue round the extra-alveolar
conducting vessels and the airways, it was necessary to examine
areas remote from the pleura.
One important observation made by Staub, Nagano and Pearce
(1967) is that alveolar flooding is an all or nothing phenomenon
- that is, no partly-filled alveoli are seen. I did not confirm
this observation. In fact, partial flooding was a fairly
frequent occurrence, with a concave meniscus seen at the entrance
to the alveolus (figs 39, 43 and 44). Also gas trapping was
seen (fig 40). I suggest this was due to the positive pressure
method of ventilation used here, which may hold open alveolar
sacs.
No conclusions can be drawn as to where the fluid filtration
which caused the alveolar flooding took place. It may be as
Iliff(1971) has claimed, that not only does it occur in the
so-called exchange vessels (capillaries) but also in large
extra-alveolar vessels.
ii) The Point-Counting Method:
a) experiments fixed by vascular perfusion
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In this preliminary series of experiments an attempt was made
to quantify alveolar oedema by counting the number of filled
and non-filled alveoli observed in each field viewed under
the light microscope. The number of filled alveoli was expressed
as a percentage of the total number of alveoli counted (Table 7a).
A little alveolar flooding was observed in experiments where no
secondary fall in CT had occurred. Since this might have beenJj
caused by the fixation method itself, or the results may have
been biased by insufficient sampling the freeze fixation method
was developed for use in the next set of experiments.
b) experiments fixed by rapid freezing
Any method using counts and/or measurements of structures
in histological sections has errors in it, some of which can
be predicted and to a certain extent corrected for (Weibel,
1963). The simplified method of Caldini, Leith and Brennan
(1975), adapted to this project, involved calculating only
the ratio of two structures. It was therefore considered
unnecessary to correct for section thickness. It also obviated
the necessity of calculating the tissue volume fraction, if
a structure were to be quantified. However, it is recognized
that filled alveoli occupy a smaller volume than do non-filled
ones (Staub, Nagano and Pearce, 1967; also see figs 39-44).
The ratio of filled to non-filled alveoli, and thus the percentage
of alveolar flooding (Table 7b and fig 48) would be slightly
underestimated, although this error would be small and was
not considered to affect the conclusions of the study. The
results from the point counting method in these experiments
agree fairly well with those calculated for perfused fixed lungs,




Pulmonary oedema and, changes in lung compliance
The results of these experiments confirm those of Hauge,
Bo and Waaler that raising P , caused an initial steep fall inLA
CT. The reported effect of raising P is to increase intra-L LA
vascular volume (Lunde and Waaler, 1969) without increasing
extravascular water as measured by the indicator dilution
technique (English, Digerness, Kirklin and Karp, 1971). This
lowered C . Possibly, as Prank (1959) has shown, this is dueL
to a competition for space between blood and gas, reducing
functional residual capacity or the volume of terminal airways.
The competition may be at the site of alveolar capillaries
and venules.
When P_ was raised in my experiments, there was almost a
doubling of preparation weight. The increase was certainly
due in the main to increases in intravascular volume of the
preparation. In preparations where PT, had been raised,LA
capillary lumens were visibly distended compared to controls.
While some interstitial fluid was observed in all preparations
where capillary filtration had occurred, especially in distended
lymphatics, no interstitial distension could have accounted
for the large increase in volume. Also, in some preliminary
experiments it was noted that returning the elevated P to
LA
zero at any time before the secondary decrease in CT resulted
^ L
in a rapid rise (within 10 sec) of C to control levels. This
suggests decreased intravascular volume and not resorbtion of
interstitial fluid caused the return of CT, since interstitial
fluid resorbtion is a slow process.
The results of quantifying interstitial oedema (Table 8)
are hard to explain. There is no correlation between increases
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in lung weight and the amount of interstitial oedema. The
most probable reason for this is that insufficient areas were
viewed and counted. Qualitatively, however, the light
microscope pictures showed that periarterial and peribronchial
interstitial compartments wrere capable of large distension.
The secondary fall in CT, shown as an increase in P inJj 1 Jr
fig 48, coincided in this preparation with an increased weight
of 9-12g. The fall be.gan gradually, then accelerated. An
increase in PmT1 of 10% of the P(nT, val„e measured immediately1 Jr Ir
after the rise in P was accepted as proof of this fall havingliA
taken place. Two experiments, 21 and 22, showed a clear increase
in P (20 and 45%) and marked alveolar oedema. Of more interest
were the results from lungs fixed at a weight gain of 8-12g.
All showed about 10% of alveoli were filled. These were lungs
fixed at the start of the secondary decrease in CT.JLi
Perhaps one surprising finding was that in lungs fixed after
only small weight gains (4-5g in experiments 4,5 and 10) there
was alveolar oedema. This is not easy to explain. It does
not necessarily mean that the sequence of fluid accumulation
in oedema outlined by Staub, Nagano and Pearce (1967) did not
happen here for one or more of the following reasons:
i. not enough points were counted. This is unlikely since
in one experiment (21) where there was considerable alveolar
y
flooding it was calculated that the counting of about 2000
points (overlying alveoli) was enough to give a reliable result,
since the result did not change when more points ( up to 6000)
were counted.
ii. the sampling method in these lungs could have been
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biased towards the dependent areas. This is probably true. In
fact, it was impossible to sample from the upper lobes which
were damaged by the clamping and freezing procedure. Also
this distorted the lung shape and it was often difficult to
locate precisely the area I wanted to sample. A bias towards
dependent areas in rapidly frozen fixed lungs may account for
the observation that flooding, although present , was less in
perfusion-fixed lungs at comparable weight increases, where it
was easier to define sampling areas.
iii. the alveolar oedema may be an artifact. For example,
atelectatic areas could have been incorrectly scored as "filled
alveoli". Also, since lungs were fixed in end expiration,
alveolar volume was small, and it was occasionally difficult
to distinguish between filled and non-filled alveoli. It is
unlikely that this caused too large an error since many sections
were counted and, when uncertainty arose, the area or point
was simply not scored. However, some errors were probably
made.
iv. since isolated lungs have no intact lymphatic drainage,
and this is an important mechanism of oedema prevention, this
may have affected the oedema formation in these preparations.
Nevertheless, an interesting point to note is that huge fluid-
filled lymphatic vessels were seen in many sections in the
\
perivascular interstitium (figs 49-51,56 and 57), which shows
that lymphatics were at least capable of being filled, and
perhaps of passively draining fluid filtered from the isolated
lungs.
v. damage to these particular lungs may have caused alveolar
flooding. A single step elevation in this preparation to 15
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or 20 inmHg may be too high. It could have caused too severe a
distension of the vascular bed and focal haemorrhages could have
occurred in the dependent areas.
A combination of these factors may account for the alveolar
flooding in experiments 4,5 and 10, since no single factor can
be completely responsible. It is probably true to say that a
small amount of alveolar flooding took place before the secondary
decrease in CT was measurable-, although the values in Table 7bli
may be an overestimate.
Relevance to the Clinical Situation
This was an experimental method of inducing acute pulmonary
oedema in normal lungs. It can not be compared with the more
chronic pulmonary congestion which is encountered clinically,
especially during prolonged mechanical ventilation, and which
may alter the mechanical behaviour of the lungs. Also, during
acute respiratory failure (or the wet lung syndrome) there are
diffuse changes in the pulmonary vasculature causing increased
capillary permeability and the loss of plasma into the inter¬
stitial space. This is certainly not analagous to the experimental
situation reported here and may be more easily reproduced by
agents which alter vascular permeability.
The time course of my experiments was fairly short, lasting
\
at most 2 hours since controlled induction of hydrostatic oedema
was the aim. Moreover, as has been discussed in section 1 parti,
during prolonged perfusion isolated lungs undergo changes from
which oedema develops spontaneously. This may explain the
apparently conflicting results of Reith et al (1972) , where
the experimental timecourse was longer and where, after relief
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of venous congestion in isolated dog lungs a further one
hour of perfusion took place before microscopic examination of
the preparation was made, at v/hich time there was clear evidence
of interstitial oedema
Conclusions
A primary fall in CT (increase in P ) was observed andi, Tp
correlated with increased intravascular volume in isolated lungs,
although some interstitial oedema was observed in all lungs
where had been raised. Weight gains of up to 10-12g produced
considerable interstitial oedema and small amounts of alveolar
flooding, while CT remained constant or fell very gradually.
XI
At larger weight gains (15-18g) lungs showed marked alveolar
flooding and a clear decrease in CT . However, the start ofli
the secondary decrease in CT (at an increase in P of 10-159°)Jj IX
was not clearly defined. It could not be exactly correlated
with the start of alveolar flooding, as the latter was seen in
certain preparations before the decrease in C was observed.
XI
Nevertheless, it did correlate with a greatly accelerated rate




It would be of great interest to discover the exact nature of
the PG-like substances released during the elevation of in
the intact animal experiments. More specific methods than the
bioassay used here would be necessary. For example, development
of the radioimmunoassay method outlined in Section 1.2. Two
very important questions could then be answered. Firstly, the
exact cause of the PG release when PT. is raised could be iden-LA
tified ( e.g. reflex sympathetic stimulation due to decreased
systemic blood pressure? ). Ganglion blocking drugs would be
useful tools here. Also the effects of the release on the lungs
themselves and on the systemic circulation, especially the kidney,
could be examined using, for example, techniques to measure
natriuresis. Are the PGs, in the amounts released, sufficient
to cause the postulated effects on the kidneys?
Another important point arising from this work would be to exam¬
ine further the mechanisms by which dextran releases PGs and the
involvement of the histamine receptors.
In seqtion 2 the role of PGs as mediators of vascular and airway
constrictor responses to microembolism was not proved, since
indomethacin prevents platelet aggregation itself. Possibly
similar experiments with ADP-induced platelet aggregation could
subatantiate these results. Also selective inhibition of TxA^
(by 5HIAA) would be interesting. However, the exact nature of the
released PGs should be examined, for example by RIA.
The experiments in Section 3 raise very many interesting questions.
The most important one is the nature of the decay of the preparation
during prolonged perfusion, which occurs even when the perfusate
is iso-osmotic with plasma. Although this has already been
extensively examined, it has not been answered, and relates to the




Krebs Ringer solution (KR).
Composition (mM) : NaCl 118.65, KC1 4.64, CaCl 2.51, KH?P04
1.183, MgS04 1.184, NaHCO 24.64 and glucose 5g/l.
Horse plasma was obtained by centrifuging heparinized (30IU/ml)
whole blood at 1000xg for 10 min. Plasma was filtered before
use.
Cat 'whole blood was obtained by cardiac puncture of anaesthetized
cats which had been given heparin (500IU/kg)i.v. 1000 un;Lts of
heparin was added to each 100 ml blood.
Krebs Ringer Dextran solution (KRj) was made by dissolving 27 g/1
of Dextran T70 (mol. wt. 70,000) in Krebs Ringer solution. The
osmolarity varied between 260 and 285 mOsrru
Measurement, of pH. The pH of the perfusate, or of cat blood>was
measured at intervals throughout each experiment (Acid-Base
Analyzer PHM71, Radiometer, Copenhagen, Denmark).
Measurement of Osmolarity. Osmolarity of the perfusates used
was measured before and at intervals during the experiments using
an Advanced Digimatic Osmometer, Advanced Instruments Inc., Needham
Heights, Mass., USA. The osmolarity of plasma in intact cats
remained between 320-328 mOsm/kg throughout each experiment.
Measurement of Hematocrit. Hematocrit measurements in intact
cats gave values of 0.27-0.35 at the start of the experiments.
Throughout the experiments a progressive reduction to values
ranging from 0.15-0,28 was observed.
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Force Transducer, A Sanborn FTA-100-1 force transducer was used
for the measurement of changes in weight of the isolated lung
preparation, A counterbalance of 50g was suspended and connected
to the transducer by means of a catgut thread over a minimum
friction two-wheeled pulley.
Pressure Transducer. P„., P„, and P, , were recorded with StathamPA' FA LA
P23D6 pressure transducers. P^. was measured by a differential
pressure transducer.
Recorders. Weight changes were amplified and recorded on a 2-
channel Hewlett Packard Oscillograph recorder ( model 700 2A ).
Full scale deflection was 5g. Pulmonary tracheal pressure was
also recorded, full scale deflection usually 10 cmH^O.
P_, and P_. and assay tissue tensions were recorded on an 8-FA LA °
channel Grass Polygraph model 7R.
Recording of bioassay tissue contractions. Tissue contractigns
were recorded isometrically by transducers made in the mechanical
workshop of the Preclinical Medical Institute of the University
of Oslo, Norway. Transducer design is shown in figs. 3 and 4.
The element was protected against light by a metal box. With
full scale sensitivity not less than 0.4g no instability, drifting
(in 4 hr.) or non-linearity of the transducers was observed.
The semiconductor transducer elements (AE 801-803) were obtained
from A/S Microelectronikk, 3191 Horten, Norway.
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Blood Donors. Cats weighing 1.5-2.5 kg. were used as blood donors
in intact cat bioassay experiments. They were anaesthetized
(r)
with 30-40 mg/kg Nembutal" ( Sodium Pentobarbitone ) i.p. and
given 500 I.U./kg heparin "Novo" i.v. Blood was withdrawn
by cardiac puncture and 1000 I.U. heparin/ 100 ml blood was added.
Drug Infusions. Drugs were infused to the intact cats by a
constant volume infusion pump, model 747, Harvard Apparatus Co.,
Mikis, Mass., USA.
Monitoring of blood flow (intact cats ). Pulsatile and mean
CO were recorded by a Nycotron square wave flow meter ( type
372, Nycotron A/S, Norway).
Epon Embedding.






NMA, DDSA and Epon were mixed thoroughly for 15 min, then DMP 30
was added and mixing continued for a further 15 min.
A slightly modified epon mixture was used for embedding of
freeze-dried tissue. The proportion of NMA to DDSA was decreased
to soften the plastic slightly and make a suitable embedding
mixture for these samples.
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These compounds were mixed as before.
Sj^rensens Phosphate Buffer (0.1M).
Solution A NaHgPO^ . H20 27.6 g/1 distilled water
Solution B Na2HP0^ . 12 H20 71.6 g/1 distilled water









19.0 ml solution A + 81.0 ml solution B diluted to 200 ml with
distilled water gives a buffer of molarity 0.1 M and pH=7.4.
(Hayat, 1970).
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1.7% Glutaraldehyde in Sprensens Phosphate buffer ( 0.03 M).
160 ml 0.1 M Sprensens phosphate buffer
14 ml 25% glutaraldehyde
26 ml distilled water
200 ml 1.7% Glutaraldehyde buffer solution.
pH=7.35
3% Glutataldehyde in Sorensens Phosphate buffer.
160 ml 0.1 M Sprensens Phosphate buffer
24 ml 25% glutaraldehyde
16 ml distilled water
100 ml 3% Glutaraldehyde buffer solution.
Tyrode
Solution A : 8.0 g NaCl
0.2 g KC1
0.05g NaH2P04 .H20
1.0 g glucose . H20
Dissolved in 300 ml dist. water.
Solution B : 0.6 g CaCl2
0.3 g MgCl2 . 6 H20
Dissolved in 3G0 ml dist. water.
Solution C : 1.0 g NaHCO^ in 10Q ml dist. H20.
Pinal Tyrode solution :
9 parts solution (A+B) + 1 part solution C + 10 parts dist. water i.e.
22.5 ml solution A
22.5 ml solution B
5.0 ml solution C
50.0 ml dist. water
100.0 ml Tyrode solution
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Tyrode pH = 7.47
Osmolarity = 210m0sm.
Ion concentrations in all solutions v/ere checked by a flame
photometer. pH and osmolarity were always measured.
Substances used.
Nembutal. Sodium pentobarbitone stock solution was 60 mg/ml.
In anaesthesia•for lung donor animals a 1:2 dilution in saline
was used.
Prostaglandins and Fpco * These were kindly supplied by Dr.
J. Pike of the Upjohn Co., Kalamazoo, Mich., USA. Stock solut¬
ions of PG were made up in 100% ethanol and stored at ~20°C.
Calibrating solutions v/ere made up daily in isotonic saline.
Metiamide. N-Methyl-U2- ( 5-nie.thylimidazol-4-yl) methyl thiolj
ethyl thiourea v/as dissolved in 1.0N HC1 and the pH returned
to 6.0 by the addition of 0.1N NaOH and water. Further dilutions
were made v/ith saline. Metiamide was a generous gift from Dr.
Owen, Smith Kline and French Ltd., Welwyn Garden City, Herts,
England.
Bradykinin, Sandoz.










"Macrodex" -6$, Pharmacia, Sweden
Heparin "novo"
Papaverine sulphate
Paraplast. Sherwood Medical Industries, St. Louis, Mass. 63103,
USA.
Dammer Xylene , Searle Ltd.
Epon 812, DDSA, NMA and DMP-30 were obtained from Ladd Industries.
"Epon" was stored in batches of approximately 20 ml in the deep
freezer at -20°C.
DDSA, dodencenyl succinic anhydride
RMA, nadin methyl anhydride
DMP-30, 2,4,6-tri-(dimethyl aminomethyl) phenol
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